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ABSTRACT 
In modern drug discovery, lead discovery is a term used to describe the overall process 
from hit discovery to lead optimisation, with the goal being to identify drug candidates. 
This can be greatly facilitated by the use of computer-aided (or in silico) techniques, 
which can reduce experimentation costs along the drug discovery pipeline. The range of 
relevant techniques include: molecular modelling to obtain structural information, 
molecular dynamics (which will be covered in Chapter 2), activity or property prediction 
by means of quantitative structure activity/property relationship models (QSAR/QSPR), 
where machine learning techniques are introduced (to be covered in Chapter 1) and 
quantum chemistry, used to explain chemical structure, properties and reactivity.  
This thesis is divided into five parts. Chapter 1 starts with an outline of the early stages 
of drug discovery; introducing the use of virtual screening for hit and lead identification. 
Such approaches may roughly be divided into structure-based (docking, by far the most 
often referred to) and ligand-based, leading to a set of promising compounds for further 
evaluation. Then, the use of machine learning techniques, the issue of which will be 
frequently encountered, followed by a brief review of the "no free lunch" theorem, that 
describes how no learning algorithm can perform optimally on all problems. This 
implies that validation of predictive accuracy in multiple models is required for optimal 
model selection. As the dimensionality of the feature space increases, the issue referred 
to as "the curse of dimensionality" becomes a challenge. In closing, the last sections 
focus on supervised classification Random Forests. Computer-based analyses are an 
integral part of drug discovery. 
Chapter 2 begins with discussions of molecular docking; including strategies 
incorporating protein flexibility at global and local levels, then a specific focus on an 
automated docking program – AutoDock, which uses a Lamarckian genetic algorithm 
and empirical binding free energy function. In the second part of the chapter, a brief 
introduction of molecular dynamics will be given. 
Chapter 3 describes how we constructed a dataset of known binding sites with co-
crystallised ligands, used to extract features characterising the structural and chemical 
properties of the binding pocket. A machine learning algorithm was adopted to create a 
three-way predictive model, capable of assigning each case to one of the classes (regular, 
orthosteric and allosteric) for in silico selection of allosteric sites, and by a feature 
selection algorithm (Gini) to rationalize the selection of important descriptors, most 
influential in classifying the binding pockets. 
  
In Chapter 4, we made use of structure-based virtual screening, and we focused on 
docking a fluorescent sensor to a non-canonical DNA quadruplex structure. The 
preferred binding poses, binding site, and the interactions are scored, followed by 
application of an ONIOM model to re-score the binding poses of some DNA-ligand 
complexes, focusing on only the best pose (with the lowest binding energy) from 
AutoDock. The use of a pre-generated conformational ensemble using MD to account for 
the receptors' flexibility followed by docking methods are termed “relaxed complex” 
schemes. 
Chapter 5 concerns the BLUF domain photocycle. We will be focused on conformational 
preference of some critical residues in the flavin binding site after a charge 
redistribution has been introduced. This work provides another activation model to 
address controversial features of the BLUF domain. 
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CHAPTER 1. Theory of Chemoinformatics Methods 
Computer-aided drug design (CADD) is a relatively time saving yet cost effective 
procedure. This is the term generally referring to the use of computational tools and 
resources that help identify potential lead candidates in the drug discovery process. At 
the early stage of drug discovery, an ensemble of computer-based methods known as 
virtual (compound) screening (VS) methods, also referred to as in-silico screening, are 
emerging as an efficient approach to screen large compound databases. These methods 
aim to identify compounds with a higher probability of binding to a given target, 
analogously to the role of high-throughput screening (HTS) in experiments. [1] Later in 
the drug discovery process, different VS methods are developed as a means to narrow 
down the size of databases or libraries to be screened for hits or leads, such as to discard 
compounds which are not drug-like (i.e. do not adhere to measures such as Lipinski’s 
Rule of Five) and those that are likely to have poor ADME (absorption, distribution, 
metabolism and excretion) and toxicity properties, thereby reducing the cost of in vitro 
research for synthesis or assays. In general, VS methods have been shown to help in 
three ways: a) to identify new active compounds as chemical starting points, b) to 
improve the molecules as leads and c) as a filtering method used to prioritise 
compounds throughout the lead optimisation process. [2]  
 
1.1 Drug discovery 
A potential drug candidate is obtained via a costly and time consuming multi-step 
process (Figure 1), starting from target identification and validation, where validation 
refers to the process of identifying a molecular target with therapeutic benefit. The 
primary goal of this step is to identify targets that are druggable, to which small 
molecules or biologic therapeutics (e.g. antibodies known to block protein-protein 
interactions) can bind and induce a biological response. This is where data mining 
comes into the picture. One relatively cost-effective way to do this is by making use of 
genomics in combination with bioinformatics approaches [3,4] mining available sources 
from publications, patent data, clinical research and gene expression data etc. This 
identification process also helps to uncover genes whose expression is correlated with 
disease progression. Using genome sequences to identify genes responsible for coding 
target proteins allows prioritisation of the most promising potential targets, or 
identification of any genetic associations, polymorphism, or mutations making a person 
more susceptible to the disease or to the disease progression. In addition, bioinformatics 
is further used in the process of validating the putative target as relevant to treatment of 
2 
 
the disease. [5] Traditionally, the process of target validation has relied on a multi-
validation of in vitro and animal model approaches, antisense oligonucleotides which 
reversibly bind to target mRNA by inhibiting the synthesis of the target protein [6], 
antibodies or transgenic animals to confirm a phenotypic response due to lack of a given 
gene. [7] 
Target identification and validation have given rise to the term chemical genomics (or 
chemogenomics) [8], where the aim is to extend chemical genetics to the genomic scale. 
By analogy to classical genetics, chemical genomics uses small molecules (‘chemical’) to 
elucidate biological processes in which its effects are equivalent to mutations in classical 
genetics. [9] In practice, chemical genomics often focuses on a class of protein targets, 
allowing screenings to be performed in parallel. In “reverse” chemical genomics, 
libraries of small molecules are tested for their ability to specifically modulate a target of 
interest (from protein to phenotype), akin to the high-throughput screening (HTS) 
process (covered in the next paragraph), and thereby knowledge gained from 
informatics and data mining tools will help to identify tool molecules that can be used to 
validate the therapeutic hypothesis of a given drug target during the target validation 
process. In contrast to “forward” chemical genomics, the active compounds that produce 
a desired phenotypic change are identified from screening of any pool of compounds so 
as to discover a target (from phenotype to protein) in which no prior knowledge of the 
target is assumed. [10]  
Once a validated target has been chosen, the next step involves compound screening 
using either in vitro or in silico based methods to identify "hits" in a screen of a library 
for compounds having the desired activity at the target of interest. In vitro assays are 
either done with a biochemical or cell-based assay based upon agreed selection criteria. 
A miniaturised and automated process, high throughput screening (HTS), has been 
employed since the 1980s [2] at the hit discovery stage, whereby large numbers of 
compounds are assayed against the target in a time-efficient manner. Focused or 
knowledge-based screening [11] is commonly adopted when the knowledge of the target 
structure and the binding site location from literature, from the constructed 
pharmacophores, molecular modelling, or from patent precedents is available to be used 
as the basis for a smaller subset consisting of compounds having desired chemical 
features. [12] There are other compound screens, such as fragment screening which uses 
libraries of smaller compounds or fragments, and tissue-based screens which look for 
desired in vivo effects, etc. 
Often, the whole screening process can be broken down into two stages: 1) the primary 
screen, in which the activities of compounds are measured at a single concentration 
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(single-dose screen) to yield "primary hits", and 2) the secondary screen, where the 
most active compounds are re-tested to confirm their activity. This activity can be 
further confirmed in follow-up screens. [13] High-throughput screening methods have a 
certain rate of false positive and false negative results occurring for a number of reasons: 
the causes of poor solubility (compound precipitation in aqueous media), low purity, 
incorrect compound concentration, fluctuations in environmental factors or other 
experimental errors. False positives can generally be recognised by the follow up 
confirmation tests. However, false negatives, which occur when active compounds are 
detected as inactive, may remain undetected. [14,15] 
 
Figure 1 - Early stages of lead discovery.  
The resulting hits found through virtual screening or high-throughput screening will 
need to be refined and prioritised. Clustering based on structural similarity is frequently 
applied throughout the process to ensure that compounds of diverse chemical classes 
are selected for consequent follow-up studies. Thereafter, compounds are analysed as 
groups, which could later form the basis of a lead series of compounds which share 
similar properties. Further studies are conducted to assess dose-response for each 
chemical, to identify chemicals with desired competitive behaviour. The assay is 
conducted for each compound at multiple concentrations and then plotted against the 
resulting percent inhibition, from which the concentration required for 50% inhibition 
can be determined, giving the IC50 value as a measure of potency for each candidate 
compound. At this stage, the representatives of each cluster are characterised for 
physicochemical properties (logP, pKa, solubility etc), ADME and pharmacokinetics (PK) 
using various in vitro assays, and checked for selectivity to other related targets using 
cross screening techniques to reduce off-target effects. [16] Tissue- or cell-based models 
are used to look at the functional response exerted by the compounds in more intact 
systems, however such an approach does not really replicate the true physiological 
environment and thus has its limitations. [17] At the end of this process, the most 
promising series are selected for further studies. 
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The compounds in a hit series appear to have different potencies due to different 
chemical groups attached to the core compound structure; these are used to derive 
structure-activity relationships (SAR) which can be used to identify substructures that 
may contribute to the activities. From a practical point of view, this step includes 
assessing whether compound series can be synthesised in parallel and thus allow a 
diverse set to be generated. Confirmed hits with biological activity predicted from a 
preconstructed SAR are termed "leads", from which researchers hope eventually to 
develop drug candidates. Following hit identification, this stage of the drug development 
process is known as "hit-to-lead", with the goal being to optimise the hits to yield 
compounds with improved potency and selectivity. [15] Leads are compounds that, in 
addition to their promising activity, should have the potential to be further developed 
from their relatively simple features, belong to a well-defined SAR series, possess the 
desired ADME properties, and have the potential to be patented. [20] 
Studies of SAR are useful to establish biological activity for each hit and to determine 
potential structural modifications of a lead to increase its potency and selectivity. The 
purpose of SAR is to relate structural changes to changes in biological activity. Screening 
a higher number of compounds might help to identify structural features associated with 
certain properties. Structure-based drug design techniques and methodologies to gain 
structural information of the targets are able to facilitate the process of establishing 
SARs. Screening at this stage provides reports on the activity of the compounds and 
target selectivity profile which address the efficacy and off-target safety issues. 
Furthermore, this stage involves examining whether the compound could be active in 
primary assays to protein orthologues of other species. Consequently, animal models are 
frequently used to study the in vivo effects, pharmacodynamic (PD)/PK profiles and 
preclinical toxicity of the compounds in disease models, and in a high throughput 
fashion for detailed understanding of the physicochemical properties, including the 
solubility and permeability profile and the ADME properties. Assays are developed to 
examine if compounds can be introduced to the body orally and absorbed via the 
digestive tract, or introduced alternatively by injection directly into the bloodstream, 
and whose effects can be diminished as it is metabolised by enzymes and eliminated 
from the body. A limited number of compounds are selected for PK evaluations to study 
how a drug is processed by the body of animals. As a general principle, it is desirable for 
a candidate to be higher than 20 percent absorbed after an oral dosing, or have a half-life 
longer than 60 minutes, given an IV-injected dose; a concept known as “bioavailability”, 
which refers to the amount of a drug dose reaching to the systemic circulation (plasma). 
These values are typically dependent upon the targets. [17]  
 
5 
 
With the help of these assays, the initial lead compounds are selected and subjected to 
"lead optimisation" before being declared as a "drug candidate" in clinical trials. At this 
stage, further work is carried out to improve deficiencies in the lead structures while 
still maintaining their favourable properties. The process of further characterising the 
leads varies by company, but in general, the measurement and reporting of certain 
properties must be in accordance with regulatory bodies throughout the development 
process. These include the genotoxicity tests by means of in vitro (for example, Ames 
test) or in vivo testing that are used to reveal possible genetic damage done by the new 
active compounds, and others tests assess the PK/PD profiles and the PK response after 
repeated dosing. All nonclinical information gathered by the end of this stage will be 
used later, during regulatory submission for approval to test on human subjects. [17] 
 
1.1.1 Filters for Druglikeness 
As mentioned previously, in silico methods are used to predict properties of chemical 
compounds based on their structures, and the predicted results can be used to prioritise 
the compounds which best match the design criteria related to potency, selectivity, 
ADME properties, etc.; thus, to identify “leads” out of the pool of hits. Nowadays the key 
considerations of library design have changed to consider the druglikeness of members, 
rather than their size, and the diversity of the library. [18] Compounds selected for use in 
libraries usually adhere to "Lipinski's Rule of Five" which defines the following limiting 
property criteria to be satisfied as a filter for drug: a molecular weight of less than 500 
daltons, an octanol-water partition coefficient (which is a measure of lipophilicity, logP) 
of less than 5, less than 5 hydrogen donors and 10 hydrogen acceptors. These rules were 
empirically derived from existing drugs that can be administered orally.  
In general, the lead optimisation process is often accompanied by an increase in 
molecular weight and changes in logP. The lead is only used as a starting point. Because 
of this, Teague et al. [19] argued that the properties used to design a library of leads that 
will need further optimisation may be different to those for constructing a druglike 
library. Besides, a novel library design has to depend on the target, their routes of 
administration and the result of pharmacokinetics to identify proper profile. [20]  
Teague et al. [19] broadly divided the leads into three types: the leadlike, the druglike 
and the high-affinity leads; leading to developing different optimisation scenarios. The 
leadlike leads consisted of small molecules with low cLogP, typically associated with low 
affinity are to be improved by increasing the molecular weight and lipophilicity. To 
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convert high-affinity leads (mostly peptidic compounds with molecular weight > 
350Da) into drugs with good pharmacokinetic properties, involves retaining its potency 
while increasing cLogP and reducing the molecular weight. The druglike leads, on the 
other hand perhaps are the most commonly reported type of lead emerging from HTS by 
filtering the combinatorial libraries; the resulting compounds tend to have low affinity. 
(Figure 2) They proposed that using the library of leads with molecules in the molecular 
weight range 100-350 and cLogP range 1-3.0 (filters defined for leadlike leads) would 
give results superior to the molecules in the druglike leads library, allowing additional 
interactions to be explored when optimising leads. In addition, smaller molecules are 
easier to locate at the desired binding site, and also more easily adapt to enhance 
selectivity, affinity, and other properties; often achieved by introducing lipophilic groups. 
[20,21] These preferable leadlike leads, averagely speaking, have lower molecular 
weight, fewer rings and rotatable bonds and are less hydrophobic and have lower 
polarisability. [20] 
 
Figure 2 - Modified from Teague et al. [19] Classification of leads according to their 
molecular weight (Mr) and cLogP values. 
 
1.1.2 In silico Virtual Screening 
Virtual screening (VS) methods can generally be categorised depending on the 
availability of experimental data into: 1) the structure-based (SBVS) or target-based 
approaches, when the structure of the receptor is available or can be determined by 
homology modelling and 2) the ligand-based (LBVS) approaches. [1] The process of VS 
is often described by analogy to a funnel, where the compounds are filtered to exclude 
inactive molecules, or ranked based on their predicted activity as assessed using a 
computational algorithm. Ultimately, this process is expected to result in a more 
manageable set of active compounds to be tested experimentally. VS methods can be 
used as an alternative to HTS when no suitable assays are available (i.e. HTS assays 
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require adequate sensitivity in identifying modulators of the enzyme activity). 
Compared to HTS, VS is lower in cost. Also, it is not limited to physically existing 
screening libraries, allowing the access to a larger chemical space. VS does not suffer 
from experimental deficiencies (i.e. poor solubility) that interfere with the assays and its 
readout. One the other hand, the success of VS depends heavily on reliable methods to 
predict binding modes and binding affinities. [22] Alternatively, VS methods can be 
complementary to HTS in identifying new hit compounds. VS can be performed prior to 
a HTS to enrich active compounds in a library, or after a HTS, to identify false negatives. 
[23] A comparison on the performance of HTS and VS (docking) against the same target 
has been published by Doman et al. [24]. The aim was to identify potential inhibitors of 
protein-tyrosine phosphatase 1B (for treatment of diabetes). In the end, they discovered 
two distinct sets of active compounds (hits), suggesting the complementary nature of 
the two methods. 
Tanrikulu et al. [2] classified the applications of VS into classic VS, parallel VS, iterative 
VS and integrated VS on the basis of various integral strategies that exist in the 
literature. Parallel VS makes use of multiple VS techniques running in parallel (each of 
which works at its own classic VS). The resulting hits from various methods which give 
complementary results are combined, either directly or by a fusion method [25] to 
increase the true positive and reduce the false positive hits. Iterative VS applies VS 
sequentially to rounds of refinement processes at various stages of drug discovery. At 
each iteration, the in silico selected compounds and their similarities, identified at 
various threshold levels, are used as starting points. These compounds are subjected to 
in vitro evaluations where experimental results are incorporated, to improve the 
subsequent in silico model leading to the discovery of more potent hits. Integrated VS, 
which is found to be the most advanced application of VS, integrates a number of 
different validated and parameterised screening procedures into a tailor-made protocol 
for a specific compound or compound type. Subsequent to HTS results, compounds are 
re-evaluated by the VS methods and with different subsequent arrangements (so as to 
take advantage of their complementary nature), to reduce the false positive hits from in 
vitro screening [26] or to reduce the size of chemical space to be searched. [27] 
Structure-based virtual screening (SBVS) involves using a known 3D biological receptor 
structure (obtained by X-ray crystallography or NMR) or 3D model (homology 
modelling) as a template to screen for potential binders (typically a 3D representation). 
Usually this is done by employing molecular docking techniques, as an estimate of how 
likely it is that this compound will bind to the target with high affinity [28] and in an 
effort to gain information on how the ligand interacts with the receptor. The structure-
based approaches include molecular docking and scoring (which will be covered in 
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Chapter 2), molecular dynamics, pharmacophore modelling, and de novo ligand design 
methods. Since structure-based screening relies on a static structure of the target, from 
which ligand binding is modelled, the results of a screening are limited by (and to) 
fixed/rigid molecular structures. Thus, a number of strategies have been proposed to 
account for receptor flexibility (explored more in Chapter 2) in SBVS, to avoid biasing 
towards a single rigid conformation. 
Ligand-based virtual screening (LBVS) emerged during the 1980s and early 1990s and 
uses known bioactive compounds as reference molecules (usually 2D representations, 
but can be 3D representations) to extract SAR. This method allows one to search for new 
hits sharing shape and/or pharmacophore features identified as being responsible for 
the activity (to identify compounds with similar bioactivity profiles). LBVS is used when 
3D structural information on the target is not available. The “similar property principle” 
(SPP) [29], formalised by Johnson and Maggiora in 1990, provides a rationale for a 
structural similarity searching, which is what the ligand-based approach relies on. The 
principle states that similar molecules are prone to display similar biological properties. 
In contrast to LBVS, SBVS employs docking, and generally depends on structural 
complementarities between the macromolecular target and its ligand.  
However, structurally similar compounds can have distinct SARs. [30] Similarity 
searching does not consider the stereochemistry, which can affect the ability of a 
molecule to bind to a target, especially where the ability of the molecule to change 
‘shape’ is limited by strong intramolecular interaction. Consequently, ligand-based 
approaches were used for targeted (or focused) library design to select compounds from 
the initial compound collection enriched with specific properties for a target or a protein 
family based on the known target and literature (or patent precedents).  
Approaches for ligand-based screening can be divided into similarity search and 
compound classification techniques. In practice, each molecule is represented using a set 
of descriptors encoding chemical features. Traditional virtual screening efforts focus on 
similarity searching using fingerprints which are binary descriptors, or various other 
similarity descriptors (see ‘Molecular Descriptors’) to provide chemical features. It is 
these fingerprints that are compared to perform similarity measures and will produce a 
similarity score (or similarity coefficient) between pairs of molecules, from which the 
clusters are based. Compounds from the same cluster that have a high similarity 
measure value are expected to interact with proteins of the same group. [31] 
Descriptors, calculated with the aim of predicting a given property, can be defined in 
terms of a subset of the chemical space (descriptor space), where each molecule is 
represented as a point with n-descriptor dimensions. The success of similarity searching 
9 
 
is dependent upon the choice of this descriptor space. The best-defined are those 
categorised within the criteria for drug-like structures, which follow the Lipinski, the 
lead-like [20] and fragment-based [32] definitions. Such constraints help to reduce the 
chemical space, limiting the chemical space to those regions containing molecules with 
favourable (drug) properties; for instance, chemical space in which the active 
compounds reside, which is referred to as the ‘biologically relevant chemical space’. 
(Figure 3) However, not all compounds with proved activity fall within predefined limits 
or other criteria (rules). [33] Compound classification techniques, on the other hand, 
can be divided further according to the training procedure implemented, with an 
ultimate goal to predict the class label for compounds using either an unsupervised 
(clustering) or a supervised (classification) machine learning algorithm to learn 
decision rules from a training set of known compounds. Then the resulting models are 
used to predict whether a given molecule will bind to a target on the basis of 
physicochemical properties. [34,35] 
However, several limitations of ligand-based approaches are listed. Firstly, the rationale 
behind a similarity search, the similar property principle (SPP), is not always valid; in 
some cases, similar compounds have dissimilar properties. The SAR data can be 
conceptualised using an “activity landscape” model proposed by Gerald Maggiora (2006) 
[36], which is similar to geographical landscapes where the third dimension forms the 
surface of an “activity landscape” that accounts for compound biological activity, and is 
added to a 2D projection of chemical space. As such, it provides a graphical 
representation of the relationships between structural similarity and biological activity. 
SARs are distinguished by how molecules respond to structural modifications. In their 
terminology, “continuous” SARs would correspond to smooth regions or gently rolling 
hills of the structure activity landscape; the areas where gradual changes in chemical 
structure result in a small or moderate effect on biological activity, and thus which would 
make reliable predictions of activities (potency) for other similar compounds. [31] In an 
extreme case, when large changes of structure result in a very small change in activity, 
SARs are known as “flat”, and most optimization efforts on this kind of SAR are fruitless. 
[37] By contrast, rugged areas represent regions of “discontinuous” SARs, where 
“activity cliffs” are more likely to be found. In the presence of “activity cliffs” the results 
appear to be inconsistent with the concept of SPP; small changes in chemical structure 
can result in a dramatic change in biological activity, yielding models with limited 
predictive power and often leading to the failure of QSAR (Quantitative Structure-
Activity Relationship). [36] The presence of “activity cliffs” is a challenge to similarity-
based approaches since they assume a continuous SAR. “Similarity cliffs” or scaffold 
hops, which in contrast to activity cliffs, occur when structures that are dissimilar but 
exhibit similar activities. 
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To put SAR in the context of target-ligand interactions, the biological activity is the result 
of interactions between small molecules and their biological targets, and since the ligand 
binding depends on chemical (i.e. hydrogen bonding, electrostatic interactions, etc.) and 
geometrical (shape) complementarity of ligand and receptor, which enables only certain 
specific interactions to occur. The “activity cliffs”, here refer to “structure-based activity 
cliffs”, in this sense, are associated with critical interactions required for the binding, 
regardless of ligand structure and properties, leading to the concepts of the term 
“activity cliff hot spots” [38,39], which are regions or atoms in the target site directly 
involved in interactions with the ligand, associated with the formation of activity cliffs. 
[40] “Continuous SAR” regions indicate permissive binding. The binding sites are able to 
accommodate ligand variability to some extent and such a binding would require a high 
degree of shape complementarity between binding site and ligand to result different 
potential interactions. [41] Evidence shows that different SAR types coexist at the active 
site. In the case of heterogeneous SARs (also termed variable activity landscapes) this 
coexistence comprises smooth regions intersected by (rough) activity cliffs. The SAR 
analysis of activity cliffs can help to drive the ligand improvement task.  
Secondly, the relative positions of compounds in chemical space vary depending on the 
particular selection of a descriptor set defining a chemical space, and based on the 
chemical representation used to describe molecules, with the “activity landscape” 
changing accordingly. This may lead to different (chemical) neighbourhood relationships 
in chemical space. [33] The aim of similarity searching is to find similar compounds 
(neighbours) to a given query, with points close in chemical space considered to be 
similar. Such a lack of consensus in listing of similar (neighbour) compounds leads to 
inaccurate ligand similarity predictions. [31] Moreover, the use of active compounds 
used as the reference structures in similarity searches may result in limited diversity 
amongst the compounds retrieved. 
Lastly, similarity searching relies heavily on the accuracy of input data in building 
reliable models. There are, however, significant error rates observed from the chemical 
data available in the literature and public databases. [31]  
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Figure 3 - Modified from [33]. The existing compound collection contained only limited 
coverage of the biologically relevant chemical space (molecules with biological activity), 
which lead to discovery of drugs (A). Virtual screening offers opportunities to expand on 
an existing collection for a greater coverage of previously unexplored chemical space 
(dashed ellipse), where drugs are likely to be found (B).   
 
1.1.3 SAR/QSAR 
The ligand-based approach employs quantitative structure-activity relationships 
(QSAR). SAR may be designed to provide either quantitative (as in QSAR) or qualitative 
predictions, based on the relationships developed using continuous data or discrete data 
(presence or absence of a particular structural feature), respectively. It is assumed in 
QSAR models that a mathematical relationship (often a statistical correlation) can be 
found between the activity (or other relevant property) of query molecules and 
measurable or computable physico-chemical descriptors used to quantify the chemical 
structure. For this, a number of models were built to relate molecular descriptors to 
biological activity with the objective to firstly, predict properties for untested data, 
secondly, to select compounds to be prioritised for synthesis or screening, and thirdly, to 
extract patterns or SARs from analogues of the lead compounds. Thus, one may study 
the effect of structure on activity (or potency), and the resulting knowledge can be used 
to guide the lead optimisation process. Lastly, QSAR can be used to get insights into the 
characteristics of the receptor binding site. [42] A QSAR model’s value depends on the 
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quality of input data; they provide only limited precision due to experimental variation 
and the incompleteness of the compound set, the choice of descriptors and statistical 
methods. 
The history of SAR originated in 1863, when Cross [43]observed that the toxicity of 
aliphatic alcohols is inversely related to their aqueous solubility, and just a few years 
later, in 1868, Crum-Brown and Fraser [44] published that the physiological action (Ф) 
of quaternized strychnine derivatives which would produce muscle paralysis (effect on 
blocking neuromuscular receptors, competitively inhibiting acetylcholine binding) is a 
function (𝑓) of its chemical constituents (C), thus proposing the first quantitative 
relationship in pharmacology and medicinal chemistry by the Equation 1: 
Equation 1 – Crum-Brown and Fraser’s formula relates chemical structure to a biological 
response: 
 
Ф = 𝑓(C) 
which is the first general form of a QSAR relationship. Due to a change in chemical 
constituent, ∆C, the effect is reflected in the biological activity, ∆Ф. Richardson (1869) 
[45] later observed that the hypnotic activity of aliphatic alcohols satisfies a 
proportional relationship with their molecular weight, then followed by Meyer [46] and 
Overton [47] in 1890s who correlated the toxicity of organic components to their 
lipophilicity (lipid-water partition coefficient). Trabe [48] and Seidell [49] were 
pioneers in using physicochemical properties as descriptors in their study. The QSAR 
concept was proposed initially by Corwin Hansch (who is honoured as the “father of 
QSAR”) and his co-workers in the 1960s showing that a variety of biological activities 
could be modelled as a function of physicochemical attributes, followed by their first 
QSAR publication, which concerned the herbicidal effects of phenoxyacetic acids and 
their derivatives, in 1962. [50]  
Various applications of QSAR are reviewed. Any QSAR study requires a data set with 
known values of activity, a set of molecular descriptors (structure-related) and a 
mathematical method. QSAR focuses on local structural features known to be relevant to 
biological activity, which is in contrast to the similarity searching based on the whole 
structure. [51] On the other hand, large numbers of descriptors would increase the 
chance of producing deceptively good models due to overfitting or chance correlations. 
It is found that predictions obtained from a model with a small number of simple 
descriptors can often outperform those from complex ones. [52] Traditionally, QSAR has 
been applied to a congeneric series of chemicals sharing a common scaffold, which 
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ideally should not contribute to differences in activity but with adequate diverse 
substituents. In contrast, recent studies focus on data with a wider chemical space. [53] 
Typically, the whole dataset is partitioned into training (used to build the model) and 
testing for model evaluation or selection. In the early stages of QSAR method 
development, linear methods such as multiple linear regression, which was first 
introduced to QSAR by Hansch and is still commonly adopted due to its simplicity and 
interpretability, and partial least squares (PLS) were often applied to generate QSAR 
models, and over time, with increased computer power, more complex machine learning 
methods such as artificial neural networks, support vector machines, random forest and 
k-nearest neighbours have come to be used in QSAR modelling. [53] 
 
1.1.4 Chemical space 
The depiction of chemical space varies from the intuitive perspective of Lipinski, to the 
review of Hopkins (2004) [54] who analogises compounds in chemical space to the stars 
in the universe, whereby the chemical space is very large in size. Others suggest that 
chemical space is composed of all possible organic molecules. [33] As introduced above, 
compounds characterised by the same set of descriptors are mapped onto the 
coordinates of a multidimensional descriptor space defined as chemical space. Each 
molecular descriptor adds a dimension to the space. Molecules are located according to 
their descriptor values [51], where similarity and dissimilarity are defined based on 
their intermolecular distance in chemical space. The choice of molecular descriptors is 
decisive for a meaningful chemical space in which if the compounds happen to be 
similar, they would be located in contiguous regions. 
 
1.1.5 Molecular Descriptors 
Descriptors are numerical values, which can be scalars, vectors or bit strings etc., created 
using a defined algorithm that transforms chemical information contained in a molecule 
or fragments of a molecule into a number used to establish QSAR. Each descriptor 
encodes only a certain subset of the information contained in a molecule. They include 
physicochemical, geometric or topological properties associated with a molecular 
structure. These could either be obtained experimentally (physicochemical properties) 
or calculated theoretically (based on fragments or the whole molecule), or both. In other 
words, descriptors are mathematical representations of a molecule. 
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Based on the data representations of these properties, descriptors can be hierarchically 
ordered as: zero-dimensional (0D), the simplest, calculated from the chemical 
composition of the molecules by simple counts of the number of atom types or bonds. 
Examples are molecular weight, atomic count descriptors etc., which are not calculated 
from a molecular graph but usually from atomic information; one-dimensional (1D) 
based on the substructure (fragment); and two-dimensional (2D) descriptors, often 
termed as “connectivity (or topological) indices” computed from a molecular graph or 
matrices reflecting the connectivity between atoms; these include binary 
representations such as structural keys and fingerprints, feature trees, etc. 2D 
descriptors are the most widely used molecular representation to the field of 
chemoinformatics and ligand screening. In practice, the 2D molecular graph of a 
chemical is converted to a 1D string (the SMILES format [55]) to calculate the structural 
descriptors. [31] Binary descriptors are represented by a Boolean array of a set of 1 or 0 
values, typically encoding the presence or absence of a specific substructure, allowing a 
chemical database to be screened at low computational costs by simple Boolean 
operations. There exist a variety of three dimensional (3D) descriptors, derived from 3D 
structure of molecules such as pharmacophores, considering the spatial configuration of 
essential features conferring specificity for a ligand binding to a specific binding site. 3D 
descriptors depend on the geometrical coordinates of the molecule’s atoms required in a 
valid conformation, which varies depending on the representative physical state. [56] 
To note that there is no “best” descriptor available as a general rule. The information 
content of the “best” descriptors should be comparable with the experimentally 
determined properties. High order descriptors (3D or higher) but irrelevant information 
with respect to the properties are usually regarded as noise on behalf of the model, 
which in turn produce instable or not predictive models. [57] 
 
1.2 Machine Learning models 
One of the major applications of machine learning is data mining. Due to the rapid 
advances in high-throughput instruments and database technologies, collections of data 
have become more readily available. Methods enabling new discoveries derived from the 
analysis of large amounts of complex data have become increasingly demanded. It is 
desirable for an algorithm to be able to train on data contaminated with experimental 
errors or missing values, and to derive empirical correlations to estimate properties of 
new data. One can perform these analyses using a machine learning approach which 
involves processing and modelling of massive amounts of experimental and computer 
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simulation data (usually referred to as descriptors in chemoinformatics) to retrieve and 
discover data patterns and to establish quantitative relationships between multiple 
features. Nowadays, machine learning has been widely used in many areas including 
computer science, bio- and chemoinformatics and biostatistics. 
Each instance in any database is represented by the same set of features which can be 
numerical (discrete and continuous), categorical and binary that is used to train a 
machine learning algorithm. The instances in a multivariate dataset can be pictured as 
points in a multidimensional space where each variable (measurement) is a dimension 
of the search space. In general, models can be trained with supervised and unsupervised 
learning algorithms. As they are named, the former contains known labels associated 
with each training instance. Other finer categories of machine learning algorithms 
include hybrid models, semi-supervised learning and reinforcement learning, which are 
beyond the scope of this thesis.  
Clustering (or segmentation) is an unsupervised classification task that requires no 
previously provided class labels. The purpose of clustering is to group related entities 
(observations) based on the hidden relationships found from the data or as a 
preprocessing step to be performed prior to actual processing. This is in contrast to 
supervised machine learning referring to a learning process from training data and the 
resulting classifier is used to generalise on previous unseen instances.  
In the case of supervised classification (or usually just classification), a classifier is a 
learning algorithm which takes a vector of feature values as inputs and returns a class 
label. The learning process starts with data preparation and data-preprocessing which 
may involve detection of outliers (noise), handling missing or imbalanced data, feature 
construction and transformation, collecting relevant or (if known) informative features 
from the dataset, and, in the case of data sets with large numbers of variables/entries, 
feature/instance selection prior to the learning process is required to reduce the 
number of features captured/data to a manageable amount, which also helps to increase 
performance. Apart from the data used to train the algorithm, a subset called the test set 
is kept independently for evaluation. In cross-validation, the training data is randomly 
partitioned into subsets of equal size, and each is used in turn for testing, treating as a 
proxy for true test data, while using the remaining data for training. The average across 
all repetitions is used to compensate for the bias caused by the reduction of the training 
set size.  
The typical goal of machine learning is to generalise on new data on the basis of 
examples in the training set. The following section addresses each of these issues on fix 
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experiment setting especially on construction of a random forest, a decision tree based 
classifier. 
 
1.2.1 Pre-processing 
The raw data has to undergo pre-processing which includes “data clearing” to fill in or 
remove the missing values, remove the noise (random errors), and curated data (errors 
in public sources), and “data reduction” to obtain a reduced representation of the 
original data, while at the same time eliminating irrelevant or redundant data. Instance 
selection involves reducing the sample size while maintaining the required quality of the 
estimates. This is often achieved by random sampling which randomly selects instances 
from the original data, or stratified sampling, to increase the sample size of minority 
groups. Whenever necessary, the data are transformed for better model development. In 
autoscaling, the variables are rescaled to have zero mean and unit standard deviation. 
Also, new features can be derived from the original features in the process of feature 
construction. Data pre-processing aims at improving data quality, to reduce the size of 
data and computational complexity, and improve the performance of the models. [58] 
Note that, the challenge to generalise well to new samples increases drastically with 
increased number of features, which easily lead to “the curse of dimensionality”. 
Typically, the performance of a classifier increases as the number of features increases; 
until an optimum is reached, beyond which the accuracy of the model decreases. This is 
due to the data points in space becoming increasingly sparse with increasing 
dimensionality. This will result in misleading approximations of the boundaries between 
classes and as a result, overfitting occurs. Most clustering algorithms rely on distance or 
similarity measures, whereby the data are partitioned into groups (clusters), such that 
the data in the same cluster are closer to each other than to the data from other clusters. 
However, as the dimensionality tends to infinity, distances for sparse high dimensional 
data follow: 
Equation 2 – The relative distance between points converges to zero with increasing 
dimensionality (d): 
lim
d →∞
distmax − distmin
distmin
= 0 
The relative difference in distance of the nearest and the farthest data points to the 
centroid tends toward zero (Equation 2), this means the distances (dissimilarity 
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measures) between data points become relatively uniform so that distance measures to 
select the nearest points (as to be assigned in the same cluster) becomes meaningless in 
high dimensional spaces. Also, the sparseness of the data in high dimensional spaces is 
not uniformly distributed in which data points mostly lie near the edges of the space far 
away from one another, with empty space in between. [59]  
To reduce the dimensionality of the data while retaining data information, feature 
selection is generally part of preprocessing. In other words, feature selection allows 
identification of relevant features. The process involves removing features that have no 
significant variation, or are correlated with other features. Alternatively, a method such 
as principal component analysis (PCA) is used to project data to a lower dimensionality, 
which would also help to remove noise from the model. Feature selection is a common 
step, appropriate to select descriptors for QSAR models, and can be done in a number of 
ways, such as stepwise selection, all possible subset selection, genetic methods and 
factor analysis. 
 
1.2.2 Imbalanced data 
Imbalanced data occurs when the number of instances of each class is not evenly 
distributed. Firstly, classifiers tend to optimise prediction for the largest class, while 
treating all others as noise so as to maximise prediction accuracy. Accordingly, there will 
be a bias produced. An instance in a minority class is more likely to be misclassified. 
Secondly, instances from the minority class may provide insufficient information to build 
a model. The collections of a class for learning shall be adequately sized to insure they 
sufficient reflect the complete chemical space. Lastly, the noise (outliers) from the 
majority class may mask the information contained in the minority class. One way to 
reduce this size-related effect is to weight the training set inversely proportionally to the 
size of the class, however this in turn causes a higher rate of misclassification. The other 
way is to even up the number of samples in each class by resampling of the training data 
(either by down- or up-sampling) in the pre-processing stage. Down-sampling (or 
under-sampling) to down-size the majority class may result in a loss of data whereas up-
sampling (or over-sampling) to make exact copies of the minority class may result in 
overfitting. [60] 
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1.2.3 Decision trees 
The decision tree algorithm is a non-parametric supervised learning method. Non-
parametric refers to no assumptions about the space distribution and the classifier 
structure which can grow with the data. Classification is performed by routing from the 
root node of a decision tree from where the tree starts growing. At each node (except the 
terminal nodes), the data is split into two or more subsets according to the value of a 
selected feature, and the process is repeated until homogeneous groups remain or the 
stopping criteria have met. The prediction of each instance is made by routing it down 
the tree according to its attribute values tested in successive nodes until a leaf node is 
reached, with which a class label is associated. Decision trees are flexible yet data-driven 
classifiers. Small differences in training data may lead to great variations to the 
classification results. [61] The complexity of a tree is directly affected by the splitting 
criteria, stopping criteria deciding when to stop growing the tree and the pruning 
methods. Most existing decision tree algorithms, including ID3 [62], C4.5 [63] and CART 
(Classification and Regression Trees) [64] are greedy as the best attribute is searched to 
split the data at each node. Typically, an optimal tree has minimum generalisation error. 
In general, decision trees tend to have low bias but high variance. To improve the 
performance, one can use an ensemble of models. It is found that the generalisation 
(test) error can be improved by adding classifiers. Bagging, boosting and stacking are 
ensemble methods. In bagging (aka bootstrap aggregation) [65], each classifier is 
learned from a different training set by resampling with replacement to create random 
variations in the training in such a way to reduce the variance. Also, all variables are 
considered at each split in the tree. The result is made by combining the votes from each 
classifier. Boosting [66] decreases the bias by using all data to train a classifier. However, 
each training sample carries a weight so that misclassified examples could have more 
focus in subsequent learning processes until all the samples are correctly learned. 
Stacking is similar to boosting, where the outputs of classifiers become input of another 
classifier as to combine the results. 
 
1.2.4 Splitting rule 
The feature resulting in the best partition of the training instances is chosen at each 
node according to a selection criterion. The tree is grown by recursively partitioning 
until a pure subset is formed or the size of subset is sufficiently small. Among numerous 
splitting criteria, however, none was observed to be superior from one another [67], 
Quinlan's C4.5 uses information gain splitting [63] and CART uses the Gini index [64]. 
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CART only allows binary splitting whereas C4.5 and ID3 use multi-way splits.  
To speed up the most time-consuming step of the training algorithm in determining the 
threshold of a split at a node for a numeric feature, one approach is to restrict the 
threshold to be based on only a subset of the instances, or to discretise the original 
values of features to intervals as a way to reduce computational efforts. Generally, 
decision trees are better for handling discrete/categorical features. The univariate 
decision trees which use a single attribute to test at each internal node are restricted to 
axis-orthogonal splits. In each partitioning, the instance space is partitioned into two 
hyperrectangles (sub-regions); this process is recursively repeated until every square 
region contains homogeneous data sets. Thus, univariate decision trees do not work well 
with problems that require diagonal splits with respect to the features’ axes of the 
feature space. (Figure 4) [68] 
 
Figure 4 – Orthogonal splits divide the feature space into axis-parallel sub-regions, each 
with a single classification label.  
 
1.2.5 Overfitting 
A decision tree may result in overfitting of the training data due to outliers and noise 
(mislabelled instances) or by the lack of representative examples, resulting either from 
insufficient amount of training data being available or as a consequence of sampling 
error. Furthermore, high dimensionality of data may lead to overfitting. Generally, 
overfitting occurs when a model learns more of the detail and the noise in the training 
data rather than underlying relationship, thereby creating a tree that is excessively 
complex and does not generalise well to new data.  
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To avoid this, one can pre-prune the decision tree by some stopping criteria to stop the 
tree growth before it gets too complex, or alternatively employ a post-pruning method to 
remove useless branches. Since the objective function based on a subsample of the 
training data is only a proxy for our goal function; one wants to generalise beyond the 
training examples, thus there is no need to fully optimise it. However, even using noise 
free training samples can still result in overfitting because any chosen sample would 
most likely not be a perfect representative of the entire sample. A tree-based ensemble 
classifier, Random Forest, is considered relatively immune to overfitting.  
Every learning algorithm has an inductive bias (or named learning bias) referring to a 
set of prior assumptions that a classifier holds in order to perform induction, that is to 
generalise beyond the training examples. In other words, inductive bias specifies a 
preference for which types of generalisation to use to bias toward a particular set of 
predictors. In decision tree models, shorter trees are preferred which naturally tend to 
avoid overfitting. As a result of inductive bias, some potential solutions cannot be 
reached. [69] This was formalised in the "no free lunch" theorem by Wolpert [70], which 
states for machine learning that there is no universal learning algorithm that can deal 
with all possible situations. Of course, at least some prior knowledge is required for 
induction. It is common to build multiple models and compare their performance since 
every model represents a certain simplification of the reality; cross validation is often 
used to determine the best model that suit the needs based on predictive accuracies.  
 
1.2.6 Evaluation functions 
The prediction accuracy is used to evaluate the performance of the classifiers by either 
the cross-validation or the out-of-bag (OOB) estimations or alternatively, leave-one-out 
validation estimate strategy. Predicting new data on the basis of an induction process for 
machine learning involves uncertainty. The classification results of a supervised machine 
learning (an induction process) is justified with reference (known responses to the 
data); thereby, the quality of the predicted value can only be guaranteed 
probabilistically. The theoretical guarantee is that given enough training data, there is a 
high probability that the learner will return a hypothesis that would either generalise 
well, or otherwise be unable to find a hypothesis that consistently classifies data 
correctly. [71] 
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1.3 Random Forest  
Random Forest [72] is a supervised machine learning approach used for classification 
and regression. The predictions are made based on a stochastically built ensemble of 
decision trees. Each tree is grown from a particular bootstrap sample by the CART 
(classification and regression trees) algorithm using data drawn randomly with 
replacement from the entire dataset, leaving approximately a third of the data for the 
internal validation as an out-of-bag (OOB) sample for each tree. Random Forest 
improves bagged trees by way of firstly, having trees grow to their maximum to reduce 
the correlation between trees; secondly, each split is determined by a random subset of 
features thus to induce diversity of the resulting trees.  
Rather than using all descriptors, the split at each node of the tree as the tree grows is 
determined by choosing the best division possible using any of a randomly chosen 
subset of mtry descriptors, where mtry is by default the square root of the number of 
descriptors available. Each splitting is based on a single valued attribute that best 
divides the training set. Random Forest is an improvement over bagging, as descriptors 
are not equally important. The Gini criterion [73] is used to select the split resulting in 
the greatest decrease in impurity. This process is iteratively continued, with a freshly 
chosen random sampling of descriptors at each node, until all the training data have 
been classified into their appropriate leaf nodes. At this point, the tree building ends and 
no pruning is carried out. Running Random Forest with the default setting of mtry 
speeds up the process compared to using larger values, as the number of splitting tests 
required at each node is smaller. The tree building process is repeated for each of the 
ntree trees in the forest, with each tree being based upon a different bootstrap sample of 
the instances from the dataset. 
The classifier is trained with labelled samples to construct a model to predict the 
category of unseen data. The predictive performance of the model is evaluated through 
internal validation. During the training, the out-of-bag (OOB) sample, which does not 
participate in the tree building, is used in parallel to evaluate the prediction accuracy of 
the trees. Each tree being trained, that is built, on a bootstrap sample comprising one or 
more occurrences of approximately 2/3 of the full training set. The class prediction of 
each sample is made based on a majority vote of those trees (averaging for regression) 
for which the given instance is in the OOB sample (and therefore uses those trees for 
which the instance has not been part of the training set). The OOB error rate is obtained 
by dividing the number of misclassified data points by the total number of points. [72] 
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In CART, the Gini criterion (or index), introduced by Breiman in 1984 [64], is used to 
select the best split for each node that leads to the greatest reduction in impurity 
between parent and child nodes. The impurity 𝑖(𝑡) of a node 𝑡 is defined as: 
Equation 3 – The Gini impurity measure: 
𝑖(𝑡) = ∑ 𝑝𝑖(1 − 𝑝𝑖)
𝑛
𝑖=1
= 1 − ∑(𝑝𝑖)
2
𝑛
𝑖=1
 
where 𝑖(𝑡) is zero when the node is pure, 𝑝𝑖  is the proportion of class 𝑖 at node 𝑡, 𝑛 
denotes the number of classes. The reduction in impurity ∆𝑖(𝑡) after a split is given by: 
Equation 4 – The reduction in impurity of a binary split: 
∆𝑖(𝑡) = 𝑖(𝑡) − 𝑃𝐿𝑖(𝑡𝐿) − 𝑃𝑅𝑖(𝑡𝑅) 
where 𝑖(𝑡𝐿) and 𝑖(𝑡𝑅) are impurity measures, and 𝑃𝐿 and 𝑃𝑅 are the proportion of 
cases that go from parent to the left and the right child nodes, respectively. [74] 
Alternatively, there are other machine learning techniques, such as support vector 
machine (SVM), that can be used for classification and regression tasks. SVM, proposed 
by Cortes and Vapnik [75], uses a kernel function to transform the data nonlinearly to a 
higher dimensional space. This spreads out the data, such that an optimal hyperplane 
can be constructed that separates the data into two classes on either side of the 
hyperplane with a maximum margin. The k-Nearest Neighbours (kNN) [76], where k is 
typically a small odd integer, calculates proximity between a query point and all of its 
neighbours using a distance function (e.g. Euclidean distance), and the class is assigned 
by voting among its k closest neighbours. In contrast, Naïve Bayes by applying Bayes’ 
rule computes the probabilities of a query belonging to each class based on various 
attributes. [77] 
 
1.3.1 Applications 
Random Forest has been applied in several contexts. A Random Forest model was built 
to classify HIV-1 protease binding pockets to one of the nine FDA approved protease 
inhibitors; while to obtain the Gini importance to identify the essential features 
responsible for the binding with various protease inhibitors. At the end, Ko et al. [78] 
identified 12 top ranked descriptors quantified the geometric and electronic properties 
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of the binding pockets which can be used to aid the design of novel HIV-1 protease 
inhibitors. Palmer et al. [79] used a data set of 988 organic molecules with which to train 
and test a Random Forest to predict aqueous solubility based on 2D descriptors and 
reported that Random Forest achieved better accuracy compared to the other models. 
Random Forest has been successfully applied to predict protein-ligand binding affinity. 
[80,81,82] 
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CHAPTER 2. Theory of Molecular Dynamics and Molecular Docking 
2.1 Introduction to Molecular Docking  
As mentioned in the previous chapter, molecular docking is the most used SBVS method, 
to ultimately identify lead compounds. Docking methods have been employed to study 
the interaction of small molecules with the target which helps to design a ligand with the 
necessary feature(s) to achieve high affinity binding. [83] 
Molecular docking relies on the availability of 3D structural data of the receptors 
obtained experimentally, or through computational modelling. Docking inherits the 
intrinsic limitations of structure-based methods, including the challenges to resolve the 
3D structure of membrane-bound receptors because of the difficulty in crystallising 
them. In addition, the crystallisation environment is not physiological, this means the 
determined structure may adopt a non-physiological fold [84] and may not retain in its 
native conformation in water or organic solvents. The choice of solvents for 
crystallisation is shown to affect protein conformation. [85] The structures of the 
unbound receptor may be of less biological relevance. This is especially true when 
receptor flexibility is not allowed in simulations. The binding site may have been 
shielded by other parts of the molecule which do not allow access of small molecules. 
Binding results in a structural rearrangement (induced fit) of the receptor. On the other 
hand, error can be found in the structures derived using homology modelling based on 
analogy or other simulation approaches, when the 3D receptor structure is not available. 
[86]  
Molecular docking simulates the recognition process of ligands to receptors. Typically, a 
docking protocol comprises: a) a global search (or a reduced search at potential binding 
sites) for exploring all the possible conformations of a protein-ligand complex, referred 
to as sampling, for predicting the binding modes, and b) a scoring method used to 
evaluate the binding energy for a particular binding mode to identify the binding mode 
with the lowest energy-reflecting shape complementarity and electrostatic amity to the 
rigid target. In silico simulation of receptor-ligand recognition processes can be justified 
theoretically, depending on the level of flexibility accounted for by a docking algorithm 
(see the “relaxed complex scheme” section), which can be described by the “lock and 
key” model, where the rigid target and ligand have exactly matching binding surfaces, or 
by models accounting for protein flexibility, including two competing hypotheses, 
“induced fit” and “conformational selection” (or population shift), with both models 
describing the mechanisms underlying molecular recognition. [87] The induced fit, 
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proposed by Daniel Koshland in 1958, [88] suggests binding induces a conformational 
change of the receptor, whereby the receptor and ligand are fitted by the binding event. 
Conformational selection [89] suggests the ligand binds selectively from the unbound 
ensemble in a “lock and key manner”, and as a result of binding causes a population shift 
toward this bound conformational state. 
 
2.1.1 Sampling 
The earliest docking programs focused on rigid-docking where docking is performed 
through rigid body translations and rotations. The first docking program, DOCK, was 
published in 1982 [90] and employs matching methods. Conformational sampling 
methods considering ligand flexibility are divided up into three categories, as follows: a) 
systematic searching, in which ligand is divided up into rigid (core fragment) and 
flexible (side chains) parts. This is achieved by either docking core fragments prior to 
adding the side chains in an incremental fashion or by covalent linking of various 
molecular fragments that were docked previously into the active site region, referring to 
as de novo ligand design strategy. [91] e.g. DOCK, b) a stochastic search e.g. genetic 
algorithm AutoDock, which will be detailed later ; and, c) simulation methods [92], such 
as the use of molecule dynamics.  
 
2.1.2 Relaxed complex scheme (RCS) 
Using a fixed receptor structure can lead to 50-70% of binding poses being predicted 
incorrectly. [93] A number of ways have been developed to account for conformational 
rearrangements upon complex formation with the ligand. (Figure 5) For example, 
multiple receptor conformations (MRCs) can be used as docking targets (a.k.a ensemble 
docking), where docking is performed on an ensemble of pre-generated conformations 
provided by experimental techniques such as NMR spectroscopy or X-ray 
crystallography, or by computational techniques such as Monte Carlo, normal mode 
analysis or a MD run (methods involving docking to multiple MD conformations have 
been termed “relaxed complex” (RC) schemes) etc.  
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MRCs could be regarded as an analogy to the “conformation selection” model, but with 
protein flexibility modelled implicitly, as the conformation of the receptors is kept rigid 
during the docking process. However, there is a possibility that a ligand may bind to less 
frequent but important conformations with this method, and that the true bound-
conformation may not be selected from the resulting conformational ensembles.  
Alternatively, to MRCs, the “Soft receptor” method is designed to allow partial overlap of 
the ligand and receptor, by specifying a smaller van der Waals repulsive term to reduce 
steric penalties. The effect of this adjustment on the van der Waals potential is to 
simulate a larger binding site, to account for a certain degree of conformational 
plasticity, thereby modelling protein flexibility implicitly. Nevertheless, there are some 
drawbacks: soft docking is limited to small side-chain rearrangements of the target (in 
the order of 1Å) and has an unfortunate tendency to increase false positives.  
Another example, “selective docking” aims to select a few “critical” side chains in the 
binding site to explicitly model their dynamics during the binding process, related to the 
“induced fit” model, by allowing some small rearrangement of the residues in the pocket 
to accommodate ligand binding. Most uses of this method will require some structural 
knowledge of the receptor and its function.  
Finally, “on-the-fly” docking models, which change the receptor’s conformations during 
docking, use various sampling and optimisation techniques. [87,94] One such strategy, 
based on the “induced fit” concept, is applied by RosettaLigand. [95] This method does 
not simultaneously sample both ligand and receptor flexibility, thus allows consideration 
of only small-scale induced-fit effects. The ligand is first docked in a rigid receptor, the 
side chains of the receptor are later changed by the use of rotamer libraries, followed by 
a minimisation of the ligand-receptor complex. Other strategies, such as energy 
minimisation, Monte Carlo or molecular dynamics simulations, are used to perform a 
post-processing refinement step after a rigid docking. 
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Figure 5 - Modified from [87]. Classification of approaches accounting for protein 
flexibility. 
The “relaxed complex” method was proposed by McCammon et al. [96] inspired by two 
experimental works. [97,98] They observed that ligand may bind to conformations that 
rarely exist in the dynamics of the receptor. Therefore, MD simulation is applied first to 
explore conformational space to discover novel binding sites, or to find conformations 
that are rare. Docking to different snapshots taken at different time scales aims to 
overcome the intrinsic limit in docking, by accounting for protein receptor flexibility. 
Application of this method led to the discovery of the first clinically approved HIV drug. 
[99] and has been used to screen a library of ~12,500 compounds against DNA 
polymerase. [100] Several selection techniques have been proposed to extract 
representative conformations from MD simulations [101,102,103]. 
 
2.1.3 Scoring 
Scoring (or potential) functions were previously categorised as either physical-based, 
empirical-based or knowledge-based scoring.  
Physical-based (force-field) energy functions (e.g., GOLD, AutoDock, Dock), which are 
derived from the laws of physics, use atomic force fields; a set of functional forms and 
parameters to calculate the energy. Force fields, also referred to as molecular mechanics 
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(MM), ignore the electronic effects of nuclear motions, and electrons are treated as 
implicit within the MM variables. 
Empirical energy functions (e.g., F-score, ChemScore, SCORE) are expressed as a sum of 
various energetic contributions, can be written in form of Equation 5, where ∆𝐺 is the 
binding free energy. Each term is scaled by a coefficient 𝑊𝑖 derived from linear 
regression in order to fit known (receptor-ligand) binding affinities. Both force field-
based and empirical scoring functions are functions of different energy terms. The 
difference is that the force field adopts an energy function derived from well-established 
theoretical models; whereas an empirical scoring method is built using a best-fit 
function obtained from regression analysis. 
Equation 5 - General empirical energy functions: 
∆𝐺 = ∑ 𝑊𝑖∆𝐺𝑖
𝑖
 
Knowledge-based (or statistical) (e.g., PMF, DrugScore), energy functions use 
experimentally determined structural data to derive distance-dependent potentials for 
interactions between pairs of receptor and ligand atoms. Pairwise potentials are 
calculated by computing the frequencies of observed structural features, occurring as 
atom-atom pairs, and converting them into free energies using the inverse Boltzmann 
relationship; which states that probability of occurrence of a given state can be derived 
by the given energy of that state. 
The lowest energy corresponds to the thermodynamically most stable complex. Docking 
can be regarded as an optimisation problem, including the global positioning of the 
ligand and a local refinement step, finding the optimal pose of small molecules in the 
receptor, as characterised by the position, orientation and shape of the ligand. The 
binding energy of every possible pose of the ligand is computed from a minimisation 
process to find the minimum of the binding energy function. Docking generally adopts a 
simpler force field, allowing a wider computational space to be explored. This allows 
blind docking to be performed, when no prior knowledge of the binding site is known. 
Recently, docking methods based on scoring have been used to prioritise those to be 
screened in vitro. In order to have a high binding affinity, a ligand must be electronically 
and sterically matched to the pocket. 
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2.2 AutoDock 
AutoDock is an automated docking tool. In a docking simulation, a ligand starts from a 
random position. The flexibility of the ligand is modelled, and the translations, 
orientations, and conformation of the ligand are explored by a search method until 
putative binding sites have been found. AutoDock employs a force field energy 
evaluation method. AutoDock uses a united atom model, in which non-polar hydrogens 
are merged and the charges are assigned to the corresponding carbon, leaving only the 
heavy atoms and the polar hydrogen atoms. 
 
2.2.1 Search method 
Genetic algorithms (GA) [104] apply the concept of Darwinian natural evolution and 
Mendelian genetics, and are suitable for problems that suffer from combinatorial 
explosions as the ligands complexity increases with increased degrees of freedom. 
AutoDock uses GA to perform a global search for best docking pose. The arrangement of 
a ligand with respect to a protein, is described with a set of real values and these refer to 
a ligand’s “state variables”, analogised as a gene in a chromosome (the chromosome 
itself refers to solutions of a problem), while the atomic coordinates are analogised to 
the phenotype. Chromosomes are evaluated for the fitness based on the calculation of 
interaction energy and decide which to pass down to the next generation. Mutation and 
crossover operations which offer a larger degree of alternation, are passed from parents 
to their children, increasing the chance of exploring other areas of the conformational 
space. Based on the evaluation of the fitness, selection allows reproduction of offspring 
better suited to the environment. 
In detail, each ligand is defined by a set of real values including three Cartesian 
coordinates, describing the ligand's translation, four values for quaternions defining the 
ligand's orientation [105], and one value for each defined conformation torsion of the 
ligand with respect to the receptor. The search process starts by creating a user defined 
number of random individuals that makes the initial population, followed by iteration 
over a number of generations until any of the termination criteria are met. A generation 
consists of mapping, fitness (energy) evaluation, selection, crossover, mutation, and 
elitist selection. (Figure 6) 
31 
 
 
Figure 6 - Modified from [106]. The process of a genetic algorithm. Each generation 
consists of the following, in the order given: mapping, fitness evaluation, selection, 
crossover, mutation, elitist selection and local search. 
Firstly, each genotype is “mapped” to corresponding phenotype (that is the ligand's 
atomic coordinates) to allow interaction energies to be evaluated by a grid-based 
approach. Then, it goes through a selection process based on fitness value, such that 
individuals with better than average fitness are ensured to have at least one offspring. 
Crossover and mutation are used to apply random perturbations to the parents. 
Crossover and mutation occur between random individuals at a user defined rate, and 
the resulting offspring replace their parents to keep the population size constant. The 
value replaced by a mutation is a random real number that has a Cauchy distribution for 
small deviates. The new generated population from the proportional selection, 
crossover, and mutation is ranked according to fitness. 
 
32 
 
A user defined fraction (0.06 was found to be in maximum efficiency) of populations 
undergo a local search, based on that of Solis and Wets method [107]. The local search is 
performed in genotypic space (as illustrated in Figure 6) rather than in the phenotypic 
space, so that the acquired traits from local adaptation can be inherited by 
their offspring; otherwise an inverse mapping approach is required to convert the 
phenotypic result of local search into its corresponding genotype. Instead of dedicating 
effort to an inverse mapping, AutoDock performs a local search operation in genotypic 
space using modified Solis and Wets method with a translational step size of 0.2, and 
orientation and torsional step size of 5. The step size of the local search is adaptive.  
The combination of the global and adaptive local search method results in the 
Lamarckian genetic algorithm. The Lamarckian method was developed, so that the 
results from LS are heritable to offsprings. A genotypic space is used in the Lamarckian 
search method, in contrast to the typical phenotypic search space.  
 
2.2.2 Energy evaluation during sampling 
AutoDock uses a grid-based approach [108,109] to reduce the run time spent for 
evaluating candidate conformations. AutoGrid is used to generate grid maps. To do this, 
a protein target is placed in a 3D grid box and a probe atom systematically visits every 
grid point. (Figure 7) The pairwise interaction energies of the probe, and of the protein 
atoms positioned within a cut-off radius of 8Å at each grid point are summed and stored 
in the grid maps, providing a pre-calculated lookup table to speed up energy evaluation. 
Grid maps, including dispersion/repulsion terms and a hydrogen-bonding energy, are 
created for each atom type in the ligand. A separate electrostatic potential grid is also 
created. During the docking, interaction energies are calculated from the pre-calculated 
grid maps using trilinear interpolation. 
 
33 
 
 
Figure 7 - Adopted from [110] illustrates the grid-based method. 
The pair-wise atomic terms include evaluations of dispersion/repulsion energies, 
calculated using the Lennard-Jones 6-12 potential with coefficient A𝑖𝑗  and B𝑖𝑗  
calculated from the well depths and equilibrium distances of homogeneous pairs using 
AutoDock force-field parameters (AMBER) [111]. Hydrogen bonds are described by the 
12-10 potentials with well depths increased by a factor of 10. The electrostatic 
interaction energy is calculated using Coulomb’s potential using a single positive charge 
probe. The resulting electrostatic interaction energy of each ligand atom is the 
multiplication of the trilinearly interpolated electrostatic potential with the ligand's 
partial charge. Intramolecular energies of the ligand are calculated at each time step 
using the functional forms described above, but with a factor of 4 in the dielectric 
constant. [112] 
 
2.2.3 Scoring  
AutoDock4 uses a semiempirical free energy force field, combining molecular mechanics 
force field with an empirical method, to predict binding free energies. It uses pair-wise 
terms to evaluate the interaction between the two molecules and an empirical method to 
consider the contribution of water implicitly. The free energy of binding ∆G (see 
Equation 6) is estimated to be equal to the sum of the intramolecular energies by 
consideration of the bound and unbound states of the ligand and the protein 
respectively; the third term gives the intermolecular energy between the bound and 
unbound states of the complex. It is assumed that the two molecules are sufficiently 
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separate in an unbound state, making (𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑃−𝐿 ) zero. As the protein (𝑃) is kept 
frozen, and considering there is no interaction in the unbound state, the energies are set 
to zero. An extended conformation of the ligand (𝐿) in which atoms could be fully 
solvated, with few internal contacts, is used as unbound state. The conformational 
entropy lost upon binding (∆𝑆𝑐𝑜𝑛𝑓) is estimated to be directly proportional to the 
number of rotatable bonds (𝑁𝑡𝑜𝑟) in the molecule. [113]  
Equation 6 - The free energy of binding is estimated by: 
∆G = (𝑉𝑏𝑜𝑢𝑛𝑑
𝐿−𝐿 − 𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝐿−𝐿 ) + (𝑉𝑏𝑜𝑢𝑛𝑑
𝑃−𝑃 − 𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑃−𝑃 ) + (𝑉𝑏𝑜𝑢𝑛𝑑
𝑃−𝐿 − 𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑃−𝐿 + ∆𝑆𝑐𝑜𝑛𝑓) 
∆𝑆𝑐𝑜𝑛𝑓 = 𝑊𝑐𝑜𝑛𝑓𝑁𝑡𝑜𝑟 
Each pair-wise evaluation (V) can be expressed as Equation 7. The weighting constants 
(𝑊) are optimised to calibrate the empirical free energy based on experimental data 
and are applied to each term. Dispersion/repulsion interactions are calculated using the 
Lennard-Jones 6-12 potential, where 𝐴𝑖𝑗  and 𝐵𝑖𝑗  are taken from the AMBER force 
field. The hydrogen bonding is based on the 12-10 potential where a directional weight 
Ε(𝑡) is used to calculate the divergence from ideal bonding geometry. A maximal well 
depths of 5 kcal/mol at 1.9Å for O-H and N-H and 1 kcal/mol at 2.5Å for S-H are used to 
derived the parameters 𝐶𝑖𝑗, 𝐷𝑖𝑗. Electrostatic interaction is evaluated using a screened 
Coulomb potential. The desolvation potential is based on the volume of the atoms 
surrounding a given atom, weighted by a solvation parameter and an exponential term. 
(weighted factor=3.5Å) [113] 
Equation 7 - The pair-wise atomic terms include: 
V = 𝑊𝑣𝑑𝑊 ∑ (
𝐴𝑖𝑗
𝑟𝑖𝑗
12 −
𝐵𝑖𝑗
𝑟𝑖𝑗
6 )
𝑖,𝑗
+ 𝑊ℎ𝑏𝑜𝑛𝑑 ∑ (
𝐶𝑖𝑗
𝑟𝑖𝑗
12 −
𝐷𝑖𝑗
𝑟𝑖𝑗
10) Ε(𝑡) +
𝑖,𝑗
𝑊𝑒𝑙𝑒𝑐 ∑ (
𝑞𝑖𝑞𝑗
𝜀(𝑟𝑖𝑗)𝑟𝑖𝑗
) + 𝑊𝑠𝑜𝑙
𝑖,𝑗
∑(𝑆𝑖𝑉𝑗
𝑖,𝑗
+ 𝑆𝑗𝑉𝑖) 𝑒
𝑟𝑖𝑗
2
2𝜎2 
The desolvation term is based on Wesson and Eisenberg’s model [114], where 𝑆𝑖 is the 
atomic solvation parameter calculated from the energy needed to transfer the atom from 
a fully hydrated to a fully buried state. They postulate that the desolvation energy is 
proportional to the change of surface area exposed to the water by comparing the 
solvent accessible surface area of the bound and unbound states. The amount of 
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desolvation 𝑉𝑖 is calculated by a modified method using volume-summing method from 
Stouton et al. [115]  
One issue of the data used in calibration is that the cost of burying a hydrogen bond 
without forming a bond to the protein is unknown. Desolvation of polar atoms is 
modelled by a constant, added in the hydrogen bonding function. It is assumed that 
hydrogen bonding to the complex is the same as bonding to water. Polar atoms that do 
not form hydrogen bonds will have an unfavourable effect on binding. Polar atoms are 
modelled by combination of the favourable hydrogen potential and the unfavourable 
desolvation potential.  
 
2.3 Introduction of molecular dynamics (MD) 
2.3.1 Energy minimisation  
Energy minimisation is a prerequisite for other simulation techniques (i.e. molecular 
dynamics) to relieve strain in the initial structure and to reduce the thermal noise 
allowing better comparison between structures. This is because the energy of a system, 
composed of kinetic and potential energies, is conserved during MD simulations. The 
kinetic energy will increase significantly if low potential energy structure is sampled, 
which can distort the structure. Therefore, it is essential for a MD to start from the 
minimised structure. An energy minimisation moves atoms systemically toward the 
atomic positions at the closest (local) minimum of the potential energy surface, resulting 
in a local minima stable state. The minimisation methods can be energy-based, gradient-
based or a minimisation taking account of the second derivative of the potential energy 
function.  
The steepest descent (or gradient descent) minimisation algorithms [116] use the first 
order derivative from the potential energy function to determine the direction for the 
next move to move toward a negative gradient (more negative, stable conformation). 
Convergence can be slow whilst in the vicinity of the local minimum, as the algorithm 
does not consider the previous steps.  
 
2.3.2 Force field 
Force field methods are also referred to as molecular mechanics (MM). It describes the 
potential energy surface by treating the electrons implicitly and expressing the energy 
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with respect to nuclear coordinates, in which the electrons are not treated, and the 
quantum character of nuclear motion is neglected, and with the atoms treated with 
classical mechanics. The interactions are parameterised beforehand and are not changed 
during the calculation. The electronic energy is calculated from summation of potentials, 
which can be divided into non-bonded, bonded and restraints.  
Equation 8 - A typical force fields: 
V = ∑
𝑘𝑖
𝑏
2
𝑏𝑜𝑛𝑑𝑠
(𝑙𝑖 − 𝑙𝑖
𝑟𝑒𝑓
)
2
+ ∑
𝑘𝑖
𝑎
2
𝑎𝑛𝑔𝑙𝑒𝑠
(𝜃𝑖 − 𝜃𝑖
𝑟𝑒𝑓
)
2
+ ∑
𝑉𝑇
2
[1 + cos(𝑛𝜔 − 𝑟)]
𝑡𝑜𝑟𝑠𝑖𝑜𝑛𝑠
+ ∑ ∑ {4𝜀𝑖𝑗 [(
𝜎𝑖𝑗
𝑟𝑖𝑗
)
12
− (
𝜎𝑖𝑗
𝑟𝑖𝑗
)
6
]} +
𝑞𝑖𝑞𝑗
4𝜋𝜀0𝑟𝑖𝑗
𝑁
𝑗=𝑖+1
𝑁−1
𝑖=1
 
The potential energy (V) is generally expressed as sum of firstly, the bonded interactions 
including (1) the bond stretching (a two-body term), modelled by a harmonic potential 
with spring constant 𝑘𝑖
𝑏. The deviation of the bond length 𝑙𝑖 from its equilibrium 
(reference) distance 𝑙𝑖
𝑟𝑒𝑓 , either stretching or compressing, result in an increase of 
energy; (2) the angle bending (a three-body term), modelled by a harmonic potential on 
the angle. 𝜃𝑖 − 𝜃𝑖
𝑟𝑒𝑓 equals to the difference between the angle 𝜃𝑖 to its reference bond 
angle 𝜃𝑖
𝑟𝑒𝑓 and 𝑘𝑖
𝑎 denotes the bending force constant; and (3) the proper and 
improper dihedrals (four-body terms), modelled by a periodic cosine function, where 𝑛 
denotes the dihedral multiplicity, 𝜔 the torsion, 𝑟 the phase shift and 𝑉𝑇 the force 
constant refers to the energy barrier associated with the rotation of a dihedral angle, 
computed based on fixed lists. The latter is used for keeping planar groups planar and to 
prevent a flip to their mirror images (Equation 8) 
Secondly, the non-bonded interactions, which include (4) the Lennard-Jones (a two-
body term) consist of a repulsion term caused by the Pauli exclusion principle and a 
dispersion term, where the equilibration distance 𝜎𝑖𝑗 between atom 𝑖 and 𝑗 depends 
on pairs of atom types, can be taken from look up table of Lennard-Jones parameters, 𝜀𝑖𝑗  
is the potential well depth and 𝑟𝑖𝑗 is the distance between pairs of atoms 𝑖 and 𝑗; and 
(5) Coulomb and modified Coulomb interactions. The expression is pair-additive, in 
which all pairs of atoms separated by at least three bonds are calculated intra- and inter-
molecularly with the Coulombic law, where 𝑟𝑖𝑗 is the distance between two partial 
atomic charges 𝑞𝑖 and 𝑞𝑗, and 𝜀0 is the dielectric constant. Calculations are computed 
based on a neighbour list, listing non-bonded atoms within a certain radius and are 
typically solved by assuming a constant dielectric environment beyond the cut off with a 
dielectric constant. (Equation 8) 
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Thirdly, constraints including position, angle distance etc. are based on fixed lists, which 
is not shown in the Equation 8. 
 
2.4 Molecular dynamics (MD) 
MD is used to simulate the dynamical behaviour of the system in real time, and under 
real conditions whilst considering solvent and ions etc. MD solves Newton's equations of 
motion (Equation 9) to derive atomic positions to describe how the system evolves with 
time. The output coordinates at regular intervals are saved to a trajectory; an ensemble 
of conformations which will reach to an equilibrium state. The method of MD is a 
deterministic method, that is the state of the system of the future can be predicted from 
current state.  
Equation 9 - Newton’s equation of motion, the forces are the negative derivatives of the 
potential function 𝑉: 
𝑚𝑖
𝜕2𝑟𝑖
𝜕𝑡2
= 𝐹𝑖 = −
𝜕𝑉
𝜕𝑟𝑖
, 𝑖 = 1 ⋯ 𝑁 
, where 𝑚𝑖 is the mass of the 𝑖th atom, and the 𝑉 is the potential energy of the system 
with respect to position 𝑟𝑖. MD calculations are broken down into small time steps to 
simulate the real time potential. At each step, the atomic forces on the atoms are 
computed and with the current positions and velocities new positions and velocities are 
generated.  
Velocities are randomly generated (temperature) as an initial step acting on all atoms. 
The system then evolves from the starting point using the velocity (v) at time t = 0 by 
solving Newton’s laws of motion; resulting in a set of coordinates at time t = 𝑖. From the 
coordinates, the potential energy can be obtained. The first derivative of this energy 
gives the force acting on each atom, which become the new velocities for the next step. 
This strategy allows exploration of a greater fraction on the energy landscape. The force 
acting on each atom is constant during the time interval, and is implemented using a 
force field. The positions of the atoms in a small-time interval can be expressed by a 
Taylor expansion that depends on the velocities, acceleration and hyperaccelerations.  
Periodic boundary conditions are applied to prevent artefacts arising from the box 
edges, and are used with the minimum image conversion where only the nearest image 
of each particle is used to compute short range non-bonded interactions. Integration 
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methods of MD can be either the velocity Verlet (Tinker) [117] or the leap-frog 
integrator (Gromacs) [118] used to update position and velocities of the MD simulations.  
In velocity Verlet algorithm, positions 𝐫𝑖(𝑡) and velocities 𝐯𝑖(𝑡) are defined at each 
time step and the trajectory for N particular are generate iteratively using Equation 10: 
Equation 10 - The velocity Verlet algorithm: 
𝐫𝑖(𝑡 + 𝛿𝑡) = 𝐫𝑖(𝑡) + 𝛿𝑡𝐯𝑖(𝑡) +
(𝛿𝑡)2
2𝑚𝑖
𝐅𝑖(𝑡) 
𝐯𝑖(𝑡 + 𝛿𝑡) = 𝐯𝑖(𝑡) +
𝛿𝑡
2𝑚𝑖
[𝐅𝑖(𝑡) + 𝐅𝑖(𝑡 + 𝛿𝑡)] 
, where 𝐅𝑖(𝑡) is the force on particle 𝑖 at time 𝑡 and is calculated from the potential 
energy function.  
The drawbacks of the MD approach, include (a) when the dynamics of the particle is 
described by the classical mechanics, hydrogen atoms and high frequency vibrations 
which require quantum mechanical treatments to properly represent are not modelled. 
One could either apply corrections to the total internal energy or constrains on bond 
lengths (or bond angles). Default setting in gromacs is LINCS or P-LINCS [119] which 
enable constraints to be parallel processing across the nodes. (b) MD describes the time 
evolution of nuclear positions alone and neglects of electronic motions, limiting MD to 
model the dynamics of reactions, breaking and formation of chemical bonds. (c) MD uses 
force field or potential energy function, which is semi-empirically derived using 
experiments and quantum mechanics calculations, to define the interactions between 
atoms. As a result, force fields are fixed during the course of simulation to mainly pair 
additive (including non-bonded forces), with the exception of long range Coulomb forces 
and that the polarizabilities are not considered.  
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CHAPTER 3. A Random Forest Model for Predicting Allosteric and 
Functional Sites on Proteins 
This chapter is based on my publication: 
Chen, A. S. Y., Westwood, N. J., Brear, P., Rogers, G. W., Mavridis, L., & Mitchell, J. B. O. 
(2016). A Random Forest Model for Predicting Allosteric and Functional Sites on 
Proteins. Molecular Informatics. 35, 125-135. 
 
3.1 Introduction to allostery  
Allostery is a universal mechanism for regulation of a protein’s activity, typically an 
enzyme, by the binding of a ligand molecule to a cleft other than the protein’s active site. 
In contrast to conventional use of orthostery as a simple on-off device, allosteric 
regulation can act as a dimmer switch, and offer greater fine modulatory control over the 
level of protein activity. [120] A typical enzyme has one active site, but may have 
multiple allosteric sites.  
 
3.1.1 Old view 
The traditional understanding of allostery focuses on those binding events that induce a 
conformational change affecting the activity of another site of the protein. The classical 
explanation of how allosteric regulation is achieved was proposed in the Monod-
Wyman-Changeux (MWC) [121] and the Koshland-Nemethy-Filmer (KNF) [122] models 
(Figure 8), where the cooperativity between subunits of an oligomeric protein is coupled 
with a conformational change. According to the MWC model, cooperativity is achieved by 
a concerted transition between two alternative states, the protein being in either the T 
(tense) or R (relaxed) state. For the KNF model, a binding-induced conformational 
change in one subunit is propagated sequentially among other subunits. Both models 
imply that the conformational change at the substrate binding site results from the 
transmission of a signal initiated by allosteric effector binding. [123,124] 
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Figure 8 – Modified from [125]. Classic models of allostery (a) the concerted MWC model 
and (b) the sequential KNF model, where S represents substrates. Each subunit is in 
either a tense (T) or a relaxed (R) state, where the R state is more receptive to ligand 
binding.  
 
3.1.2 New view 
Conformational state redistribution is a concept that has been proposed to explain 
allosteric regulation. The native protein appears to exist as a conformational ensemble. 
[126,127] In contrast to the oversimplified classical models, Weber proposed that the 
binding results merely in a population shift of conformational states which were 
experimentally proved to have an effect on function. [128] Population redistribution 
enriches certain pre-existing conformations which were previously hardly seen due to 
low population. It is through the interconversion of the functional conformations that 
allosteric regulation is achieved. [129,130] 
Thus, Del Sol et al. [120] think of allosteric regulation as redirecting the levels of traffic 
on dynamic communication pathways that already existed prior to effector binding, 
rather than establishing new pathways. They note that allosteric regulation can occur in 
the absence of significant conformational change, though some kind of communication 
between sites must take place. 
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3.2 Allostery and Drug Design 
The discovery of new allosteric sites is of interest for drug design. In contrast to active 
site inhibitors, allosteric binding can lead to either an increase or decrease in activity of 
a protein. In addition, allosteric effectors do not necessarily share similar chemical 
properties with the natural substrate, as a site distinct from the active site is targeted. 
This provides an alternative route for the discovery of promising new leads for 
regulation of the same target. Allosteric sites on proteins are also subject to lower 
evolutionary pressure compared to the active site, which is beneficial when designing 
target-specific inhibitors. [131] 
Despite the advantage of variation among homologs that an allosteric site has, this may 
cause difficulty in studying allosteric mechanisms, since the allosteric sites are hard to 
predict by traditional homology methods based on sequence similarity. [131] For 
protein families where a reasonably large number of sequences are available, a more 
effective approach to sequence-based allosteric site prediction is to assume that 
allosteric sites are associated with networks of co-evolving residues. [132,133] In this 
way, Novinec et al. [134] identified a network of co-evolving residues putatively 
responsible for communication between allosteric and functional sites from a multiple 
sequence alignment of papain-like cysteine peptidases. This prediction, along with 
associated experimental work, allowed them to identify a promising inhibitor candidate. 
Panjkovich and Daura [135] applied normal mode analysis (NMA) to consider changes in 
the flexibility of a protein upon ligand binding. To achieve this, ligands were represented 
as dummy atoms arranged in an octahedron. For each putative binding site, the NMA-
derived B-factors of the apo and the bound states were compared in order to identify 
any large changes in the B-factors, these indicating potential allosteric sites.  
A two-way classification model was proposed to differentiate allosteric from non-
allosteric sites by Huang et al. [136] They developed a support vector machine (SVM) 
based machine learning model, based on 90 allosteric sites selected from allosteric 
database (ASD) and 1360 predicted non-allosteric sites from the same set of proteins 
using the Fpocket algorithm. For their SVM model, sets of site descriptors were derived 
to characterise the topological structure and physicochemical properties of both types of 
sites, obtaining a total of 41 site descriptors. A somewhat related method has been 
adopted by van Westen et al. [137] to select allosteric modulators based on the 
physicochemical and structural descriptors calculated for those molecules from the 
ChEMBL database. [138] Several machine learning approaches have also been used with 
other dynamic-or NMA-based approaches to predict the location of allosteric sites. 
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[139,140] 
Other studies relevant to the prediction of allosteric interactions focus on simplified 
models of protein dynamics, using approaches like NMA [135], energy exchange [141], 
and Monte Carlo path generation [142]. 
 
3.3 Serendipitous binder 
Almost all protein crystal structures contain non-cognate bound ligand molecules, such 
as stabilising agents and buffers used during crystallisation [143], which was originally 
regarded as a crystallisation artefact and was once believed to have no effect on protein 
function, despite their role in maintaining protein solubility and stability for NMR 
experiments. Yet growing evidence of its effect on protein dynamics implies that protein 
function will be affected by ligand binding [144]. These molecules represent a potential 
starting point to design novel probes for new allosteric sites and as a tool to study 
changes in protein dynamics induced upon the binding of a buffer molecule. [145] In this 
study, buffer molecules are introduced as potential binders to identify locations of 
possible allosteric sites. 
 
3.4 Aims and Objectives 
In this work, we focused on identifying potential allosteric sites, while making better use 
of available crystal data in the PDB. We used the co-crystallised ligands to calculate 
descriptors from the ligand and from the structures of the sites, thus building a machine 
learning model. Our aim is to identify binding sites which are purely crystal contacts 
from potential allosteric sites. These bound ligands could be a starting point to guide 
experiments aimed at probing the nature of the sites. 
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3.5 Method 
To do this, we use a complementary approach, founded on a deeper analysis of the 
structures of potential binding sites. We assemble collections of three kinds of site based 
on its function: first, known orthosteric functional (active) sites of proteins in which the 
main cognate ligand binds; second, allosteric sites in which allosteric effectors can bind; 
third, a structurally representative set of other protein clefts, expected to be neither 
functional nor allosteric. For these three sets of sites, descriptors are proposed to 
identify and discriminate the binding state of individual ligands between the three 
different subsets. We use our existing protein-ligand scoring function RF-Score [146] and 
a new accessibility-like algorithm called CavSeek to compute structurally-based binding 
descriptors and descriptors pertaining to the composition and flexibility of the clefts. We 
use these as features in a ternary predictive model, employing the Random Forest 
machine learning algorithm. We take advantage of the out-of-bag data, [147] and 
separately those instances omitted from the stratified balanced samples, to conduct a 
fair validation, which uses only data excluded from model building. Then the model is 
subsequently used to predict the types of sites where CHES binds, with the objective of 
identifying candidate allosteric sites on proteins. The challenge was to differentiate the 
binding sites based on a combination of descriptors. In presenting our result, we 
investigated whether the results previously obtained through manual inspection 
corresponded to those obtained with our computational approach.  
Our work is distinct from Huang et al.’s [136] in our design of a three-way predictive 
model containing two classes other than allosteric, and distinct from van Westen et al.’s 
[137] in that our work predicts allosteric sites (not molecules) using co-crystallised 
molecules and descriptors derived from the structure of the sites as well as from the 
ligands. 
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Workflow 
Figure 9 - A flowchart of the methodology. 
 
 
3.6 Collection of training data 
We have annotated our data according to where the ligand has bound to its protein using 
three classes: allosteric, regular and orthosteric sites. Each subset was included 
independently, and for convenience these are denoted by the capital letters A, R and T, 
respectively.  
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3.6.1 Allosteric Sites (A) 
A total of 91 proteins adopted from Panjkovich and Daura’s work were initially used to 
represent the subset of allosteric sites in the training set. [131] The data were primarily 
collected from the online AlloSteric Database (ASD) and from the literature, and were 
further filtered to be structurally non-redundant by the sequence clustering program 
BLASTClust. The protein with the highest resolution structure of each of the resulting 91 
groups was selected to represent that group. ASD [148] provides a list of the allosteric 
residues in the given protein. We compared those residues, thus annotated as 
comprising an allosteric site, to the list of residues involved in ligand binding extracted 
from PDBsum. [149] From this, we can identify any ligand that is bound in the allosteric 
site in order to obtain descriptors which capture the binding profile of the ligand in the 
allosteric pocket. If there are many instances in which the same ligand adopts an 
equivalent binding mode, the one with the highest RF-score value is kept in the subset to 
represent the particular binding pattern. Thus, the list has been whittled down to 59 
representative allosteric (A) protein pockets. (see Table 1 in Appendix for protein lists) 
 
3.6.2 Orthosteric Sites (T) 
A total of 195 protein-ligand complexes representing the subset of orthosteric (T) sites 
were retrieved from the PDBbind database (version 2007). [150] These data were 
originally used for the purpose of validating scoring functions in Cheng et al.'s study. 
[151] The data contain experimentally determined binding affinity values obtained from 
the literature. Cheng et al. further filtered their initial collection of data to account for 
the quality of structures, the quality of binding data, the components of complexes and 
redundancy of protein sequences, to avoid over-representing certain families. They 
clustered the remaining complexes according to sequence similarity and selected the 
complexes with the highest, the median and the lowest binding affinity to represent each 
of the 65 clusters, giving 195 complexes in total. In this study, we have further whittled 
down the number to 159 complexes which have only small molecules in the pocket. 
 
3.6.3 Regular Sites (R) 
The regular site subset was derived from a representative set of protein domain 
structures, each of which is given by CATH [152] as an example representing the 
homologous superfamily to which it belongs. From each such structure, one ligand 
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binding site is selected according to PDBsum. [149] For enzymes, we chose sites having a 
ligand which is neither a cofactor nor similar to the enzyme’s product or substrate. 
Ligands were selected to have no contact with any residues of any allosteric site given in 
ASD. Therefore, the sites occupied by the selected ligands are unlikely to be active sites 
or allosteric pockets. The regular subset is expected to have the weakest binding affinity 
and the lowest burial value of the three subsets. These weak interactions correspond to 
the regular binding events by which non-cognate ligands bind, possibly as accidents of 
crystallisation.  
A total of 99 instances were selected for the subset of regular (R) sites. The number 
representing each class was designed to be proportional to the prevalence of that 
structural class amongst all CATH [152] superfamilies (2620 superfamilies in total). 
There are four top C-level classes defined in the CATH database. Table 1 shows the 
number of entities included from each CATH class.  
Table 1 - Distribution of regular sites amongst CATH C-level classes. 
 
Class No. 
Mainly alpha 32 
Mainly beta 20 
Alpha beta mixture 42 
Few Secondary Structures 5 
 
3.7 Collection of external testing data (CHES) 
The PDB crystal structures containing the buffer molecule CHES (2-(N-cyclohexylamino) 
ethane sulfonic acid) were investigated. CHES is one of the many buffer molecules that 
commonly complex with proteins during the crystallisation process. 
In total, 82 CHES containing entries had been released in the PDB up to Dec 2013. From 
these, our external testing CHES set of 158 CHES-protein binding sites (some proteins 
have multiple CHES ligands) has been identified and each site is characterised by a set of 
descriptors individually calculated for it. We noted 14 cases in which CHES was bound in 
a protein's defined pockets [145], from which only one of these 14 CHES molecules was 
found in an allosteric site, that of a bacterial sialidase (NanB). [153] There results were 
manually identified by Brear and Westwood [145], who were hoping to see if the CHES 
was bound at the site where other small molecules can also bind. We have further 
specified which one or more of multiple CHES molecules in a given structure were being 
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referred to in their review results by using literature searching to identify the cavities as 
allosteric sites or otherwise. 
 
3.8 Random Forest 
We used the randomForest package in R [154,155] to build predictive models with the 
default setting of mtry to the square root of the number of descriptors and with ntree set 
to 10,000. Random Forest is widely considered relatively immune to overfitting. Each 
tree is grown by stochastic recursive binary partitioning, and the individual trees carry 
independent information because of the substantial random element in their 
construction.  
Three further considerations apply to the use of Random Forest in this work. First, each 
tree is built by bootstrap sampling from the same balanced dataset, which we 
constructed by stratified sampling (subsampling) to include an equal number of objects 
(53) from each class, a total of 159 sites to avoid bias due to imbalanced class sizes. 
Within this stratified balanced set, the bootstrap sampling means that approximately 
63% ( 1 – 1/e) of the data are used once or more in the building of each constructed 
tree, and the remaining 37% ( 1/e) or so are reserved for OOB validation of that tree. 
The bootstrap sampling from the balanced set is repeated afresh for each of the 10,000 
trees.  
Further, the performance of the Random Forest model is assessed firstly on the OOB data 
and secondly on the external test set consisting of the158 sites (46 R, 106 T and 6 A) 
omitted from the stratified (balanced) dataset. Those data excluded from the stratified 
balanced set in advance of the bootstrap sampling form an external test set which was 
separately used for further validation. This entire process of generating 10,000 trees was 
itself repeated ten times with different random seeds to avoid losing information from 
the majority class in training the models, see Figure 9. 
Finally, Random Forest is designed to handle the inclusion of redundant and irrelevant 
descriptors through the process of selecting possible splits at each node from a 
substantial set of randomly chosen options. [147] This obviates any need for an explicit 
descriptor selection step, and is particularly useful when a bespoke descriptor set is 
used, as in the present work.  
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3.9 Descriptor 
Every binding instance was characterised by the same set of descriptors.  
Table 2 - List of descriptors and their abbreviations. 
 
RFSCxCSK The RF-Score (R) times average burial over nine 
thresholds estimated by CavSeek 
Binding Site 
RF.score The unadjusted RF-Score (R) Binding Site 
NormRFScore The normalised RF-score (R/E) Binding Site 
Function_F195 The expected RF-score (E), calculated by a fitting 
function E=2.222 N⅓ 
Binding Site 
B_protein Average B-factor of the protein Binding Site 
B_pocket Average B-factor of the contact residues defined as 
protein residues <4Å to the ligand 
Binding Site 
noContact_resi Number of contact residues Binding Site 
 
3.9.1 CavSeek 
 
Figure 10 - The burial percentage is calculated as the number of distances considered to 
be “in contact” (less than or equal to a certain threshold) over the total number of 
measurements taken. The distance is measured between points of any CHES atom (on 
the left) to the van der Waals sphere of any protein atom. 
rw, r1w: vdw radii of individual atoms 
“In contact”: R-r1w threshold  
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In order to measure the burial of a ligand within the cavity of the protein binding site, we 
developed an accessibility-like program called CavSeek using a script written in Java. For 
a given protein and ligand, we calculate the percentage of possible point-to-atom 
contacts which are shorter than a given threshold value and hence are said to be “in 
contact”. A number of thresholds from 0.5 to 2Å have been selected to profile optimally 
and identify a ligand’s binding site. The aim of this program is to make it possible to 
discriminate computationally between surface-binding molecules and pocket-binding 
molecules. Ligands that are found within a protein cleft in a small binding pocket will 
have a higher percentage of sub-threshold contact distances. The percentage burial 
increases with the size of the thresholds as more points are counted. To generate 
descriptors from CavSeek, one can either include the result at each different threshold as 
a separate descriptor, or calculate an average burial as a single descriptor. For this study, 
we have included the burial at nine individual thresholds and also the average burial.  
In detail, CavSeek first centres the protein-ligand complex at the geometric centre of the 
ligand. We remove all protein atoms which are more than 20Å away from this origin, 
since there is a very little prospect of those atoms having a significant interaction with 
the modestly sized ligands that we study. We then represent each ligand atom as a 
sphere using the following van der Waals radii (r) in Ångstron: Br (1.85), C (1.7), Cl 
(1.75), F (1.47), Fe (2.0), I (1.98), N (1.55), O (1.52), P (1.8) and S (1.8). [156] For an 
atom at (x, y, z), we define six points on the van der Waals sphere along the co-ordinate 
axes at (x±r, y, z), (x, y±r, z) and (x, y, z±r). (Figure 10) For each of these six points, we 
calculate the shortest distance to the corresponding van der Waals sphere around any 
protein atom. The hydrogen atoms in both ligand and protein are ignored. For a ligand 
with M atoms, this results in 6M distances, each of which is compared with the 
threshold. All distances less than or equal to the threshold are taken to be “in contact” at 
that threshold, and the percentage of the 6M distances that are “in contact” is recorded. 
This is repeated for all nine chosen threshold values. In the cases when crystal structure 
reveals alternative conformations of the side chain due to a partial occupancy, the first 
conformation listed in the PDB file was kept for this study. 
 
3.9.2 RF-score 
RF-Score [146] is our group's machine learning approach to predicting protein-ligand 
binding affinity, especially for docked structures. Previous knowledge-based approaches 
used ensembles of observed protein-ligand crystal structures to infer binding energies 
from atom-atom distance distributions. That approach makes the dubious assertion that 
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Boltzmann energetics apply, assuming a particular exponential functional form to 
transform distance distributions into binding energies. [157] RF-Score uses Random 
Forest to predict binding affinities from both structural data and the affinity data that 
are left unused in most knowledge-based approaches, yielding a much more accurate 
and flexible scoring function. 
In order to make the scores of differently sized ligands comparable, and to compensate 
for the intrinsic size-dependency of scoring functions, we calibrate RF-Score according 
to the number of heavy atoms (N) of its ligand. [158,159] Figure 11 illustrates the 
variation of the unadjusted scores, which we empirically fitted to a small number of 
physically justifiable functional forms. We empirically found that the best fitting function 
defining the expected score (E) for a ligand of given size was 
E = 2.222 N1/3 
For each ligand, we calculate the unadjusted RF-Score (R), the expected score (E), and 
the normalised score (R/E).  
 
Figure 11 – Normalisation of RF-Score. 
Each point represents an individual RF-Score of a different protein-ligand complex 
selected from the PDBbind database [150] used in this study as part of the subset of 
orthosteric sites within the training set. The fitted curve illustrates the function used to 
calibrate the scores with the ligand size. 
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3.9.3 Temperature Factor 
To include features that describe flexibility, we have used the temperature factor (or B-
factor). The B-factor, which reflects the degree of atomic displacement from their 
equilibrium positions in the crystals due to thermal motion, was extracted from the X-
ray crystallographic structures of the protein-ligand complexes in the PDB. A higher B-
factor implies that the atom has greater mobility. The average B-factor of the contact 
residues is divided by that of the protein to obtain values that reveal the differences in 
flexibility of the ligand binding region with respect to the entire protein. Firstly, to 
consider the bias arising from chain termini; the average B-factor of the protein with 
gradual omission of up to 10 residues at both ends was calculated. The results showed 
no significant change in the average B-factor between each omission; accordingly, 
proteins have been kept without terminal elimination. Secondly, the solvent and other 
ligands or cofactors were removed to obtain a B-factor resulting solely from the protein 
residues. The contact residues herein were defined as residues having at least one atom 
within 4Å of the centre of any atom of the ligand. B-factors of all the atoms of the contact 
residues and the protein are averaged and were included both as ratios and as separate 
descriptors in this study.  
 
3.9.4 Contact Residues  
Contact residues, which were defined as residues with an atom (or atoms) that are 
closer than 4Å to any atom of the ligand (as defined above), were utilized as descriptors 
to reflect the physicochemical composition of the ligand binding site. This includes a 
simple count of the total number of residues and the occurrence frequency of each of the 
20 amino acids. Moreover, the contact residues are further grouped according to their 
side chain chemistry into charged (R, H, K, D and E), polar (S, T, N and Q), hydrophobic 
(A, V, I, L, M, F, Y and W), aromatic (F, Y, W and H) and special (C, G and P) categories. 
Each count was taken as an individual descriptor.  
 
3.9.5 Small Molecule Descriptors  
We used the Chemistry Development Kit (CDK) [160] to compute descriptors for small 
molecules. CDK is an open source library written in Java for structural informatics 
calculations. First, the chemical structures of the ligand were inputted as SMILES 
extracted from each ligand structure file (in SDF format). Second, we calculated 277 CDK 
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descriptors for each compound, and removed features without discriminant power, 
those having either the same or an undefined value for all compounds in any of the 
training subsets. As a result, only the remaining 141 CDK descriptors were kept for 
further analysis.  
 
3.10  Result and Discussion 
3.10.1 Predictive performance (OOB) 
Prediction is based on a majority vote over the set of 10,000 trees (ntree). One vote is 
made by each tree for each instance that is OOB (not used in building the tree, because it 
was not chosen during the bootstrap sampling) by passing the OOB data down each tree 
to obtain a class prediction. From the aggregated OOB predictions, classes are assigned 
to each OOB instance by a majority vote of the trees. The OOB error, which shows the 
percentage of misclassification in the dataset, was calculated based on the known and 
predicted class labels. Separately, we also test the Random Forest’s predictivity by 
passing down each tree the external test set comprising those data that were omitted 
from the balanced set (46 R, 106 T and 6 A sites). 
Random Forest is insensitive to values of mtry except close to its high and low extreme 
values. [161] It was empirically shown in [147] that the performance of the Random 
Forest remains unchanged over a wide range of mtry values, and the defaults work the 
best for the majority of cases. For all 10 repeats (each of 10,000 trees per model), the 
default mtry was used. Five models were built using various sets of descriptors, which 
are classified as either small molecule or binding site descriptors according to the 
physicochemical features captured. Some of the most significant descriptors are listed in 
Table 2. For each model, we computed the average OOB error to estimate the prediction 
error thus to assess the accuracy that is independent of particular repeats; see Table 3. 
The OOB error is sensitive to the random determination of which protein-ligand 
complexes are kept in the training set, in general, with 3-4% deviation from the average. 
The first Random Forest model was trained using a total of 151 small molecule 
descriptors including 141 CDK descriptors and the heavy atom counts of each ligand. 
(see Table 2 in Appendix for the lists) The average OOB error of the Random Forest 
models obtained is 36.48% on the stratified balanced set, in which the pocket has been 
assigned a class label solely based on the small molecule descriptors of the ligand that 
binds to it. By the addition of 43 binding site descriptors, the second Random Forest 
model which includes properties of all calculated descriptors of both the bound ligand 
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and the site has a slightly improved error of 33.64%. Both models contained descriptors 
based on the structures of the small ligand molecules. These are invariant within the 
CHES set as the same compound CHES was used to characterise the pocket in each case. 
Thus, those models are not used in predicting our CHES set since these are descriptors 
without discriminating power for that set.  
Our third model used 43 binding site descriptors that describe ligand binding in terms of 
predicted affinity (RF-score), a percentage scoring scale for ligand burial (CavSeek), 
binding site flexibility (B-factor) and binding site hydrophilicity or hydrophobicity 
derived from analysis of the pocket composition. The model produced an average OOB 
error of 38.6% on the stratified balanced set. Subsequently, it was used on the CHES set 
to generate predictions for the CHES-protein binding pockets.  
Table 3 - Average OOB error rates for the different models.  
 
The OOB errors are presented as the percentage of misclassified data points in the 
stratified balanced set and separately in the external test set (comprising data excluded 
from the stratified set). Standard deviations are calculated over a hundred runs using 
different random seeds (10,000 trees per run), using N-1 = 99 in the denominator. 
 
3.10.2 Descriptor importance 
The importance of the individual descriptors can be evaluated either with the 
permutation method by observing the effect on the predictivity of Random Forest 
models of ‘noising up’ each descriptor, or alternatively with the Gini index, an impurity 
measure. The mean decrease Gini (MDG) (calculated over all trees) is a measure of 
improvement to the purity when that descriptor is made available to split the trees, thus 
producing greater purity in the resulting nodes. The decreases in Gini impurity for each 
descriptor used to form splits are summed over all trees and then normalised. A higher 
value implies greater importance of the variable concerned. Here, we report the results 
of variable importance as measured by impurity reduction, see Figure 12.  
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The top ranked binding site descriptors obtained by averaging the Gini importance 
values from 10 repeats are obtained. The leading descriptors are: first the product of the 
RF-Score and the average score of CavSeek (RFSCCSK), second the RF-Score values 
(RF.score), followed in third place (but with a significant decrease in importance) by 
protein flexibility (abbreviated to B_protein), fourth the residue count of the ligand 
binding site (noContact_resi), and fifth the normalised RF-Score (NormRFScore).  
The subsequent important descriptors are: sixth the flexibility based on the contact 
residues (B_pocket), and seventh the expected RF-Score (Function_F195, computed by 
size calibration with the number of heavy atoms N to the original score as 2.222N⅓). 
Those two have very similar Gini importance values. 
Similar importance rankings were found in all ten repeats, but they sometimes slightly 
differed in order. The calculation of relative importance allows a further assessment 
firstly of the classifiers based on the full set and secondly on classifiers based only on a 
few of the most important descriptors as a potential way to improve the performance, 
since generalisation tends to perform better in a lower dimension. To achieve this, we 
select the top 7 descriptors (from which to build the fourth model) and top 5 descriptors 
(for the fifth model) due to the breaks in the curve of the Gini importance plot, Figure 
12, indicating a considerable drop of importance from the fifth to the sixth variables and 
similarly from the seventh to the eighth. The predictive ability of the models with 
reduced numbers of descriptors, as measured by the OOB error, is shown in Table 3. An 
increased overall OOB error is observed as the number of variables is decreased by 
3.04% and 4.83% for the stratified set, relative to the model based on all binding site 
descriptors. Apart from the OOB error calculated, we also look for consensus of the 
results of computational predictions and literature findings, as discussed below.  
The results also show that our largest threshold of 2Å is desirable for CavSeek to achieve 
optimal discrimination between binding sites, based on the relative descriptor 
importance of the CavSeek scores at different thresholds. The version with the 2Å 
threshold is listed eighth in the variable importance ranking. CavSeek is combined with 
RF-Score by multiplication to increase their discriminative power, hence avoiding the 
difficulties inherent in adding or subtracting quantities with different dimensions. The 
combined descriptor of RF-Score and CavSeek improved the RF-Score by itself and is 
listed as the most important variable averaged from ten runs. RF-Score itself is listed as 
the second.  
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Figure 12 - The mean Gini importance values of each descriptor from the third model, 
averaged over ten repeats.  
The plot shows variable importance on the y-axis ordered from the most to the least 
important. The descriptors with the highest decrease in Gini impurity make the major 
contributions to partitioning the data into homogeneous classes.  
 
3.10.3 Predictions for the CHES set 
Here we collate the number of times each class is predicted for each CHES binding 
instance and report the class with majority votes from hundred repeats. (Appendix 
Table 3 and 4) The numbers assigned to each class are given so as to express the 
approximate level of confidence with which a class has been assigned from hundred 
repeats.  
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The model trained using all binding site descriptors returns six orthosteric (T) sites, of 
which four (pdb codes: 2VW2, two sites in 3OQI, and 3NOQ) showed matches with the 
manual annotation. The remaining two were known bind to the domain interface (both 
in 2ICH) interacting with conserved residues which were inferred to have functional role 
among homologs. [162] 
Among the 15 CHES binding instances predicted as allosteric (A), there is lack of 
literature for 4DQ0 and 3G8W. Both contain multiple CHES binding instances. Our 
results uncover three potential allosteric sites, which are not known orthosteric sites, 
supported by the literature. Four were found experimentally in sites considered [145] 
likely to be orthosteric (two in 3RIG, 1Q1Q and 1V30), see Table 3 in Appendix. 
Since CHES is not a natural cognate ligand for any protein it binds to, it is perhaps not 
surprising that orthosteric sites where the CHES binds (active sites evolved to bind other 
ligands) have been predicted as allosteric. The ligands in the orthosteric (T) subset of 
the training set from which the model was built were chosen to be more specific to the 
corresponding protein; thus, the more buried and stronger binding ligands were 
expected to be the cognate ones. In the potential future use of this methodology to 
predict allosteric sites using serendipitous binders, the workflow would therefore be 
designed to filter out known orthosteric sites from the set of allosteric predictions.  
In contrast, our fifth model using the top 5 descriptors resulted in more promising 
results. Five orthosteric sites have been predicted of which four are consistent with the 
previously discussed full binding site descriptor model (2VW2, two sites in 2ICH, and 
3OQI). An equal number of predictions amongst the 10 repeats assigned 3OQI to the 
orthosteric and allosteric classes. Three out of five orthosteric predictions were indeed 
experimentally determined to be orthosteric (2VW2, 3OQI and 1V30), while the 
remaining two are found at the domain interface (2ICH).  
The top 5 descriptor model identified 30 allosteric sites, of which 15 lack definitive 
description in the literature, six pockets correspond to manually annotated orthosteric 
sites (two in 3RIG, and one in each of 1Q1Q, 3OB9, 3NIB, and 4H75), and nine pockets 
were potential allosteric sites. The allosteric sites we have referred to are non-
orthosteric clefts, based on the literature. Yet, it is not known whether those pockets are 
functional allosteric sites, see Table 4 in Appendix. 
Unfortunately, the allosteric site obtained manually (2VW2, A1001) by Brear and 
Westwood [145] was not predicted correctly by either model; the cleft was identified as 
regular (R). We observed that CHES shares this pocket with a glycerol molecule which is 
lying deeper in the cavity. (Figure 13) 
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Figure 13 – View of a glycerol (coloured in green) bound to the same pocket with CHES 
(orange). Structure taken from PDB ID: 2VW2 (purple). 
We notice that three interface cavities were assigned to classes A or T (two in 2ICH, and 
4ATG), implying that there may be shared features of interface interaction common to 
the allosteric and orthosteric subsets. Indeed, the interface can potentially act as a 
binding site for an allosteric modulator. Binding of allosteric modulators at the interface 
between subunits of GABA receptor has been shown to have varying effects on the 
receptor's function. [163] Stanget et al. [164] revealed an allosteric binding site at the 
homodimeric interface of caspase-6 zymogen that impairs function. Descriptors to 
identify specifically the interaction interface can be exploited; perhaps interface cavities 
might be included in future work as an independent subset. 
One positive note is that, in spite of high error rates (38.6% for the full binding site 
descriptor model and 43.43% for the top 5 descriptor model) estimated using OOB data, 
both models have given promising results for potential allosteric sites. Nearly half of our 
prediction instances are not confirmed by the literature, yet instances that can be found 
in the literature are annotated as either orthosteric or in a binding cavity different from 
the orthosteric site. In fact, our top 5 descriptor model predicts most of the defined 
pockets (10 out of 14) that have been identified by Brear and Westwood to be either 
allosteric or orthosteric.  
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Our method provides a fast and low computational cost way to identify potential 
allosteric sites on large number of crystal structures. The co-crystallised non-cognate 
ligands and buffers that are commonly seen on most crystal structures are used, from 
which we extract binding site features. It is implicitly assumed that the crystal structures 
downloaded from the PDB have the correct ligand binding orientations, though we note 
that docking and ligand reoptimisation may in future play a role. The predictions were 
made based only on structures with non-cognate ligand bound. Thus, an adequate 
description of a binding cleft might not be possible. Also, potential allosteric sites 
containing no co-crystallised compound are invisible to our trained algorithm. The 
models were not trained to predict based on specific families. Thus, the number of 
regular sites included for each of the four structural classes at the C-level of the CATH 
classification [152] is roughly proportional to its prevalence in the CATH database. 
However, we noted that a known allosteric site is dominant in some families [137] or 
perhaps may only exist in particular families, thus introducing a systematic bias. Even 
though these issues may have contributed to the difficulties in predicting allosteric sites, 
resulting in a higher-than-ideal error rate, many of our allosteric sites predictions are in 
agreement with literature findings. Moreover, those non-cognate ligands that co-
crystallised with potential allosteric sites can be used as starting structures for the 
design of probes specifically created for these sites.  
 
3.11  Conclusion 
Allostery is a regulatory mechanism that affects protein function by the binding of small 
molecules to a site distinct from the active site. In contrast to traditional drug design by 
mimicking natural substrates, allosteric effectors offer therapeutic benefit for target-
specific drug design. The discovery of new allosteric sites in protein cavities has 
emerged as a new drug design approach to identify novel pharmaceutical agents.  
In this study, we have used Random Forest to build a three-way classification model for 
predicting allosteric pockets. We then report the results for a test set in which we 
consider instances of a buffer molecule, CHES, as a potential binder to allosteric sites; 
Brear and Westwood [145] observe 14 matches supported by the literature and 
structural analysis, wherein 10 of these 14 pockets were identified as either the 
allosteric or orthosteric sites of the protein by our top 5 descriptor (final) model. 
Although it is questionable whether other predicted pockets are truly functional, the 
implementation of a machine learning scheme allows discrimination between binding 
sites according to features that are captured from the protein-bound ligand 
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conformations. This can help reduce the number of PDB files needing to be looked at 
when hunting for potential novel allosteric sites, prioritising those which are predicted 
to belong to the allosteric category. Thus, this study shows promising results from using 
adventitiously binding buffer molecules as agents for allosteric site discovery. However, 
we also note that predictions of orthosteric pockets were hardly ever made for binding 
sites of CHES, a non-natural ligand for any protein. CHES appeared to be associated with 
lower binding affinity and lower burial in protein cavities compared to the ligands of the 
orthosteric subset used in the model’s training. However, mispredictions of orthosteric 
sites as allosteric will be easy to remove from a set of allosteric predictions, since the 
orthosteric sites are generally known for the PDB structures we are using. We found 
several CHES molecules bound in sites predicted to be either allosteric or orthosteric, 
though actually located at an interface. These can potentially be allosteric modulator 
binding sites. 
We have evaluated the descriptor importance by the Gini importance measure. RF-Score 
and its combination with CavSeek appeared to have significant discriminative power in 
identifying the binding pockets. These descriptors reflected the binding states of ligands 
with respect to their strength of interaction and to their degree of burial in the cleft of 
the protein. 
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CHAPTER 4. Docking Novel Ratiometric Sensors for Guanine 
Quadruplex Structures 
 
4.1 Introduction to DNA G-quadruplex 
A non-canonical DNA structure, a G-quadruplex, is composed of stacks of guanine 
tetrads, G-quartets, stabilised by coordinated cations within the central cavity and by π-
π stacking interactions between adjacent G-quartets. A G-quartet is a planar association 
of four Hoogsteen hydrogen-bonded guanines arranged in a cyclic fashion. These four-
stranded DNA structures can be formed in guanine-rich DNA and RNA sequences, and 
adopt different conformations as a result of different sequences, experimental 
conditions such as different cations (Na+ or K+) or different concentrations and degree 
of molecular crowding. [165] For example, experiments have demonstrated that G-
quadruplexes are stabilised by K+ ions at 10-50 mM concentration. [166] Molecular 
crowding, chaperones and dehydrating conditions would accelerate the folding of G-
quadruplexes. [167] 
In 1910, Bang [168] observed a gel-like aggregate formed from concentrated guanylic 
acid. X-ray diffraction studies in the 1960’s found this aggregate to be four guanine bases 
hydrogen bonded together in one plane. [169] A decade later, it was found that guanine 
repeats can form four-stranded nucleic acid secondary structures, named G-
quadruplexes. In 1989, Williamson et al. [170] reported G-quadruplex to be stabilised by 
central monovalent cations. 
Quadruplex structures can be of two types, depending on strand polarity: parallel 
quadruplexes, in which all guanine glycosidic bonds are in the anti-conformation, and 
anti-parallel quadruplexes, in which both syn- and anti-conformations are present. [171] 
Balagurumoorthy and Brahmachari [172] suggest that Na+-rich solutions seem to 
promote the formation of intramolecular anti-parallel folds, whereas the presence of K+ 
appeared to promote parallel fold conformation.  
Repetitive G-rich sequences can also be found in promoter regions (i.e. c-Myc, H-Ras and 
K-Ras), 5’ and 3’ untranslated regions (UTRs), introns, and the 3’ single-stranded end of 
the telomere (which is 100-200 bases long in a human). In general, G-quadruplexes 
could fold into either: 1) intramolecular structures formed by folding of a single strand, 
that could potentially regulate gene expression and chromosome stability or 2) 
intermolecular G-quadruplexes formed by two (dimeric) or four (tetrameric) separate 
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strands, which are structures formed as intermediates or precursors to recombination 
(DNA exchange between chromatids) and/or viral integration. (Figure 14) [173] 
 
Figure 14 - Modified from [174] shows the structure of intra- and inter-molecular G-
quadruplexes. 
G-quadruplex specific nucleases have been identified in yeast KEM1 [175] and in human 
GQN1 (G-quartet nuclease 1) [176], which cut single-stranded DNA located upstream 
(toward 5’) of a quadruplex structure, releasing intact quartets. These endonucleases 
function to cleave: a) intramolecular G-quadruplexes at telomeres, to allow access of 
telomerase for telomere maintenance, and b) intermolecular G-quadruplexes that form 
during chromosome pairing in meiosis. [177] G-quadruplexes function as regulatory 
elements in gene expression; the characterisation of G-quadruplex specific nucleases 
clearly supports this view, indicating that G-quadruplexes could be a viable target for 
therapy. Efforts have been made to identify small molecules that can bind to G-
quadruplexes with high specificity, such as N-methyl mesoporphyrin (NMM) [178] and 
telomestatin [179]. (Figure 15) 
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Figure 15– Chemical structures of (a) N-methyl mesoporphyrin (NMM) [180] (b) 
telomestatin and (c) TMPyP4 [181]. 
 
4.2 The significance of docking to G-quadruplexes 
G-quadruplexes have been shown to influence carcinogenesis through transcription 
regulation, and inhibition of telomere elongation by telomerase (Figure 16). The Hurley 
Lab has uncovered a correlation between G-quadruplex stabilisation and the 
suppression of promoter activity. Binding of small molecules such as TMPyP4 (Figure 
15), a well-known G-quadruplex stabiliser, to G-quadruplex was found to decrease the 
promoter activity by more than 50%. [182] Potential G-quadruplex-forming motifs 
(G3+N1-7)4+ (where G is guanosine and N is any nucleotide) have been found in 30-40% 
of human promoters. The formation of a G-quadruplex in the promoter region of c-MYB 
oncogene containing GGA repeats has been reported to be involved in both 
transcriptional activation and repression. Targeting G-quadruplexes has emerged as a 
strategy to deactivate the promoters of oncogenes, suppressing transcription by using G-
quadruplex-targeting ligands. [183] 
Human telomeric DNA typically consists of tandem 5’-TTAGGG-3’ repeats with a G-rich 3’ 
overhang (capable of folding into G-quadruplex). Telomeres protect chromosome ends 
from recombination, from degradation and end to end fusions, and from inappropriate 
repair processes (to distinguish it from double-stranded breaks). Telomeres, however, 
shorten with every cell cycle, and this leads to aging. The formation of G-quadruplex 
structures in telomeric DNA has been shown to disrupt telomeric capping and 
maintenance (to be sensed as DNA damage, inducing apoptosis) and to disrupt 
telomerase from telomere, thereby inhibiting over-elongation of telomeres in 80-85% of 
human tumor cells. Such DNA-containing G-quadruplex structures are no longer 
recognised as substrates by telomerase. Cellular events such as recombination and 
replication involve separation of the DNA strands, thus providing opportunities for the 
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G-rich strand to form the G-quadruplex structures. G-quadruplex ligands that induce 
and/or stabilise G-quadruplexes are promising therapeutic agents for the treatment of 
cancer, and are able to inhibit telomerase activity and activate a DNA-damage response, 
leading to apoptosis or replicative senescence. [184] 
 
Figure 16 - Modified from [173]. G-quadruplexes can reduce the expression of oncogenes 
and inhibit telomerase activity. 
Unfortunately, most chemotherapy agents used bind nonspecifically to DNA. Possible 
anticancer drugs, however, occupy two types of binding sites for G-quadruplex ligands. 
(Figure 17) Firstly, co-facial end-stacking or hemi-intercalation binding mechanisms 
involve polyaromatic molecules (called end-stackers) with planar geometries, for 
binding to the ends of the G-quartets; stabilising the quadruplex via π-π stacking 
interactions. Many of these compounds are porphyrin derivatives. However, these 
molecules generally have poor drug-like properties and selectivity. Secondly, a small 
drug molecule may bind to grooves and/or loop regions. Binding is sensitive to subtle 
variations in topologies, groove widths, and loop sequences conferring selectivity. 
Groove binders are more selective than end-stackers, and are specific to different groove 
conformations, suggesting promising potential for site-specific design. [185] Examples 
are steroids and their derivatives, which recognise DNA particularly, and show a 15-fold 
higher selectivity for G-quadruplex compared to dsDNA.  
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Figure 17 - Binding modes of small molecules with G-quadruplexes. 
 
4.3 Ligand-ratiometric sensor 
The ligand that was used is 2-(2′-hydroxyphenyl)-3H-imidazo[4,5-b]pyridine (HPIP-b) 
which binds all kinds of G-quadruplex structures. 
 
Figure 18 - Molecular structures of the normal (N) form of HPIP-b and the tautomer (T) 
form obtained after ESIPT. 
HPIP-b is a ratiometric fluorescent sensor. In the ground state, HPIP-b exists in 
equilibrium between two isomeric normal (N) species: the cis-form, which is the most 
stable form, and the trans-form. Upon excitation (which triggers protonation or 
deprotonation), an intramolecular proton transfer occurs along the hydrogen bond 
coordinate to give the tautomer (T). (Figure 18) This process of excited state 
intramolecular proton transfer (ESIPT) occurs only in the cis-form, as it requires both 
the acidic and basic groups to be in close proximity in the same molecule. [186] 
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Figure 19 - Obtained from Penedo-Esteiro’s group, fluorescence spectra of HPIP-b in 
aqueous buffer with emission of tautomer (T) and normal (N), Tautomer/normal ratio 
of HPIP-b at different concentration of telomeric sequence (middle and right graph) The 
darker the line, the higher the concentration of telomeric DNA.  
HPIP-b exhibits a dual fluorescence band emission (Figure 19, Left). The normal (N) 
species is responsible for the emission band at 380nm, and the emission at 480nm is due 
to the tautomer (T). From experiment, we known that 80% of HPIP-b is in the trans-
form in water, and perhaps the majority of the ligand is still in the trans-form upon 
binding. So, we used the trans-form to carry out this study. However, as the 
concentration of DNA increases, the equilibrium shifts towards a higher concentration of 
the bound T form conformer, so that the ligand somehow undergoes a change from the 
N/trans- to the N/cis-form. Thus, it becomes structurally possible to undergo an ESIPT 
process upon excitation, giving the tautomer, as shown by a binding isotherm graph 
(Figure 19, Right). The middle graph shows their relative intensity changes with the 
concentration of quadruplex. The tautomer becomes dominant at a higher concentration 
of quadruplex. Their ratio is affected by solvent polarity, and by the pH of the medium. 
These two isomers display different excited-state properties, making HPIP-b an excited-
state proton transfer probe with high sensitivity to the environment. Due to this dual-
band ratiomatic property, HPIP-b is an attractive sensor for studying binding 
interactions of G-quadruplexes. HPIP-b also interacts with double strand DNA, though 
this is thought to be a much weaker interaction. 
 
4.4 Method 
We performed a docking study to investigate the binding pattern of HPIP-b upon G-
quadruplexes [AGGG(TTAGGG)3]. We used molecular dynamics to firstly simulate large-
scale conformational changes of G-quadruplex in the presence of explicit solvent and 
ions, and secondly to explore more possible binding sites, from which snapshots of the 
G-quadruplex structures were extracted for subsequent docking. An ensemble docking 
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strategy was adopted to implicitly account for receptor flexibility. At the end of the 
simulation, we extracted five snapshots at 200ps intervals. Subsequently, each rigid 
receptor structure will undergo an independent docking run. AutoDock [187] was used 
to perform a blind docking against each of the snapshots, to obtain the most probable 
binding modes presented, indicated by better estimated binding energies. Due to the 
limitations posed by docking, there arises the need to adopt a theoretical method to 
account for a certain degree of protein flexibility. In this regard, we carried out a post-
docking refinement step using a two-layer QM:QM ONIOM model to optimise and 
rescore docked complexes. The ONIOM method (our own N-layer integrated molecular 
orbital molecular mechanics) developed by Morokuma et al. [188], employs a 
subtractive (or extrapolative) QM/MM scheme, in which the total energy of the system, 
𝐸𝑄𝑀/𝑀𝑀(𝑠𝑦𝑠𝑡𝑒𝑚), is calculated using Equation 11. Here, 𝐸𝑀𝑀(𝑠𝑦𝑠𝑡𝑒𝑚), is the MM 
energy of the whole system, 𝐸𝑄𝑀(𝑄𝑀), is the QM energy of the QM region and 
𝐸𝑀𝑀(𝑄𝑀), is the MM energy of the QM region. [189]  
Equation 11 – The energy of a two-layer ONIOM(QM:MM) calculation: 
𝐸𝑄𝑀/𝑀𝑀(𝑠𝑦𝑠𝑡𝑒𝑚) = 𝐸𝑀𝑀(𝑠𝑦𝑠𝑡𝑒𝑚) + 𝐸𝑄𝑀(𝑄𝑀) − 𝐸𝑀𝑀(𝑄𝑀) 
In the end, we reported our docking studies from AutoDock, which revealed electrostatic 
effects between HPIP-b and G-quadruplexes. 
 
4.4.1 Structure preparation  
DNA 
The crystal structure of the parallel 22-mer human telomeric G-quadruplex (PDB entry 
1KF1), sequence d [AGGG(TTAGGG)3], was obtained from the PDB. The structure 
consists of three G-quartets and three external TTA loops extended outward from the 
guanine core resulting in a propeller-like shape. (Figure 20) Adjacent G-quartets are 
stacked with a 30° twist and are separated by 3.13Å. [190] The loops connect the 
adjacent parallel chains, from the top of one strand to the bottom of the other. The 
second thymine of each TTA loop is located at the tip of the loop, within the adenine base 
swung back, intercalated between two thymine bases. These loops are thought to be 
involved in intermolecular interactions, for example hydrogen bonding, and stacking 
interactions with telomeric proteins.  
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This initial structure was arranged into a dimer using Chimera, making use of 
crystallographic symmetry information from the PDB file. This dimer was used in this 
study to model the structure of extended quadruplex telomeric sequences. Packing of 
two G-quadruplexes through G-quartets results in a stacked 5' to 5' hydrophobic surface. 
In contrast, a 3' surface is more hydrophilic. The dimer structure consists of a core of six 
G-quartets and five K+ ions in the central channel.  
 
Figure 20 - Chemical structure of the G-quartets. (PBD ID: 1KF1) 
Internal K+ ions were retained between consecutive G-quartets throughout these 
studies. The double-stranded DNA of similar sequence 5’-GTTAGGGTTAGGG-3’ (PDB 
entry 1IV6) was used for comparison. (Table 4) 
 
G-quadruplex dsDNA 
1KF1 (Human telomeric DNA) 1IV6 
5’-AGGG(TTAGGG)3-3’ 5’-GTTAGGGTTAGGG-3’ 
3’-CAATCCCAATCCC-5’ 
Single stranded Double stranded with base pairing 
Table 4 - The structures and sequences of the DNA used in this study. 
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4.4.2 Molecular Dynamics 
MD simulations were carried out with GROMACS version 4.6.7 [191,192,193] using the 
Amber03 force field. The dimeric G-quadruplex was solvated in a 6.55Å3 box, with 8687 
TIP3P water molecules and neutralised by replacing random water molecules with 18 
Mg2+ ions and 1 K+ ion to bring the net charge to zero. Periodic boundary conditions 
were applied to minimise edge effects. 
During pre-optimisation, the solvent was relaxed at 0K by a steepest descent 
optimisation with restrained nucleic acids, followed by an overall system optimisation. 
The steepest descent method, which uses first derivatives in energy minimisation, is 
applied in all simulations to avoid failure when the force is large, and to remove thermal 
noise. The method takes a step downhill by moving in the direction of the greatest 
negative gradient.  
The hydrogen bonds are constrained with the P-LINC algorithm. The system was 
gradually heated from 0 to 300K with 100ps equilibration for each successive 
temperature step and equilibrated at 300K for 100ps, using a time step of 0.001ps. This 
equilibration was followed by 1000ps simulations under NPT (fixed pressure, 
temperature and number of atoms) conditions at 300K, during which coordinates were 
saved to the trajectory every 10ps, resulting in a set of 101 coordinates.  
The same procedure was repeated with dsDNA in a cubic box of 6.41Å edges with 8452 
TIP3P water molecules. Five structures saved after every 200ps along a 1000ps MD 
simulation were obtained for use in the following docking studies.  
 
4.4.3 Molecular Docking 
Dockings of HPIP-b to parallel telomeric G-quadruplexes (PDB ID: 1KF1) were carried 
out using AutoDock 4.2 [187], employing a Lamarckian genetic search algorithm (LGA) 
to generate docked poses, and a semi-empirical force-field-based scoring function to 
estimate the free energy of binding. A HPIP-b molecule was built and optimised with the 
semi-empirical PM3 method using Gaussian 09, and was in the trans-configuration 
during docking. 
Five G-quadruplex structures were extracted from the MD trajectory for docking using 
AutoDock Tools (ADT) version 1.5.6 [187], a graphical user interface, used to a) merge 
non-polar hydrogens, by adding Gasteiger charges [194] to each constituent atom of the 
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ligand and the receptor, and b) assign rotatable bonds prior to the docking. AutoGrid 
was used to generate grid maps for each atom type in the docked ligand, which store 
grids of interaction energy used as a lookup table, to speed up the interaction energy 
calculation during the conformational search (sampling stage). Default values were used 
for AutoGrid parameters. A grid map with 126 x 126 x 126 points, and a grid spacing of 
0.375Å was used, and the maps were centred on the DNA, covering the entire DNA. The 
DNA was kept rigid, while the ligand was allowed to be flexible during sampling. 
50 independent docking runs were performed for each G-quadruplex structure, with an 
initial population size of 50 individuals, a maximum number of 5 x 107 energy 
evaluations per run, and a maximum number of 27000 generations. Mutation and 
crossover were applied at rates of 0.02 and 0.8, respectively. All other parameters were 
set to default values. The local search was based on the Solis and Wets method, with a 
maximum of 300 iterations per search, local search rate of 0.06, step sizes of 0.2Å for 
translations and 5° for orientations and torsions. The resulting docked structures were 
clustered, using the Clusterings module in ADT, by the conformation with the lowest free 
binding energy (with a 2Å cut-off RMSD), to obtain clusters of similar binding modes. 
The low-energy conformations were chosen from the largest and lowest-energy cluster 
for further processing. This same process was applied to the dsDNA for comparative 
purposes in this work. 
This docking process is semi-flexible, where the ligands are allowed to explore their 
conformational space, while keeping the DNA rigid. The flexibility of a ligand molecule is 
modelled with six external degrees of freedom (three translations along the coordinate 
axes and three rotations) plus internal (conformational) degrees of freedom due to 
rotations around bonds. Since it is impractical to fully explore the conformational space 
in practice, an approximation (i.e. the rigid body approximation, treating each DNA as a 
rigid body) is assumed to reduce the dimensionality of the space. [195] In the next 
experiment, ONIOM was employed to optimise and rescore the docked complexes, for 
considering a certain degree of protein flexibility explicitly after the docking process 
(post-docking refinement).  
 
4.4.4 Thermodynamic cycle-ONIOM QM/QM 
To quantify the electrostatic effects arising from the binding region of the docked ligand, 
a two-layer ONIOM QM/QM calculation using hybrid density functional theory (DFT) 
and PM6 was performed with Gaussian 09. Using the ONIOM scheme the binding region 
was divided into subsystems that are treated at different levels of theory. This is in the 
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interest of making a challenging and time consuming calculation more readily tackled on 
currently available hardware while still providing a reasonable degree of accuracy and 
insight. The system was built upon the docked position of HPIP-b containing residues 
that are within 4Å of the ligand. This included water molecules in order to account for 
electrostatic solvation effects and hydrogen bonding (which are crucial in describing 
ligand effects). As shown in Figure 21, hydrogen atoms were used for capping the lower 
layer. The ligand was fully optimised using DFT at the M06/6-31G(d,p) level, whereas in 
its surroundings atoms heavier than hydrogen are fixed and treated by PM6.  
  
Figure 21 - ONIOM was applied upon the docked position of the ligand including 4Å 
around the ligand. The ligand (circled in dash) is treated at DFT (M06) level, while the 
remainder is treated at a lower level of theory (PM6).  
We constructed a thermodynamic cycle (Figure 22), used to determine the electrostatic 
forces in the ligand docked region. In this cycle, the capital in the bracket indicates 
where the ligand has been optimised (W refers to water) while the superscript indicates 
where the calculation was performed; either in the gas phase, in a PCM solvent model, or 
in the point charge field of DNA. The ligand was optimised with DFT at M06/6-31G(d,p) 
level via a self-consistent reaction field (SCRF) method using the polarisable continuum 
model (PCM), developed by Tomasi et al. [196]. PCM is used to simulate implicit solvent 
effects, [Ligand, W], wherein the solute is embedded in a spherical cavity surrounded by 
a homogeneous dielectric continuum, which is dependent on its dielectric constant. The 
optimised ligand was then calculated in the gas phase at the same geometry using DFT at 
M06/6-31G(d,p) level, from which the energy differences are calculated to obtain the 
solvation energy of the ligand (left arrow of Figure 22 (a)). 
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The ligand was optimised in DNA (by ONIOM). The optimised ligand was calculated in 
the gas phase and subsequently in the point charge field of neighbouring structures 
updated with optimised (PM6) hydrogen position. In this portion of the model, every 
atom, including the whole DNA and solvent within 15Å of the optimised ligand, was 
considered as a point charge using Amber03 and TIP3P parameters from Gromacs. We 
calculated the energy difference between the ligand in the gas phase and embedded in 
the point charge field, to obtain a measure of electrostatic forces at the ligand docked 
region. (right arrow in Figure 22 (b)) 
The energy differences (EGeom) between optimised structure of the ligand from the 
water and DNA calculated in the gas phase allowed us to calculate the energy cost of 
changing the geometry upon binding, represented by the top arrow in the 
thermodynamic cycle shown in Figure 22 (c). 
The energy differences of the ligand between its different optimised structures in water 
and its binding conformation in the DNA represented by a point charge field (PCF) is 
calculated to obtain the binding energy (bottom arrow, Figure 22 (d)). 
 
Figure 22 - Thermodynamic cycle employed for electrostatic calculations.  
 
4.4.5 Potential energy surface  
We explore a potential energy surface (PES) that gives the ground state electronic 
energy contained in a molecule at a given nuclear geometry. Since there is a relatively 
large difference in mass between electrons and nuclei, the nuclear equations of motion 
can be described either by quantum mechanics, or else classically via Newton's 
equations. The nuclei appear to stay motionless (be fixed) in their equilibrium positions 
in space compared to the fast-moving electrons that adjust themselves instantly to 
changes in molecular conformation, thereby following the Born-Oppenheimer 
approximation (formulated by Max Born and Julius Robert Oppenheimer in 1927), 
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according to which electronic and nuclear motions are treated separately. The dynamics 
of nuclear motions on the ground state electronic surface are obtained from solving the 
time independent Schrödinger equation for the electrons, and the changes in the 
electronic energy due to nuclear displacement are independent of the kinetic energy of 
the nuclei, and are independent too of the nucleus mass. Hence, isotopic species result in 
the same potential surface, unless vibrations of the nuclei have been taken into 
consideration. [197] 
A relaxed PES scan with respect to two dihedral angles, for rotation around the hydroxyl 
and the C3-C4 bond (see Figure 25 for structure), was performed by DFT at the M06/6-
31G(d,p) level, each to be scanned from 0 to 360 degrees by varying the torsion angle 
H(11)-O(10)-C(5)-C(4) and N(8)-C(3)-C(4)-C(12) in steps of 15 degree increments of 
24 steps in total to get the potential energy surface and the lowest energy configuration 
of HPIP-b. 
 
4.5 Result and Discussion 
4.5.1 RMSD plot 
 
Figure 23 – Backbone RMSD from the trajectories of the simulations of dsDNA and G-
quadruplex. 
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The RMSD (the root mean square difference) of the DNA backbone with respect to the 
staring structure (the first frame of the production run) were calculated over the 1ns 
trajectory, as can be seen a rapid increase occurs during the first 100ps and then levels 
off, and remains stable for the rest of the simulation time. The differences in fluctuation 
amplitudes show that G-quadruplex (indicated by the red line) is more rigid than dsDNA 
(black). (Figure 23) 
 
4.5.2 Ligand Scan 
A contour plot of the PES is shown in Figure 24. The resulting energy surface has two 
minima and the lowest corresponds to the cis-form (Figure 25, C), which forms an 
intramolecular hydrogen bonded cyclic ring with a planar geometry, and is as expected, 
the most stable form [198]. The trans-form (Figure 25, A), which can be stabilised by an 
intramolecular hydrogen bond between the OH-group and the N-H hydrogen on 
imidazole ring, corresponds to a local minimum (Figure 24A). It is found that trans-form 
is more stable than cis-form in solution due to hydrogen bonding with the solvents. 
[199] The energy difference between the trans- and cis-form (A and C) is about 7.51 
kJ/mol, and between conformers A and B is about 22.81 kJ/mol. 
 
Figure 24 - Contour plot of the potential energy surface for HPIP-b resulting from the 
DFT scan, with energy in atomic units (a.u.). The dihedral angle H(11)-O(10)-C(5)-C(4) 
(y-axis) and the N(8)-C(3)-C(4)-C(12) (x-axis) in degree. 
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Figure 25 - The cis- and trans- conformers of HPIP-b, corresponding to the minima on 
the PES (Figure 24). 
 
4.5.3 Predicted binding modes (Docking) 
To obtain probable binding sites and orientations of HPIP-b on G-quadruplex structures, 
50 independent docking runs to each of the five snapshot G-quadruplex structures were 
performed (saved every 200ps from the MD trajectory), and the resulting docked poses 
were clustered (independently for each snapshot) using a cut-off distance of 2Å.  
As expected, no end-stacking was observed. All 5 x 50 runs with HPIP-b resulted in 
binding to either the loop or groove regions of the G-quadruplexes. Among all docking 
runs, the best docked conformation, with the lowest binding free energy of -7.5 
kcal/mol, is formed through the loop, binding to the equilibrated structure obtained at 
200ps from the MD trajectory (Table 5a). This is followed by the second-best 
conformation (-7.13 kcal/mol), which also binds to the loop region to the same snapshot 
structure. HPIP-b displays a higher affinity overall to this structure (at 200ps). However, 
these configurations were not in the most populated cluster. Instead, the fifth (second to 
last) cluster consisting of 20 members out of 50 was the most populated, with an 
average binding free energy of -6.58 kcal/mol by binding to the groove, see Figure 26(a). 
As can be seen from the lowest-energy cluster of each snapshot (the charts of Figure 26), 
the loops form the preferred site of binding of HPIP-b to the 200ps and 1000ps snapshot 
structures, with the latter having an average binding free energy of -6.78 kcal/mol. 
However, this finding is not conclusive, as the lowest-energy cluster and the most 
populated cluster obtained from other structures (extracted at different time points) 
suggested that HPIP-b binds at the groove. (Figure 26(b), 26(c), 26(d)) In fact, only 
groove bindings have been reported for a snapshot at 800ps with the lowest binding free 
energy of -6.50 kcal/mol; and no cluster is significantly populated for a snapshot at 
400ps, in which the differences in binding free energy and population between clusters 
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are small; ranging from 2 (the least energetically favourable conformation -5.76 
kcal/mol) for the smallest cluster to 8 (the first and the third cluster that the HPIP-b 
binds to the groove and the loop, respectively) for the largest cluster.  
 
Table 5 - Shows the binding free energy of the best docked conformation (ΔGbest), 
corresponding to the docked complex in Figure 26, and the average energy of the lowest-
energy cluster (ΔGaverage) for each G-quadruplex structure. Units are in kcal/mol. 
Selection of the best conformer is typically primarily based on the lowest-energy cluster, 
and secondly the most populated cluster. Cluster analysis reveals that, in general, the 
binding energy differences between clusters are small. In cases where the lowest-energy 
cluster is less populated, the binding free energies of the most populated cluster are all 
within 2.5 kcal/mol energy difference, the estimated standard error of the AutoDock 
scoring function. Thus, it is hard to say which of the configurations is the more probable 
solution. The overall finding seems to suggest that groove and loop binding showed no 
significant differences in terms of binding free energy. To be specific, we defined 1) 
groove binding in which HPIP-b was either in the cavities bound by the neighboring 
phosphate backbones or within the extra cavities adjacent to the loops at the sides of the 
G-quadruplex units and 2) loop binding occurred when HPIP-b was buried in between 
the external loop and the G-quartets. HPIP-b is nearly rigid and conformationally 
restricted with only a single rotatable bond, via the hydroxyl group, during docking. Such 
docking is similar to a lock and key mechanism, as AutoDock does not account for 
receptor flexibility during docking. Thus, docking of HPIP-b is likely to be dependent on 
the target selected conformation. The resulting docked conformation of HPIP-b from the 
best cluster (both the most populated and the lowest-energy cluster) have unfavourable 
(positive) internal energy (not shown). However, the binding free energy obtained from 
the default value of Autodock 4.2 assume that the internal energy of the ligand in 
solution is the same as in the complex, thus results in a zero contribution of internal 
energy to the total binding energy. The results given were all calculated based on the 
above assumption. In general, binding a frozen ligand is more likely to overestimate the 
gain of free energy of binding, mostly due to the energy required to distort the ligand 
 Clus Rank Run Num in Clus ΔGbest ΔGaverage Binding mode 
a 1 42 5 -7.50 -7.50 Loop 
b 1 43 8 -7.02 -7.00 groove 
c 1 33 26 -6.32 -6.32 groove 
d 1 4 24 -6.50 -6.48 groove 
e 1 25 16 -6.78 -6.78 Loop 
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from the preferred unbound to the bound conformation. The consideration of the 
internal energy is necessary to obtain a result that is close to reality.  
A comparative study has been applied on dsDNA of a similar sequence. All runs of dsDNA 
resulted in minor groove recognition, with a very favourable average binding energy of -
6.61 kcal/mol and the most favourable docked conformation (-6.62 kcal/mol). (Table 
6c) This is in comparison to docking G-quadruplexes, where a relatively larger number 
of clusters were found, possibly reflecting the complexity and the large surface tested of 
the G-quadruplex structures. The results are in agreement with experimental findings 
that HPIP-b displays slightly stronger interactions with the G-quadruplex than with 
dsDNA.  
 
 Clus Rank Run Num in Clus ΔGbest ΔGaverage Binding mode 
a 1 32 34 -6.31 -6.30 groove 
b 1 36 41 -6.02 -6.01 groove 
c 1 39 46 -6.62 -6.61 groove 
d 1 49 22 -6.31 -6.31 groove 
e 1 35 29 -6.29 -6.14 groove 
Table 6 - Shows the binding free energy of the best docked conformation (ΔGbest), 
corresponding to the docked complex in Figure 27, and the average energy of the lowest-
energy cluster (ΔGaverage) for each dsDNA structure. Units are in kcal/mol. 
In summary, we performed blind docking to obtain putative binding sites of HPIP-b on G-
quadruplex and dsDNA with no prior assumption of binding sites. Autodock does not 
account for the receptor flexibility. We obtained a rather small difference between 
energetically similar cluster for HPIP-b with the binding energies ranging from -4.5 
kcal/mol to -7.5 kcal/mol with results in either loop or groove binding. However, these 
docking studies could be the start of using a more sophisticated force field or methods 
for post-processing of docking results. To further ensure the stability of the binding 
structure of ligand, we carried out a higher level of calculation for a comparison between 
MM energies and QM energies. We selected the lowest energy conformation from each 
cluster to represent the whole cluster for further analysis. 
Docking can produce both false positives and false negatives. [200] It is known that most 
docking programs use rigid receptor models, and that these errors could occur because 
DNA is a rather flexible molecule existing as an ensemble of isoforms, not modelled well 
with rigidity. To take receptor flexibility into account, we performed ensemble docking, 
in which the ligand is docked to a pre-generated ensemble of rigid structures, 
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to implicitly account for receptor flexibility. However, this leads to two observations. 
Firstly, the docking performance is biased by the selected structural ensembles. A 
selection strategy to choose representative conformations from MD trajectories is still 
needed; and secondly, MD simulations normally explore only local minima and have 
difficulty overcoming high energy barriers. In some cases, using an ensemble of 
conformations did not outperform using a single structure. [201]  
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Figure 26 - Cluster profiles from docking of HPIP-b to G-quadruplex structures extracted from MD every 200ps, (a) at 200ps, (b) at 400ps, and so on. Each 
cluster is a bar, where the height of the bar indicates the number of conformations in the cluster (50 in total) and the colour indicates the binding mode: loop 
in blue and groove in green. Only the best docked pose with the lowest binding free energy score are shown, with unit in kcal/mol. 
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Figure 27 - Cluster profiles from docking of HPIP-b to dsDNA structures extracted from MD every 200ps, (a) at 200ps, (b) at 400ps, and so on. Each cluster is 
a bar, where the height of the bar indicates the number of conformations in the cluster (50 in total) and the colour indicates the binding mode: loop in blue 
and groove in green. Only the best docked pose with the lowest binding free energy score are shown, with unit in kcal/mol. 
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4.5.4 QM Binding energy 
ONIOM was used to refine the docking poses, allowing limited ligand/receptor induced 
fit effects to be modelled, with optimised positions of the hydrogen atoms of the 
receptor, while holding all other atoms fixed. We selected the lowest-energy docked 
structure from each cluster as a sample conformation for each pocket.  
 
Figure 28 - Structure of HPIP-b with atomic labelling and definition of the dihedral 
angles A and B considered in the PES scan. 
As expected, the ligand adopts an energetically more favourable conformation in solvent 
than in DNA (positive values for EGeom). This may arise as the ligand does not adopt its 
lowest energy conformation in the binding site with the energetic cost of binding from 
solvent offset by interactions with the binding site. Normally, this higher energy 
conformation can be compensated with the gain of the aforementioned interaction 
energy with the receptor such as forming of hydrogen bonds or van der Waals 
interactions. The ligand in PCM solvent model adopts a virtually planar conformation 
(the torsion angle of H11-O10-C5-C4 and N8-C3-C4-C12 are -179.9° and 179.9°, 
respectively; see Figure 28) corresponding to the local minimum (A) on the potential 
energy surface (PES) in Figure 24. Comparing the energy value of EGeom to the dsDNA, 
the bound ligand in G-quadruplex may be more restricted in terms of the conformation it 
can adopt. As a result, the geometric energy cost that is paid for binding with the G-
quadruplex is greater than that associated with binding to dsDNA. We expect that this is 
due to the more complex structure of G-quadruplex. The solvation energy is -33.926 
kJ/mol. The experimental measured desolvation of polar group OH is 36.4 kJ/mol, [202] 
and the desolvation of a polar group is enthalpically unfavourable. The nitrogen offers an 
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additional hydrogen bonding moiety, so might impact the total solvation energy 
accordingly. 
We inspected the docked poses and positions which give the lowest binding energy to 
study how these changes contribute to the electrostatic and binding energy. The analysis 
of the hydrogen-bonding patterns was carried out using VMD (version1.9.3) [203], with 
a distance cut-off of 4Å and an angle cut-off of 40°, and for producing figures (Figure 29 
and 30). The obtained energy considered only the effect of electrostatics (previous work 
has found that electrostatic interactions are the primary interactions from DNA [204]). A 
positive value for Ebind corresponds to an unfavourable interaction. We obtained five 
most favourable binding energies which are lower than -100 kJ/mol (four for G-
quadruplex, one for the dsDNA). HPIP-b interacts with G-quadruplex through both the 
grooves (in cases of 60_39 and 20_39) and the loops (for 60_04 and 20_11), see Table 7. 
 
Figure 29 - The lowest energy configuration of docking to G-quadruplex. (60_04 in Table 
7) 
The energy cost from the conformational change of the ligand on binding to the receptor 
is 50.347 kJ/mol (60_04 in Table 7). The dihedrals are measured: 11-10-5-4=84.6, 8-3-
4-12=164.7 (see Figure 28 for labelled structure). The ligand does not hydrogen bond 
to its docked cleft, formed by a TTA propeller-type loop, but is hydrogen bonded by its 
OH group and N-H moiety of the heteroaromatic ring, with two vicinity oxygens of the 
phosphate group on the stand connecting the G-quartets. It also shows hydrogen 
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bonding with three nearby water molecules. Here, the nitrogen lone pair (an area of 
negative charge) is creating the hydrogen bond to the water hydrogen (positively 
charged). The water is also used to hydrogen bond with other sections of the G-
quadraplex. The electrostatic energy obtained is -210.029 kJ/mol, which is the largest 
amongst the 27 binding instances studied. However, from manual inspection, a large 
amount of the electrostatic interactions that result in a total favourable binding energy is 
more likely due to a hydrogen bond network formed by water molecules around the 
ligand.  
 
Figure 30 - The lowest energy configuration of docking to dsDNA. (ds80_27 in Table 7) 
We note that a binding instance to dsDNA (ds80_27 in Table 7) achieved the lowest 
binding energy value (-132.027 kJ/mol) of all complexes in this test set, which is 
unexpected as we know from the experimental collaboration and results furnished from 
these studies that HPIP-b binds more strongly to the G-quadruplex. However, from the 
energy calculations, we see that the docked conformation is relatively energetically 
favourable with only a small additional conformational energy cost of 7.549 kJ/mol. This 
is because the ligand adopts an approximately planar conformation 11-10-5-4=161.3, 
8-3-4-12=-170.8 when complexed with the DNA. The energy cost might be due to the 
hydroxyl group pointing to the solvent, which was found able to form a hydrogen bond 
with nearby water (1.641Å). On the opposite site of the ligand, the nitrogen (N7) in 
imidazole could hydrogen bond to the guanine backbone. The electrostatic energy from 
the point charge field of the surrounding it is the largest at -173.502 kJ/mol.  
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Mutual polarisation of the ligand and the DNA structures are included in ONIOM, while 
the docking program used a force field method; such a MM approach is limited to set 
parameters which may not completely or accurately describe the system in question. 
Binding energies obtained by the docking do not show significant difference. As the 
protein motion is ignored, the difference in the intramolecular energy of the bound and 
unbound state of the receptor is zero. The intramolecular energy difference is also zero, 
as it is assumed the bound and unbound configuration of HPIP-b is the same, 
nevertheless HPIP-b is rather rigid.   
DNA flexibility plays an important role during ligand binding. Our best four results from 
docking to G-quadruplex structures seem to focus on two snapshots of the conformation 
(60ps and 20ps). Water molecules contribute electrostatic effects to the binding energy. 
As observed in Figure 29, a hydrogen bond network is formed which leads to strong 
electrostatic effects, it appears that hydrogen bonding has occurred between the ligand 
and G-quadruplex backbone, the ligand and the water molecules, and water to G-
quadruplex. A possible improvement to the methodology is the expulsion of water from 
the binding site and calculation of the electrostatic effects purely due to the DNA.  
The loop confers conformational polymorphism, and is considered to make 
intermolecular interactions. The grooves in G-quadruplexes are V-shaped and do not 
simply comprise phosphate-sugar backbones, distinct from double-stranded DNA. A 
dimeric G-quadruplex structure has eight phosphate grooves, together with the extra 
cavities adjacent to the loops, providing extra binding surface for binding. [190] The 
complexity of the loop conformation may confer greater specificity.  
The special structural arrangement of G-quadruplexes makes it possible to provide 
distinct surfaces for interaction with small molecules in which quartets provide a 
hydrophobic aromatic planar surface, and loops provide a hydrogen bonding surface. 
Also, the grooves are involved in hydrogen bonding to water molecules with the sugar 
(O3'), the phosphate O1P atom or guanine (N2 atom) in the quadruplex grooves. 
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Table 7 - The docked poses are ranked according to the binding energy (Ebind). The top panel is computed from the G-quadruplex structures, whereas the 
bottom is obtained from dsDNAs. The name of the docked ligand is expressed as 60_04 where this denotes that the structure was taken at 60ps of the MD 
trajectory, and it is the 4th out of 50 docking runs. Units are in kJ/mol.
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4.6 Conclusion 
G-quadruplexes have emerged as an attractive target for site-specific drugs for anti-
cancer therapy. Guanine-rich sequences, known to form polymorphic quadruplexes, can 
be found in the promoter regions of oncogenes, introns and human telomeres. 
A docking study to predict the binding mode of HPIP-b to G-quadruplex was performed 
using ensemble docking. Our docking protocol involves three steps. First, multiple 
conformations of the target are generated by molecular dynamic simulations, using NPT 
and periodic boundary conditions for the production run of 1000ps, from which five 
snapshot are extracted at 200ps intervals. Second, docking is performed to each 
snapshot structure, to implicitly account for receptor flexibility. Third, we use a two-
layer ONIOM QM:QM to perform a post-docking refinement to optimise and rescore the 
docked complexes. 
Semi-flexible docking does not simulate conformational changes of the receptor which 
occur upon ligand binding, unlike the real docking process, and thus limits its 
applicability in practice. Of the 50 x5 docking trials, HPIP-b resulted in binding to either 
the loop 55 (22%) or groove regions (78%) of the G-quadruplexes. 
Our findings indicate that the inclusion of water molecules lead to strong electrostatic 
effects which are related to the formation of a hydrogen bond network between the 
aromatic NH and OH groups of HPIP-b to (a) G-quadruplex backbone (b) to water 
molecules and (c) between water molecules with other sections of the G-quadruplex, 
thus result in a total favourable binding energy.  
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CHAPTER 5. How Conformations Change: A new model for activating 
the blue-light sensing using flavin photoreceptor domain 
 
5.1 Introduction to the photoreceptor system 
Plants and photosynthetic organisms rely on photosensory receptors that allow them to 
perceive the changing environment and to adjust their metabolism or behaviour 
accordingly to better adapt to variations in light conditions (including the intensity, 
wavelength, direction and duration of ambient light) which is essential for optimal 
photosynthesis. Currently, six photoreceptor protein (referred to as light sensory 
proteins) families are known: the rhodopsins, (bacterio) phytochromes, xanthopsins, 
and the three blue-light photoreceptor families utilising flavin conjugates as cofactors; 
these are the cryptochromes (cry), phototropins (containing light-oxygen-voltage (LOV) 
domains) and BLUF (sensor of Blue Light Using FAD or flavin adenine dinucleotide) 
containing photoreceptors. Blue light which falls within the wavelength range of 455nm 
to 492nm is known to be an important signal for its effects upon mediating 
phototropism and photosynthesis, and is used to activate photolyases, enzymes involved 
in UV-damaged DNA repair.  
The photoreceptor consists of a protein moiety and an (or several) embedded light-
absorbing molecule(s) either covalently or non-covalently attached, known as 
chromophores involved as cofactors and whose presence is essential for photoreceptors 
to function. On absorption of a photon, the chromophore induces the so-called primary 
photoreaction (photochemical reaction); that is, the initial chemical changes result 
directly from irradiation with light. It begins with a photochemical change of the 
chromophore making a transition to an excited state [205], in which the electrons are 
rearranged, thereby making the various photochemical reactions possible. The 
photochemical reactions are specific with regard to the photoreceptor domain at hand 
but are consistently accompanied by a conformational change of the chromophore-
protein complex that moves from the ground equilibrium (resting) state to the 
electronic excited metastable (signaling) state conformation for a period of time before 
returning back to the ground state. Accordingly, the photoreceptor serves as a signal 
converter whereby the external light signal perceived by the light sensitive portion of the 
photoreceptors is transduced from the signalling molecule into a biological signalling 
cascade, which is known to affect different downstream effectors involved in mediating 
various physiological responses [206].  
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The photochemical reaction leading to the formation of the signalling state is specific to 
each photoreceptor type. The photochemical reaction of xanthopsins, phytochromes and 
rhodopsins causes a cis-trans isomerization at the C=C double bond of the chromophore 
upon light irradiation. This excitation involves a transition of an electron from π to 
π* orbital, whereby the planar geometry of the double bond is distorted, and a 90° 
rotation about the bond becomes energetically favourable in the excited state. The 
subsequent relaxation of the molecule back to planarity can lead to either the cis- or 
trans-configuration, resulting in cis-trans isomerization of the double bond. In contrast, 
the photoexcited flavin-binding photoreceptors are known to undergo an intramolecular 
electron transfer (ET) from the close-by aromatic residues (from an adjacent tyrosine 
for BLUF and a conserved triad of tryptophan for cry) to the excited state (oxidised) 
flavin, where it acts as an electron acceptor. Electron transfer gives rise to the radical 
intermediate which undergoes a photochemical reaction, that produces a 
conformational change of the protein.  
Each of the three types of flavin-binding photoreceptors gives rise to different 
photochemistry even though they share the same flavin chromophore; any difference in 
photochemistry must be attributed to the protein environment surrounding the flavin. 
The photochemically active flavin in cry undergoes photoreduction by which it formed a 
relatively long lived radical (signalling) state. [207] For LOV domains, light excitation of 
the flavin leads to a covalent adduct between a conserved cysteine residue in the LOV 
domain and the flavin at the C-4a position (Figure 31) as the signalling state and this 
adduct is reversed in the dark. The BLUF domains, on the other hand, undergo a 
photocycle involving a subtle rearrangement of the hydrogen-bond network between the 
flavin and nearby residue side chains, and such an alteration in hydrogen bonding is 
thought to be dependent on flavin-radical intermediates. [208]  
Focusing on the blue light system, the essential cofactors used in the blue-light 
photoreceptors are flavins, specifically riboflavin (vitamin B2) derivatives 
(flavoprotein), most commonly seen in the form of flavin mononucleotide (FMN) or 
flavin adenine dinucleotide (FAD), which consists of a tricyclic isoalloxazine ring (Figure 
31) substituted at the N-10 position with a ribityl phosphate (for FMN) or a ribityl 
adenine diphosphate (in case of FAD).  
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Figure 31 - Structure with atom numbering of the isoalloxazine moiety. 
 
5.2 BLUF photocycle 
BLUF domains are found primarily in prokaryotes and eukaryotic algae, but not in 
plants. In the dark, the BLUF domains contain flavin in the oxidised state (FAD), which 
acts as an electron acceptor upon irradiation. Light excitation of the flavin leads to an 
electron transfer from the proximal tyrosine to the excited flavin (which occurs on 
timescale of fs or a few ps depending on their distances and orientations relative to one 
another) and thereby initiates a reversible photocycle.  
The formation of the anionic semiquinone (one electron reduced) radical (FAD•−) 
resulting from the single electron transfer is subsequently protonated by the 
neighbouring tyrosine to form the neutral semiquinone radical (FADH•) in 7-9ps, with 
this process generally referred to as proton-coupled electron transfer (PCET). (Figure 
32) PCET is an essential part of signalling state formation. [209] The changes in the 
redox state of the flavin (formation of radical intermediates) will induce a 
conformational change that leads to reorientation of several residues (see later on 
“photoactivation mechanism”), affecting the hydrogen bond network in the flavin-
binding pocket. The hydroxyl proton of Tyr21 is presumably attracted by the negatively 
charged N5 of the flavin as a result of electron transfer and thereby disrupts its hydrogen 
bond with Gln63, which in turn destabilises the hydrogen bonding network, enabling 
Gln63 reorientation to occur, leading to an altered hydrogen bonding pattern between 
Gln63 with its immediate environment. [210]  
90 
 
 
Figure 32 - Modified from [206]. The BLUF domains undergo a photocycle, in which two 
intermediates anionic (FAD•−) and neutral (FADH•) flavin semiquinones are formed, the 
latter subsequently decay to form the red-shifted signaling state (FADred). 
Indeed, the side chain of the nearby Gln63 is assumed to rotate (and/or tautomerize 
[211]) to form a new hydrogen bond to the C4=O carbonyl of the flavin, followed by the 
decay of the semiquinone radical, probably occurring through a radical-pair 
recombination which locks the newly oriented Gln63 into place and results in the 
signalling state. [212,213] A semi-empirical calculation (AMPAC program using AM1 
Hamiltonian) [214] shows that an increase in electron density at the N5 of the flavin due 
to photoexcitation does appear to be correlated with an increase in the proton affinity. 
[215] The fast formation of the signalling state (photoproduct) of the BLUF domain (in 
less than 1ns) would cause a spectral red shift of 10-15nm-1 in the UV-vis spectrum with 
respect to the initial dark state. The red shift is due to the additional hydrogen bond to 
flavin at O(=C4) as evidenced by the FTIR spectrum of AppA (activation of 
photopigment and puc expression A), which shows the stretching vibration of C(4)=O is 
downshifted by about 20cm-1 upon light excitation. [216] As observed, the neutral flavin 
radical decays into the red-shifted photoproduct within 10ns. [212] Kraft et al. described 
photoproduct formation as a biphasic process in which 10nm red-shifted of flavin 
absorption is quickly formed after light excitation (in less than 1μs), followed by a 
slower conformational change of the protein on a 5ms timescale. [217]  
The photocycle is completed by the decay of the red-shifted signalling state back to the 
initial (ground) state, and known to have a relatively long half-life ranging from seconds 
to tens of minutes. A multi-exponential excited state decay of FAD was observed, which 
is attributed to structural microheterogeneity of the mutual orientation of Tyr21 and 
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flavin in the resting state. Irradiation of flavin results in only minor changes in the 
structure, unlike in LOV domains, where light causes the formation of a covalent adduct. 
Furthermore, the flavin redox state is unchanged in both the dark-adapted and light-
induced states, remaining in the fully oxidised state as evident from the UV-visible 
absorption spectrum. [209] 
Fukushima et al. [218] reported on the photocycle of T110078 (cyanobacterial BLUF 
protein). They suggest that the 5-nm red shift occurring at a low temperature (below 
50K) is caused by local changes limited to the chromophore and/or its immediate 
surroundings, and that a 10-nm red shift occurs above 50K, indicative of a further 
conformational change that is allowed only at higher temperatures.  
The BLUF domain as a FAD-containing photosensor domain was first discovered in 
AppA, which is a regulatory protein negatively regulating the photosynthetic gene 
expression in the purple bacterium Rhodobacter sphaeroides in response to light and 
oxygen. The BLUF domain, as the name suggests, contains flavin as the light receptor 
molecule specialised for blue light, and was later found in many bacteria and algae. The 
N-terminal photosensory domain of about 100-110 residues is organised in a 
ferredoxin-like βαββαββ fold in which the isoalloxazine ring of flavin is bound non-
covalently in a cleft between two α-helices (α1 and α2), oriented perpendicular to a five-
stranded antiparallel/parallel β-sheet with a strand order of 4-1-3-2-5. (Figure 33) The 
ends of the domain are capped by α-helices of roughly 40-50 residues acting as linkers, 
connecting to the C-terminal effector domain mostly involved in cyclic nucleotide 
metabolism. [219] Light induced conformational changes are propagated to the effector 
domain where regulation takes place affecting enzymatic activity and quaternary 
structure (signal transduction) [220]. AppA acts as an antirepressor to the 
photopigment suppressor protein R (PpsR) protein, a transcription repressor of 
photosynthetic genes, through the activity of the cysteine-rich C-terminal catalytic 
domain to reduce a disulfide bond in PpsR and due to the formation of the PpsR2-AppA 
complex, the PpsR lost its ability to bind DNA in the anaerobic dark state. On the other 
hand, upon aerobic illumination, a conformational change occurred that prevented the 
light-activated AppA from interacting with PpsR; as a means to achieve regulation. [221] 
Essentially, most of the conserved residues that are located around the flavin appeared 
to be involved in hydrogen-bonding interactions. 
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Figure 33 – The crystal structure of AppA BLUF (PDB ID 2IYG) contains a ferredoxin-like 
domain. The flavin (shown in green stick) is noncovalently bound between the two α-
helices. 
 
5.3 Structural Models  
There remains a debate due to the contradictory findings among studies of the side-
chain orientation and/or position of several key residues close to the flavin 
chromophore for both the resting and signalling states of BLUF, these include:  
1) Gln63, which is known essential for the photocycle (which actually involves Tyr21 
and Gln63, as previously discussed), and depending on its orientation, the Gln63 side 
chain can give rise to two sets of hydrogen bonds. So far, the available crystal 
structures of BLUF are not informative enough to distinguish between the side chain 
amidic oxygen and nitrogen atoms.  
 
2) Trp104 (and Met106) was found to adopt two different conformations; either with 
its side chain (Nε-H) in close proximity to flavin located at hydrogen-bonding 
distance to Gln63(O), denoted as Trp-in, or on the surface of the β-sheet, denoted as 
Trp-out. The β-sheet was found either to act as a dimerization interface or to be 
shielded from solvent by the C-terminal capping helices. The positioning of Trp104 
and Met106 leads to different hydrogen bonding patterns: Gln63 to Trp104 (Trp-in) 
or as a possible hydrogen bond donor to Met106 (Trp-out).  
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3) Other residues, Ser41 and Asn45 (Figure 34), whose mechanisms have remained 
obscure, are found conserved among the BLUF domains. Ser41 [222] appears to have 
two conformations, with the oxygen atom oriented towards (Sflav) or away from 
flavin (Sback, for backbone). Since different forms exhibit different spectral behavior, 
the light-induced switching of Ser41 from Sflav to Sback has a red-shifted response, 
thereby making a contribution to the overall (by ~10nm) red shift observed in the 
absorption spectra. Since the different orientations of Trp104 do not affect the 
absorption spectrum [222], the other contribution arises from the switching of 
Gln63. This movement breaks the hydrogen bond with Trp104 leading to a change in 
the β5 strand, and a consequent exchange of the Trp104/Met106 pair occurs [223] 
(possibly Trp104 moves out while Met106 moves in to fill the void [222] or changes 
orientation [224] upon illumination). Also, as a result of this change, a hydrogen 
bond is formed between Gln63 and the (C4=O) flavin; this new additional hydrogen 
bond to flavin is indicated by a red shift in the absorption spectra. However, 
experimental evidence for a direct effect of the Gln63 rotation on the conformational 
switch of Trp104 and Met106 is still lacking. Asn45 [224], on the other hand, forms 
hydrogen bonding with flavin, with an increase in the strength of the hydrogen bond 
upon photoexcitation promoting a red shift. 
 
 
Figure 34 – The key residues close to the flavin, from PDB ID (a) 2IYG (b) 1YRX 
showing the position of residues Ser41 and Asn45 relative to flavin. Met106 is 
located near the flavin (the Trp-out conformation) instead of Trp104.  
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The role of relevant residues has been investigated. Site-directed mutants of AppA 
replacing Tyr21 with either leucine or phenylalanine were found to abolish the 
photocycle activity. The results from an early study assumed that Tyr21 may form a π-π 
stacking interaction with the isoalloxazine of flavin which would induce the photocycle. 
[217] However, the structural analysis reveals that the two rings are actually 
perpendicular to one another. Mutating Tyr21 to phenylalanine disrupts its hydrogen 
bond with Gln63 and the photochemical reaction. Tyr21 and Gln63 are considered as 
being responsible for the photocycle of AppA. Mutation of a conserved Trp104 to alanine 
or phenylalanine reduces the stability of the signalling state, and no structural changes 
of the β-sheet are observed, suggesting Trp104 has a role in transforming the light signal 
into changes in β-sheet structure. [223] Confusingly, by comparison with analogous 
mutations in SyPixD and bPAC, Trp104Phe leads to stabilisation but Trp104Ala leads to 
destabilisation of the structure. [225] It was observed that some variants lack of 
essential residues (i.e. glutamine and tyrosine) show a weaker signalling, suggesting the 
formation of a transient radical is sufficient to drive the signalling transduction. [226] 
 
5.4 Photoactivation Mechanisms 
Critical residues in the flavin binding pocket are in dynamic conformational exchange of 
both side chains and the backbone. Since NMR experiments suffer from the difficulty of 
assigning resides due to line broadening, multiple orientations can be proposed on the 
basis of NMR data. Thus, there are debates on what immediately surrounds the flavin. 
Two conflicting experimental structures of the BLUF domains are the PDB entries 1YRX 
(Trp-in) and 2IYG (Trp-out) which show considerable differences in:  
(1) the backbone conformations of β5, where a kink is formed that introduces a shift of 
two residues in 2IYG. The carbonyl oxygen of His105 in 2IYG forms a hydrogen bond 
with the amide of Asn45. Met106 is hydrogen bonded to Gln63, whereas Trp104 is 
exposed to the solvent, as shown in Figure 35 (a). In contrast, in the Anderson dark-
state structure (Figure 35 (b)), the amide of Asn45 is perpendicular to the indole 
ring of Trp104, found in close proximity to flavin. The carbonyl oxygen of His105 is 
hydrogen bonded to Leu54 (not shown). Met106 and Trp104 are both relevant for 
the photocycle, conserved in the BLUF domains, and both forming a H-bond to 
Gln63.  
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(2) the side chain of Gln63. Anderson et al. [221] claimed that the Trp-in conformation 
belongs to the dark-state. The Gln63 makes hydrogen bonds with the Tyr21, Trp104 
and to the FMN(N5), and upon excitation this hydrogen bond breaks and Gln63 
undergoes a rotation. A light-induced rotation of the Gln63 side chain was shown to 
disrupt its hydrogen bonding with Trp104, thus it adopts a conformation that allows 
hydrogen bond formation between Gln63(NH2) and FMN(O4). 
 
Figure 35 - Modified from [224]. The dark-state of the flavin-binding pocket (a) 2IYG 
(Trp-out conformation) (b)1YRX (Trp-in conformation). 
Alternatively, Jung et al. [224] proposed a different orientation of Gln63, with oxygen 
toward the Tyr21 in the ground state such that the formation of protonated N5 leads to 
unfavourable interactions which promote the reorientation of Gln63.  
Overall, the experimental evidence agrees: a hydrogen bond is formed between 
FMN(O4) and the protein matrix in the signalling state. [227] This observation could 
only be explained by a Gln63 rotation as the oxygen atom of the Gln63 must be pointed 
toward the Trp104 so that the Gln63(NH2) to FMN(O4) hydrogen bond formation could 
be possible, assuming the Trp-in is in the signalling state. Domratcheva et al. suggest a 
Gln63 rotation occurring in the signalling state. [228] Other groups say that Gln63 could 
be presented in a tautomeric form, thus suggesting that it could be the bond donor and 
acceptor at the same time. [229]  
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Comparisons among available studies are difficult. First of all, this could be due to 
variations in the BLUF sequence. For example, BlrP1 BLUF contains a threonine instead 
of the conserved Trp104, which is known to be of functional importance as discussed 
above. This significant difference from the BLUF domain of AppA makes comparison 
difficult. Secondly, the models are different in size, depending on the presence of capping 
of the helices (as linkers) at the C-terminus. Some studies work on BLUF domains in 
solution by using dimeric models derived from the x-ray crystal structure. Those 
structures variance will expect to perform differently during simulations. In this work, 
we cut the chains to analogous length to obtain equally sized proteins. [230] 
 
5.5 Aims and Objectives 
The aim of this project is to investigate whether the redistributed charges in the flavin 
binding site of the BLUF domain would result in a driving force to change the 
conformational preference of the protein domain, in such a way to simulate the 
formation of FAD•− after a light-induced electron transfer from tyrosine to the flavin 
chromophore as the first step of the BLUF photocycle. At the end of this work we will be 
able to assign the Trp-in and Trp-out conformations to either of the two states ‘active’ or 
‘resting’. A better understanding of the BLUF domains would lead to applications in 
optogenetics, which uses light to control cellular events.  
To do this, we used two conflicting structures, differing in the position of the tryptophan 
(Trp104 in AppA), which can be either exposed to the solvent (the ‘Trp-out’) or close to 
flavin (the ‘Trp-in’ conformation). Both of these structures have been attributed to the 
dark state (as reported by Jung et al (PDB code: 2IYG) [224] and by Anderson et al (PDB 
code: 1YRX) [221]). Both structures were used as the starting geometry of the protein 
domain to construct a “2 by 2” scheme of four calculation sets. Due to various 
contradictory claims on the assignment of the Trp-in and Trp-out conformations to the 
functional states of the BLUF domain, we make no assumptions as to the state of the 
structure prior to our experiments. In this work, we considered the state of the flavin 
binding site, described by two set of charges for each structure, the regular AmberGS 
charges and an altered set of charges as mimicking the electronically excited state of the 
flavin binding site.  
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A further aim of this work was to investigate the structural basis in response to the 
charge difference. We analyse the repositioning of the nearby residues around the 
Flavin: 1) we measured the distance between two atoms focusing on functionally 
relevant residues. 2) we studied the side chain orientation of Gln63 as it might convert 
to the other conformation over the course of the simulations. 
 
5.6 Methods 
As observed earlier, on photoexcitation, the N-terminal domain of AppA undergoes a 
photocycle that is indistinguishable from that of the full-length AppA [210]. As a result, 
current computational works on BLUF are mainly on the N-terminal domain. According 
to Rieff et al. (2011) [231], the structures of 1YRX and 2IYG are the most reliable. We 
adopted 1YRX Trp-in and 2IYG Trp-out conformations as starting geometries. We cut the 
origin structure extracted from the PDB to include equal size (including residue 13-121) 
for a fair comparison.  
We considered excitation from the starting geometry of the protein focusing on the 
flavin binding site, applying individually both ground state (GS) charge taken from 
AmberGS and a set of relocated charges based on the AmberGS force field, from which 
charges for the excited Tyr21-flavin charge transfer state (ES) were calculated using 
time-dependent density functional theory.  
Previous studies mainly focus on reproduction of UV/vis and IR spectra from MD 
snapshots, which are normally carried out on a single structure. This procedure is 
potentially statistically insufficient, as can be seen from the diversity of results obtained. 
This indicates that it is necessary to study the system dynamically. We applied MD to 
study the thermal movement of BLUF using snapshots from a preliminary MD trajectory 
generated by Bilal as described in the preprocessing section. Götze et al. (2012) have 
proposed that the initial velocity could affect the consequent hydrogen bonding 
behaviour of Gln63. [232] Therefore, we have repeated eight times for each of four 
calculation sets (16 trajectories for each calculation set, 8 for the GS and 8 for ES) to 
obtain the average effects.   
As a result of this work, we aim to provide another activation model for the BLUF 
domain. The proposed driving force for activation is provided by a charge distribution. 
We used standard MD simulations to investigate the conformational change. Previous 
pure MD studies on multiple ns trajectories mainly focused on hydrogen bonding 
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between BLUF domain and its effector domain. [233] Other MD studies which aim at 
resolving the hydrogen bonding patterns in the flavin binding site, however, are hard to 
compare due to the use of different force field, equilibrium parameters and protonated 
state of histidine. [232,234,235] 
 
5.6.1 Preprocessing 
All simulations were carried out with Gromacs 4.3.6 using the AmberGS force field [236] 
for the protein and ions, and an explicit solvent (TIP3P model). The charges of the FMN 
were taken from Schneider & Sühnel (1999). [237] The force field was chosen by 
comparing the optimised structure obtained using different force fields with the original 
crystal structure, and choosing that which gave the smallest RMSD. 
The structures of the BLUF domains of AppA were taken from PDB code 2IYG (the Trp-
out) [224] and 1YRX (the Trp-in conformation) [221]. Both were cut out into equal sized 
residues comprising the residues 13-121 of the chain A. The MD simulation systems 
consisted of either structure solvated in a box of TIP3P water then subjected to energy 
minimisation using the steepest descent method with convergence criterion of either a 
maximum number of 50000 steps or until forces reached 10 kJ mol-1 nm-1. Periodic 
boundary conditions were applied and electrostatic forces were evaluated using the 
particle Mesh Ewald algorithm with a short range cut off radius of 1nm.  
After energy minimisation, the systems were gradually heated up from 0K to 300K, 
during which a 100ps NPT equilibration was performed at each successive temperature 
step, followed by a 1ns production run at 300K with a time step of 0.001ps. The H-bonds 
were constrained using P-LINCS. The initial structure was heated up (from initial 
temperature 0K) eight times with velocities randomly assigned from a Maxwell-
Boltzmann distribution, resulting in eight 1ns trajectories for each structure.  
 
5.6.2 Assignment of atomic charges for the excited state 
A random snapshot was taken from each of the resulting 1ns trajectories for each 
structure. (eight for 1YRX and eight for 2IYG) from Bilal’s work. To obtain average 
charge redistribution between the Tyr21 and the flavin (FMN) upon excitation, we have 
limited the system to tyrosine and the isoalloxazine ring in which the link atoms are 
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replaced by hydrogens. (Figure 36) The system was calculated using TD-DFT at the 
CAM-B3LYP/6-31G* level with the rest of the protein atoms and the solvent 10 Ångstron 
radii around the protein represented as point charges. We identified the excited state 
where electron density moves from Tyr21 to FMN and used the excited state number 
(root) with key word density to set up a calculation for the excited state charge 
distribution. The changes in redistribution of the charge from the ground to excited state 
for each Tyr21 and flavin pair over eight were averaged and the amount of change was 
applied to the regular charges to obtain the excited Tyr21-flavin charge.  
  
Figure 36 - Setup for TD-DFT. 
 
5.6.3 Dynamic simulations 
Snapshots were extracted every 100ps from each 1ns trajectory (resulting in 10×8 for 
each structure), as shown in Figure 37. We performed a 100ps run for each snapshot 
with regular AmberGS charges and the excited charges. We made comparisons between 
the two trajectories, analysing the conformational changes during the course of the 
simulations. All simulations were performed at 300K using an NVT ensemble. 
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Figure 37 - Scheme of the methodology.  
 
5.6.4 Criteria of comparison between GS & ES 
5.6.4.1 Distance 
To investigate the repositioning of residues at the flavin-binding site in response to the 
change in charges, we calculated the average distance between each of the selected two 
atoms restricted to functionally relevant residues around flavin over the 100ps 
simulation. (see Table 8) We excluded the first 20ps to allow the conformations to reach 
their equilibrium. 
 
 Atom pairs 
1 OH(Y21) - N5(FMN) 
2 OH(Y21) - OE1(Q63) 
3 OH(Y21) - NE2(Q63) 
4 NE1(W104) / S(M106) - N5(FMN) 
5 NE1(W104) / S(M106) - OE1(Q63) 
6 NE1(W104) / S(M106) - NE2(Q63) 
7 OH(S41) - N5(FMN) 
8 OH(S41) - S(M106) 
9 N5(FMN) - OE1(Q63) 
10 N5(FMN) - NE2(Q63) 
Table 8 - Lists pairs of atoms for distance measures.  
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5.6.4.2 Dihedral angle 
Current crystal structures have insufficient resolution to distinguish between side chain 
amidic oxygen and nitrogen of Gln63. One could have a hydrogen bond between 
Tyr21(OH) to Gln63(OE1) or to Gln63(NE2) for the dark-state 2IYG and 1YRX, 
respectively, as shown in Figure 35. In order to study the changes in the orientation of 
the Gln63 side chain over the 100ps simulation, two dihedral angles were measured 
formed by the atoms Y21(CZ)-Q63(CG)-Q63(CD)-Q63(NE2) and Y21(CZ)-Q63(CG)-
Q63(CD)-Q63(OE1).  
We plotted the angle vs time graphs taking the whole 100ps simulation time and 
rescaled the angles and count the number of switching events. We averaged the distance 
between Tyr21(OH) and Gln63 before and after the switching event. Depending on the 
starting geometry of the respective trajectory, switches may or may not occur. We aim to 
make a conclusion as to which of the two structures is more disturbed by the change in 
Coulomb parameters. 
 
5.7 Results & Discussion 
5.7.1 Charge 
Light excitation of the flavin initiates an electron transfer from the proximal tyrosine 
(Y21) to the flavin creating Tyr21 (+)/FMN (-) radical pair. The electron density 
increases at the isoalloxazine ring and, as expected, an increased electron density at N5 
of the flavin is observed from the relocated (ES) charges, see Table 5 in Appendix. 
 
5.7.2 Distance 
The system behaves as expected, with a drop in Tyr21 (+) and FMN (-) distance 
compared to the distance between their neutral counterparts. A shorter distance can be 
seen from both structures which is a favourable conformation for the electron transfer. 
Previous work [238] observed a decrease in distance between 1) Tyr21(OH) and 
Gln63(O) and 2) Gln63(NH2) and FMN(N5) based on 2IYG, our results clearly 
confirmed these findings. In the “Trp-out” conformation, a more negative FMN(O4) (also 
FMN(N5)) will result in Gln63(NH2) getting closer to FMN(O4). However, we observe 
102 
 
an increase in distance between Gln63(NH2) and FMN(N5) in 1YRX. We rationalise this 
is due to the Gln63 rotation, as the Gln63(NH2) is often hydrogen bonding to 
Tyr21(OH), thus with the Gln63(O) oriented towards the FMN. A larger negative charge 
at FMN would repel the Gln63(O) unless a switch occurs. (see Table 11 and 12) 
 
5.7.3 Angle 
The conformational transition (switch) of the Gln63 side chain was analysed. Table 13 is 
a summary of the number of switches on picosecond timescale for 1YRX. The angle vs 
time graphs are plotted in the Appendix. The “Trp-in” conformation (1YRX) with the 
Q63(NH2) oriented towards OH(Y21) should have a dihedral angle Y21(CZ)-Q63(CG)-
Q63(CD)-Q63(NE2) close to zero for the ground state.  
1YRX unfortunately has plenty (>50%) of geometries that effectively start in the 
switched conformation. (see Appendix Figure 1-8) In four (2,6,7,8) trajectories, it is 
completely in the switched Gln63 orientation, which with no evaluation value. Because it 
is no longer in its initial conformation before we apply anything, we hope to see if any 
switch will happen from its initial conformation. No switch is observed for the first set of 
trajectories. Three (3,4,5) trajectories each have one case starting in the switched 
orientation so that the corresponding trajectories are not evaluated. The life time of the 
switched conformation is prolonged in the excited state in comparison to the 
corresponding ground state trajectory. In future work, one may produce more 
trajectories on unswitched 1YRX. 
Here, we reported the average distance between Tyr21(OH) and Gln63 (O) before and 
after the switching event (Table 9). This effect of the switch is the most significant 
among all of our distance measures, as the Gln63(OE) is close to hydrogen-bonding 
distance upon switching, after being far away before the switch. 
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ES 
 
switch time 
(ps) 
avg distance before 
switching (nm) 
avg distance after 
switching (nm) 
Back switching 
(nm) 
3 1000 55 0.761494 0.452574 
 
4 600 20 0.521298 0.260246 
 
 
700 85 0.559946 0.26549 
 
 
800 5 0.445159 0.278662 
 
5 300 35,65 0.424301 0.266453 0.471271  
900 55 0.710382 0.266118 
 
Table 9 - Average distance between Tyr21(OH) and Gln63 (O) before and after a switch 
is occurred. 1nm=10Å . 
In contrast, the position of the Gln63(NH2) group is very random, but appears to form 
weak interactions with FMN in all switching states. (see Appendix Table 6-8) The 
Tyr21(OH) and Gln63(NH2) distance is slightly larger in the switched state, which 
makes sense as the Gln63 (O) forms a hydrogen bond to Tyr21(OH) and Gln63 (O) and 
Gln63(NH2) are located at opposite ends of the end group of Gln63. (Table 10) 
 
ES 
 
switch time 
(ps) 
avg distance before 
switching (nm) 
avg distance after 
switching (nm) 
Back switching 
(nm) 
3 1000 55 0.613805 0.607003 
 
4 600 20 0.408162 0.454528 
 
 
700 85 0.469891 0.411732 
 
 
800 5 0.431713 0.43768 
 
5 300 35,65 0.356078 0.421399 0.331078  
900 55 0.568704 0.429289 
 
Table 10 - Average distance between Tyr21(OH) and Gln63 (NH2) before and after a 
switch is occurred. 
Switching only happens in the 1YRX (Trp-in conformation) state. The 2IYG seems to be 
the signalling state because no switching event has been found after applying an excited 
charged state. (see Appendix Figure 9-16) We have artificially created a state of charge 
reversal, an artificial Tyr (-)/FMN (+) state, where we forced the system to make 
switching happen in the Trp-out. (Table 14) 
The “Trp-out” conformation (2IYG) with the Q63(O) oriented towards OH(Y21) should 
have a dihedral angle Y21(CZ)-Q63(CG)-Q63(CD)-Q63(OE1) close to zero for the ground 
state. The Q63(NE2) graph which is made for comparison will yield a switch for the 
same cases. Using an artificial charge state, switching was observed in 15 out of 80 
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trajectories leading to OH(Y21) and Q63(NE2) bridge. In general, those switches 
happened very early, typically within 5ps. (Table 14 and Appendix Figure 17-24) 
 
5.8 Conclusion 
The BLUF domain is a FAD-binding blue-light-sensing protein, which regulates 
photosynthesis gene expression in the purple bacterium. The BLUF domain undergoes a 
photocycle upon illumination involving a subtle rearrangement of the hydrogen network 
in the flavin binding site. The photochemical reaction involves both electron and proton 
transfer from nearby residues. In this work, we aim to investigate whether the 
redistributed charges in the flavin binding site would result in a driving force to change 
the conformational preference of the protein domain so as to assign the functional state 
of the two conflicting geometries “Trp-in” and “Trp-out”. Our results show that switching 
only happens in the 1YRX (“Trp-in” conformation) state. The switched conformation 
prefers the ES charge distribution, as seen from the few cases where the switches 
happened very early. Our study shows that 2IYG to be the signaling state as no switching 
event was observed from all eight trajectories, suggesting the “Trp-out” conformation 
appears to favour the ES charge distribution. Switching only happens in the Trp-out case 
using an artificial Try21 (-)/FMN (+) state. 
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Table 11 - Presents the distance averaged over the course of the 100ps simulations, excluding 
the first 20ps, for 1YRX (Trp-in conformation).  
 
 
GS ES Change 
  
GS ES Change 
OH(Y21)-N5(FMN)-100 0.5045 0.4489 -0.0557  
 
OH(S41)-N5(FMN)-100 0.3631 0.3782 0.0150  
OH(Y21)-N5(FMN)-200 0.5194 0.4453 -0.0741  
 
OH(S41)-N5(FMN)-200 0.3585 0.3695 0.0110  
OH(Y21)-N5(FMN)-300 0.5174 0.4361 -0.0813  
 
OH(S41)-N5(FMN)-300 0.3529 0.3674 0.0145  
OH(Y21)-N5(FMN)-400 0.5472 0.4288 -0.1185  
 
OH(S41)-N5(FMN)-400 0.3551 0.3696 0.0145  
OH(Y21)-N5(FMN)-500 0.5404 0.4510 -0.0894  
 
OH(S41)-N5(FMN)-500 0.3558 0.3660 0.0102  
OH(Y21)-N5(FMN)-600 0.5095 0.4570 -0.0525  
 
OH(S41)-N5(FMN)-600 0.3540 0.3705 0.0165  
OH(Y21)-N5(FMN)-700 0.5117 0.4537 -0.0581  
 
OH(S41)-N5(FMN)-700 0.3568 0.3634 0.0066  
OH(Y21)-N5(FMN)-800 0.5169 0.4253 -0.0916  
 
OH(S41)-N5(FMN)-800 0.3593 0.3688 0.0095  
OH(Y21)-N5(FMN)-900 0.5287 0.4460 -0.0827  
 
OH(S41)-N5(FMN)-900 0.3560 0.3655 0.0095  
OH(Y21)-N5(FMN)-1000 0.4976 0.4317 -0.0659  
 
OH(S41)-N5(FMN)-1000 0.3568 0.3731 0.0163  
OH(Y21)-OE1(Q63)-100 0.4024 0.3323 -0.0700  
 
OE1(Q63)-N5(FMN)-100 0.3873 0.3995 0.0121  
OH(Y21)-OE1(Q63)-200 0.4762 0.4430 -0.0332  
 
OE1(Q63)-N5(FMN)-200 0.4239 0.4598 0.0360  
OH(Y21)-OE1(Q63)-300 0.5008 0.4116 -0.0892  
 
OE1(Q63)-N5(FMN)-300 0.4367 0.4361 -0.0006  
OH(Y21)-OE1(Q63)-400 0.5279 0.4203 -0.1076  
 
OE1(Q63)-N5(FMN)-400 0.4273 0.4427 0.0154  
OH(Y21)-OE1(Q63)-500 0.5070 0.4768 -0.0302  
 
OE1(Q63)-N5(FMN)-500 0.4249 0.4539 0.0290  
OH(Y21)-OE1(Q63)-600 0.4826 0.4042 -0.0785  
 
OE1(Q63)-N5(FMN)-600 0.4251 0.4239 -0.0012  
OH(Y21)-OE1(Q63)-700 0.4591 0.4498 -0.0093  
 
OE1(Q63)-N5(FMN)-700 0.4269 0.4466 0.0197  
OH(Y21)-OE1(Q63)-800 0.4946 0.3790 -0.1156  
 
OE1(Q63)-N5(FMN)-800 0.4254 0.4367 0.0113  
OH(Y21)-OE1(Q63)-900 0.5058 0.4431 -0.0628  
 
OE1(Q63)-N5(FMN)-900 0.4260 0.4307 0.0047  
OH(Y21)-OE1(Q63)-1000 0.4767 0.4203 -0.0564  
 
OE1(Q63)-N5(FMN)-1000 0.4306 0.4652 0.0346  
OH(Y21)-NE2(Q63)-100 0.4667 0.4571 -0.0096  
 
NE2(Q63)-N5(FMN)-100 0.3445 0.3567 0.0121  
OH(Y21)-NE2(Q63)-200 0.5049 0.4602 -0.0447  
 
NE2(Q63)-N5(FMN)-200 0.3540 0.3779 0.0240  
OH(Y21)-NE2(Q63)-300 0.5177 0.4597 -0.0580  
 
NE2(Q63)-N5(FMN)-300 0.3658 0.3793 0.0135  
OH(Y21)-NE2(Q63)-400 0.5346 0.4418 -0.0928  
 
NE2(Q63)-N5(FMN)-400 0.3417 0.3552 0.0135  
OH(Y21)-NE2(Q63)-500 0.5186 0.4920 -0.0267  
 
NE2(Q63)-N5(FMN)-500 0.3426 0.3798 0.0372  
OH(Y21)-NE2(Q63)-600 0.4949 0.4732 -0.0218  
 
NE2(Q63)-N5(FMN)-600 0.3554 0.3617 0.0062  
OH(Y21)-NE2(Q63)-700 0.4768 0.4813 0.0044  
 
NE2(Q63)-N5(FMN)-700 0.3538 0.3625 0.0087  
OH(Y21)-NE2(Q63)-800 0.4988 0.4446 -0.0542  
 
NE2(Q63)-N5(FMN)-800 0.3573 0.3773 0.0200  
OH(Y21)-NE2(Q63)-900 0.5094 0.4702 -0.0393  
 
NE2(Q63)-N5(FMN)-900 0.3542 0.3636 0.0093  
OH(Y21)-NE2(Q63)-1000 0.4880 0.4749 -0.0131  
 
NE2(Q63)-N5(FMN)-1000 0.3650 0.3970 0.0320  
NE1(W104)-N5(FMN)-100 0.5703 0.5587 -0.0116  
     
NE1(W104)-N5(FMN)-200 0.6042 0.6185 0.0143  
     
NE1(W104)-N5(FMN)-300 0.6258 0.6001 -0.0257  
     
NE1(W104)-N5(FMN)-400 0.6245 0.6255 0.0010  
     
NE1(W104)-N5(FMN)-500 0.6016 0.6234 0.0218  
     
NE1(W104)-N5(FMN)-600 0.6060 0.6018 -0.0043  
     
NE1(W104)-N5(FMN)-700 0.6206 0.6224 0.0018  
     
NE1(W104)-N5(FMN)-800 0.6134 0.6223 0.0089  
     
NE1(W104)-N5(FMN)-900 0.6292 0.6311 0.0018  
     
NE1(W104)-N5(FMN)-1000 0.6188 0.6436 0.0248  
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NE1(W104)-OE1(Q63)-100 0.4826 0.5107 0.0281  
     
NE1(W104)-OE1(Q63)-200 0.4633 0.4431 -0.0203  
     
NE1(W104)-OE1(Q63)-300 0.4509 0.4460 -0.0049  
     
NE1(W104)-OE1(Q63)-400 0.4592 0.4419 -0.0173  
     
NE1(W104)-OE1(Q63)-500 0.4542 0.4291 -0.0250  
     
NE1(W104)-OE1(Q63)-600 0.4374 0.4737 0.0363  
     
NE1(W104)-OE1(Q63)-700 0.4626 0.4531 -0.0095  
     
NE1(W104)-OE1(Q63)-800 0.4437 0.4664 0.0228  
     
NE1(W104)-OE1(Q63)-900 0.4501 0.4696 0.0194  
     
NE1(W104)-OE1(Q63)-1000 0.4390 0.4429 0.0039  
     
NE1(W104)-NE2(Q63)-100 0.4351 0.3921 -0.0430  
     
NE1(W104)-NE2(Q63)-200 0.4457 0.4181 -0.0276  
     
NE1(W104)-NE2(Q63)-300 0.4442 0.4136 -0.0306  
     
NE1(W104)-NE2(Q63)-400 0.4539 0.4258 -0.0281  
     
NE1(W104)-NE2(Q63)-500 0.4430 0.4169 -0.0261  
     
NE1(W104)-NE2(Q63)-600 0.4346 0.4169 -0.0178  
     
NE1(W104)-NE2(Q63)-700 0.4549 0.4238 -0.0311  
     
NE1(W104)-NE2(Q63)-800 0.4419 0.4226 -0.0193  
     
NE1(W104)-NE2(Q63)-900 0.4489 0.4400 -0.0089  
     
NE1(W104)-NE2(Q63)-1000 0.4382 0.4171 -0.0211  
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Table 12 - Presents the distance averaged over the course of the 100ps simulations, excluding 
the first 20ps, for 2IYG (Trp-out conformation). 
 
 
GS ES Change 
  
GS ES Change 
OH(Y21)-N5(FMN)-100 0.4499 0.4293 -0.0205  OH(S41)-S(M106)-100 0.5551 0.5568 0.0016 
OH(Y21)-N5(FMN)-200 0.4554 0.4218 -0.0336  OH(S41)-S(M106)-200 0.5735 0.5753 0.0018 
OH(Y21)-N5(FMN)-300 0.4623 0.4299 -0.0324  OH(S41)-S(M106)-300 0.5704 0.5771 0.0066 
OH(Y21)-N5(FMN)-400 0.4571 0.4325 -0.0246  OH(S41)-S(M106)-400 0.5710 0.5659 -0.0051 
OH(Y21)-N5(FMN)-500 0.4573 0.4298 -0.0275  OH(S41)-S(M106)-500 0.5670 0.5603 -0.0067 
OH(Y21)-N5(FMN)-600 0.4543 0.4281 -0.0262  OH(S41)-S(M106)-600 0.5640 0.5741 0.0100 
OH(Y21)-N5(FMN)-700 0.4504 0.4326 -0.0178  OH(S41)-S(M106)-700 0.5644 0.5573 -0.0071 
OH(Y21)-N5(FMN)-800 0.4571 0.4384 -0.0187  OH(S41)-S(M106)-800 0.5644 0.5802 0.0158 
OH(Y21)-N5(FMN)-900 0.4605 0.4402 -0.0203  OH(S41)-S(M106)-900 0.5698 0.5642 -0.0056 
OH(Y21)-N5(FMN)-1000 0.4614 0.4310 -0.0304  OH(S41)-S(M106)-1000 0.5683 0.5662 -0.0021 
OH(Y21)-OE1(Q63)-100 0.2726 0.2629 -0.0097  OH(S41)-N5(FMN)-100 0.3556 0.3639 0.0084 
OH(Y21)-OE1(Q63)-200 0.2717 0.2621 -0.0097  OH(S41)-N5(FMN)-200 0.3592 0.3753 0.0162 
OH(Y21)-OE1(Q63)-300 0.2715 0.2620 -0.0095  OH(S41)-N5(FMN)-300 0.3574 0.3755 0.0181 
OH(Y21)-OE1(Q63)-400 0.2722 0.2615 -0.0107  OH(S41)-N5(FMN)-400 0.3537 0.3771 0.0235 
OH(Y21)-OE1(Q63)-500 0.2723 0.2619 -0.0104  OH(S41)-N5(FMN)-500 0.3552 0.3794 0.0242 
OH(Y21)-OE1(Q63)-600 0.2729 0.2623 -0.0106  OH(S41)-N5(FMN)-600 0.3516 0.3773 0.0257 
OH(Y21)-OE1(Q63)-700 0.2730 0.2622 -0.0108  OH(S41)-N5(FMN)-700 0.3596 0.3849 0.0253 
OH(Y21)-OE1(Q63)-800 0.2729 0.2619 -0.0111  OH(S41)-N5(FMN)-800 0.3508 0.3722 0.0214 
OH(Y21)-OE1(Q63)-900 0.2726 0.2620 -0.0107  OH(S41)-N5(FMN)-900 0.3635 0.3832 0.0197 
OH(Y21)-OE1(Q63)-1000 0.2725 0.2619 -0.0107  OH(S41)-N5(FMN)-1000 0.3536 0.3666 0.0130 
OH(Y21)-NE2(Q63)-100 0.4333 0.4314 -0.0019  OE1(Q63)-N5(FMN)-100 0.3533 0.3530 -0.0003 
OH(Y21)-NE2(Q63)-200 0.4371 0.4273 -0.0098  OE1(Q63)-N5(FMN)-200 0.3522 0.3537 0.0014 
OH(Y21)-NE2(Q63)-300 0.4348 0.4319 -0.0029  OE1(Q63)-N5(FMN)-300 0.3575 0.3542 -0.0033 
OH(Y21)-NE2(Q63)-400 0.4343 0.4317 -0.0026  OE1(Q63)-N5(FMN)-400 0.3574 0.3582 0.0007 
OH(Y21)-NE2(Q63)-500 0.4361 0.4297 -0.0064  OE1(Q63)-N5(FMN)-500 0.3558 0.3557 -0.0001 
OH(Y21)-NE2(Q63)-600 0.4345 0.4267 -0.0078  OE1(Q63)-N5(FMN)-600 0.3561 0.3566 0.0005 
OH(Y21)-NE2(Q63)-700 0.4283 0.4333 0.0050  OE1(Q63)-N5(FMN)-700 0.3587 0.3542 -0.0046 
OH(Y21)-NE2(Q63)-800 0.4348 0.4318 -0.0030  OE1(Q63)-N5(FMN)-800 0.3592 0.3583 -0.0010 
OH(Y21)-NE2(Q63)-900 0.4374 0.4351 -0.0024  OE1(Q63)-N5(FMN)-900 0.3599 0.3574 -0.0025 
OH(Y21)-NE2(Q63)-1000 0.4371 0.4303 -0.0068  OE1(Q63)-N5(FMN)-1000 0.3607 0.3578 -0.0029 
S(M106)-N5(FMN)-100 0.5712 0.5733 0.0021  NE2(Q63)-N5(FMN)-100 0.3170 0.3014 -0.0156 
S(M106)-N5(FMN)-200 0.5762 0.5784 0.0022  NE2(Q63)-N5(FMN)-200 0.3144 0.3027 -0.0118 
S(M106)-N5(FMN)-300 0.5707 0.5736 0.0029  NE2(Q63)-N5(FMN)-300 0.3147 0.3020 -0.0127 
S(M106)-N5(FMN)-400 0.5750 0.5749 -0.0001  NE2(Q63)-N5(FMN)-400 0.3168 0.3077 -0.0091 
S(M106)-N5(FMN)-500 0.5786 0.5750 -0.0036  NE2(Q63)-N5(FMN)-500 0.3161 0.3033 -0.0128 
S(M106)-N5(FMN)-600 0.5722 0.5723 0.0001  NE2(Q63)-N5(FMN)-600 0.3167 0.3026 -0.0141 
S(M106)-N5(FMN)-700 0.5711 0.5743 0.0032  NE2(Q63)-N5(FMN)-700 0.3161 0.3032 -0.0129 
S(M106)-N5(FMN)-800 0.5666 0.5692 0.0026  NE2(Q63)-N5(FMN)-800 0.3211 0.3035 -0.0177 
S(M106)-N5(FMN)-900 0.5698 0.5700 0.0002  NE2(Q63)-N5(FMN)-900 0.3175 0.3028 -0.0147 
S(M106)-N5(FMN)-1000 0.5708 0.5719 0.0011  NE2(Q63)-N5(FMN)-1000 0.3174 0.3031 -0.0143 
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S(M106)-OE1(Q63)-100 0.5470 0.5430 -0.0040      
S(M106)-OE1(Q63)-200 0.5440 0.5412 -0.0029      
S(M106)-OE1(Q63)-300 0.5432 0.5355 -0.0077      
S(M106)-OE1(Q63)-400 0.5434 0.5434 -0.0001      
S(M106)-OE1(Q63)-500 0.5459 0.5369 -0.0090      
S(M106)-OE1(Q63)-600 0.5423 0.5378 -0.0045      
S(M106)-OE1(Q63)-700 0.5397 0.5423 0.0026      
S(M106)-OE1(Q63)-800 0.5400 0.5367 -0.0033      
S(M106)-OE1(Q63)-900 0.5390 0.5333 -0.0057      
S(M106)-OE1(Q63)-1000 0.5415 0.5343 -0.0071      
S(M106)-NE2(Q63)-100 0.3544 0.3507 -0.0037      
S(M106)-NE2(Q63)-200 0.3489 0.3529 0.0040      
S(M106)-NE2(Q63)-300 0.3481 0.3465 -0.0016      
S(M106)-NE2(Q63)-400 0.3479 0.3537 0.0058      
S(M106)-NE2(Q63)-500 0.3512 0.3475 -0.0037      
S(M106)-NE2(Q63)-600 0.3476 0.3475 -0.0001      
S(M106)-NE2(Q63)-700 0.3453 0.3507 0.0055      
S(M106)-NE2(Q63)-800 0.3472 0.3454 -0.0018      
S(M106)-NE2(Q63)-900 0.3439 0.3433 -0.0006      
S(M106)-NE2(Q63)-1000 0.3469 0.3450 -0.0019      
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Table 13 - Number of switches (on ps timescale) observed from the eight trajectories of 1YRX. 
 
ps 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 (1) 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 
4 (1) 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 3 3 3 3 
5 (1) 0 0 0 0 0 0 1 1 1 1 2 2 2 2 2 2 2 2 2 2 
6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Sum 1 1 1 2 2 2 3 3 3 3 5 5 5 5 5 5 6 6 6 6 
 
 
Table 14 - Number of switches (on ps timescale) observed from the eight trajectories of 2IYG by applying an artificial Tyr (-)/FMN (+) state. 
 
ps 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 
1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
2 3 4 4 4 4 4 5 5 5 6 6 6 6 6 6 6 6 6 6 6 
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
6 1 1 1 1 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 
7 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
8 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 
Sum 9 10 10 10 11 11 12 12 12 13 13 13 14 14 14 14 14 14 15 15 
110 
 
 
  
111 
 
Appendix 
Table 1 – List of 59 representative allosteric pockets. 
 
 PDB Ligand 
1 1AO0 ADP 468A 
2 1CSM TRP 501B 
3 1CZA ADP 922N 
4 1EGY 9AP 801A 
5 1ESM COA 403D 
6 1EYJ AMP 341A 
7 1H5U CHI 920A 
8 1I1Q TRP 1001A 
9 1IE9 VDX 500A 
10 1JL0 PUT 2020B 
11 1JQN ASP 884A 
12 1KFL PHE 5354E 
13 1LTH FBP 320R 
14 1M8P PPS 576C 
15 1NTK AY1 383C 
16 1NXG NAD 3000A 
17 1PJ3 FUM 700A 
18 1PSD SER 451A 
19 1RD4 L08 3328D 
20 1S9J BBM 1001A 
21 1SHJ NXN 401B 
22 1T36 U 1093E 
23 1V4S MRK 501A 
24 1W25 C2E 505B 
25 1W96 S1A 1567A 
26 1X88 NAT 802B 
27 1XJF DTP 1001B 
28 1XXA ARG 1F 
29 1YXD LYS 1300B 
30 1ZDQ MSM 1509C 
31 2AL5 4MP 801A 
32 2CLK G3H 1268A 
33 2D5Z L35 1200C 
34 2FZC CTP 901B 
35 2G50 ALA 6106F 
36 2I80 G1L 400A 
37 2JC9 ADN 1497A 
38 2JHR PBQ 1780A 
39 2JJX ATP 1246C 
40 2ONB 7PA 319A 
41 2P2N ASN 8004D 
42 2P9H IPT 998A 
43 2PIV T3 933A 
44 2Q5Q KPV 5004A 
45 2V8Q AMP 1327E 
46 2VD4 P21 1454A 
47 3BEO UD1 372B 
48 3D2P ARG 438B 
49 3DC2 SER 600A 
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50 3F6G ILE 1A 
51 3FZY IHP 8000A 
52 3GCP SB2 361A 
53 3H30 RFZ 337A 
54 3HRF P47 1374A 
55 3I0S RT7 601A 
56 3IAD 15X 901D 
57 3JVR AGX 901A 
58 3KCC CMP 302B 
59 3R1R ATP 762B 
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Table 2 – List of 151 small molecule descriptors. Detailed can be found in the CDK 
documentation. 
 
1 AtomCount:C 
2 AtomCount:O 
3 AtomCount:N 
4 AtomCount:P 
5 AtomCount:Cl 
6 AtomCount:F 
7 AtomCount:S 
8 AtomCount:Br 
9 AtomCount:I 
10 Total_HA 
11 ZagrebIndex:Zagreb 
12 XLogP:XLogP 
13 WienerNumbers:WPOL 
14 WienerNumbers:WPATH 
15 WeightedPath:WTPT-5 
16 WeightedPath:WTPT-4 
17 WeightedPath:WTPT-3 
18 WeightedPath:WTPT-2 
19 WeightedPath:WTPT-1 
20 Weight:MW 
21 VAdjMa:VAdjMat 
22 TPSA:TopoPSA 
23 RuleOfFive:LipinskiFailures 
24 RotatableBondsCount:nRotB 
25 PetitjeanShapeIndex:geomShape 
26 PetitjeanNumber:PetitjeanNumber 
27 MolWt:MWt 
28 MDE:MDEN-33 
29 MDE:MDEN-23 
30 MDE:MDEN-22 
31 MDE:MDEN-13 
32 MDE:MDEN-12 
33 MDE:MDEN-11 
34 MDE:MDEO-22 
35 MDE:MDEO-12 
36 MDE:MDEO-11 
37 MDE:MDEC-44 
38 MDE:MDEC-34 
39 MDE:MDEC-33 
40 MDE:MDEC-24 
41 MDE:MDEC-23 
42 MDE:MDEC-22 
43 MDE:MDEC-14 
44 MDE:MDEC-13 
45 MDE:MDEC-12 
46 MDE:MDEC-11 
47 MannholdLogP:MLogP 
48 LongestAliphaticChain:nAtomLAC 
49 LargestPiSystem:nAtomP 
50 LargestChain:nAtomLC 
51 KierHallSmarts:khs.sssSnH 
52 KierHallSmarts:khs.sSnH3 
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53 KierHallSmarts:khs.sBr 
54 KierHallSmarts:khs.ddssSe 
55 KierHallSmarts:khs.dssSe 
56 KierHallSmarts:khs.aaSe 
57 KierHallSmarts:khs.dSe 
58 KierHallSmarts:khs.sSeH 
59 KierHallSmarts:khs.sssssAs 
60 KierHallSmarts:khs.sssdAs 
61 KierHallSmarts:khs.sssAs 
62 KierHallSmarts:khs.ssAsH 
63 KierHallSmarts:khs.sAsH2 
64 KierHallSmarts:khs.sssGeH 
65 KierHallSmarts:khs.ssGeH2 
66 KierHallSmarts:khs.sGeH3 
67 KierHallSmarts:khs.ddssS 
68 KierHallSmarts:khs.dssS 
69 KierHallSmarts:khs.aaS 
70 KierHallSmarts:khs.ssS 
71 KierHallSmarts:khs.dS 
72 KierHallSmarts:khs.sSH 
73 KierHallSmarts:khs.sssssP 
74 KierHallSmarts:khs.dsssP 
75 KierHallSmarts:khs.sssP 
76 KierHallSmarts:khs.ssPH 
77 KierHallSmarts:khs.sOH 
78 KierHallSmarts:khs.aasN 
79 KierHallSmarts:khs.sssN 
80 KierHallSmarts:khs.sssNH 
81 KierHallSmarts:khs.tCH 
82 KappaShapeIndices:Kier3 
83 KappaShapeIndices:Kier2 
84 KappaShapeIndices:Kier1 
85 HybridizationRatio:HybRatio 
86 HBondDonorCount:nHBDon 
87 HBondAcceptorCount:nHBAcc 
88 FragmentComplexity:fragC 
89 FMF:FMF 
90 EccentricConnectivityIndex:ECCEN 
91 ChiPath:VP-7 
92 ChiPath:VP-6 
93 ChiPath:VP-5 
94 ChiPath:VP-4 
95 ChiPath:VP-3 
96 ChiPath:VP-2 
97 ChiPath:VP-1 
98 ChiPath:VP-0 
99 ChiPath:SP-7 
100 ChiPath:SP-6 
101 ChiPath:SP-5 
102 ChiPath:SP-4 
103 ChiPath:SP-3 
104 ChiPath:SP-2 
105 ChiPath:SP-1 
106 ChiPath:SP-0 
107 ChiPathCluster:VPC-6 
108 ChiPathCluster:VPC-5 
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109 ChiPathCluster:VPC-4 
110 ChiPathCluster:SPC-6 
111 ChiPathCluster:SPC-5 
112 ChiPathCluster:SPC-4 
113 ChiCluster:VC-6 
114 ChiCluster:VC-5 
115 ChiCluster:VC-4 
116 ChiCluster:VC-3 
117 ChiCluster:SC-6 
118 ChiCluster:SC-5 
119 ChiCluster:SC-4 
120 ChiCluster:SC-3 
121 ChiChain:VCH-5 
122 ChiChain:VCH-4 
123 ChiChain:VCH-3 
124 ChiChain:SCH-5 
125 ChiChain:SCH-4 
126 ChiChain:SCH-3 
127 CarbonTypes:C4SP3 
128 CarbonTypes:C3SP3 
129 CarbonTypes:C2SP3 
130 CarbonTypes:C1SP3 
131 CarbonTypes:C3SP2 
132 CarbonTypes:C2SP2 
133 CarbonTypes:C1SP2 
134 CarbonTypes:C2SP1 
135 CarbonTypes:C1SP1 
136 BPol:bpol 
137 BondCount:nB 
138 BCUT:BCUTp-1h 
139 BCUT:BCUTp-1l 
140 BCUT:BCUTc-1h 
141 BCUT:BCUTc-1l 
142 BCUT:BCUTw-1h 
143 BCUT:BCUTw-1l 
144 BasicGroupCount:nBase 
145 AtomCount:nAtom 
146 AromaticBondsCount:nAromBond 
147 APol:apol 
148 AminoAcidCount:nW 
149 AminoAcidCount:nM 
150 AminoAcidCount:nP 
151 AcidicGroupCount:nAcid 
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Table 3 - Results of Model 1 (43 descriptors) for the CHES set. 
 
A R T Prediction PDB Ligand Literature 
1 5 94 T 2VW2 A1000 active site    
19 5 76 T 3OQI A258 catalytic pocket    
25 0 75 T 2ICH B2 interdomain interface    
10 16 74 T 3NOQ A501 active site    
29 0 71 T 2ICH A1 interdomain interface    
41 1 58 T 3OQI B258 catalytic pocket    
90 9 1 A 3RIG A2001 active site-acyl pocket   
84 16 0 A 1YI1 A696 ≈20Å from the active site 
68 32 0 A 3RIG B2002 active site-acyl pocket   
67 33 0 A 1Z8N A696 ≈20Å from the active site 
64 35 1 A 1Q1Q A354 active site-competes with substrate  
58 5 37 A 1V30 A2854 probably active site   
51 49 0 A 1YI0 A696 ≈20Å from the active site 
95 5 0 A 4DQ0 C202 to be published   
93 7 0 A 4DQ0 B201 to be published   
66 34 0 A 4DQ0 C201 to be published   
74 26 0 A 3G8W A168 to be published   
68 32 0 A 3G8W A167 to be published   
62 32 6 A 3G8W C167 to be published   
57 24 19 A 3G8W A169 to be published   
43 39 18 A 3G8W C170 to be published   
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Table 4 - Results of Model 5 (five descriptors) for the CHES set. 
 
A R T Prediction PDB Ligand Literature 
15 0 85 T 2ICH A1 interdomain interface    
16 0 84 T 2ICH B2 interdomain interface    
1 20 79 T 2VW2 A1000 active site    
23 27 50 T 1V30 A2854 probably active site   
41 18 41 T/A 3OQI B258 catalytic pocket    
100 0 0 A 1Q1Q A354 active site-competes with substrate  
95 5 0 A 1YI1 A696 ≈20Å  from the active site 
92 7 1 A 3RIG A2001 active site-acyl pocket   
91 9 0 A 1Z8N A696 ≈20Å  from the active site 
88 12 0 A 3RIG B2002 active site-acyl pocket   
86 14 0 A 4EV1 A302 hydrophobic pocket    
84 16 0 A 3GXZ A301 primary oligosaccharide-binding sites   
79 21 0 A 3OB9 A540 peptide (methyllysine) binding pocket  
78 22 0 A 3NIB A276 active site    
72 28 0 A 4H75 A304 aromatic cage for methyllysine binding 
71 29 0 A 1YI0 A696 ≈20Å  from the active site 
67 33 0 A 1YBH A696 ≈20Å  from the active site 
61 39 0 A 1YHY A696 ≈20Å  from the active site 
61 39 0 A 1YHZ A696 ≈20Å  from the active site 
58 42 0 A 4ATG A401 interface of symmetry-related molecules 
95 5 0 A 3G8W A168 to be published   
90 9 1 A 3G8W A167 to be published   
88 12 0 A 3G8W C167 to be published   
87 12 1 A 3G8W C170 to be published   
72 28 0 A 3G8W C168 to be published   
62 38 0 A 3G8W A169 to be published   
62 38 0 A 3G8W C171 to be published   
52 48 0 A 3G8W C169 to be published   
95 5 0 A 3IXS C1 no comment    
92 8 0 A 3CGG A195 to be published   
91 9 0 A 1L5B A301 no comment    
91 9 0 A 3KSP A129 to be published   
83 17 0 A 3R97 A315 to be published   
83 17 0 A 4DQ0 B201 to be published   
76 24 0 A 4DQ0 C202 to be published   
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Table 5 - Lists the atomic charges used to perform MD simulations. The ground or dark-
state (GS) charges were taken from AmberGS force field and a set of relocated charges 
(ES), which was obtained from a TD-DFT CAM-B3LYP/6-31G* calculation.  
 
 1YRX 2IYG 
 GS ES GS ES 
N -0.4157 -0.4157 -0.4157 -0.4157 
H 0.2719 0.2719 0.2719 0.2719 
CA -0.0014 0.0665 -0.0014 0.0677 
HA 0.0876 0.0876 0.0876 0.0876 
CB -0.0152 -0.0991 -0.0152 -0.1062 
HB1 0.0295 0.0860 0.0295 0.0812 
HB2 0.0295 0.0832 0.0295 0.0826 
CG -0.0011 0.1497 -0.0011 0.1683 
CD1 -0.1906 -0.1516 -0.1906 -0.1628 
HD1 0.1699 0.2014 0.1699 0.2056 
CE1 -0.2341 -0.1593 -0.2341 -0.1790 
HE1 0.1656 0.2206 0.1656 0.2161 
CZ 0.3226 0.4721 0.3226 0.4592 
OH -0.5579 -0.3814 -0.5579 -0.3602 
HH 0.3992 0.4213 0.3992 0.4168 
CE2 -0.2341 -0.1823 -0.2341 -0.1378 
HE2 0.1656 0.2156 0.1656 0.2143 
CD2 -0.1906 -0.1394 -0.1906 -0.1864 
HD2 0.1699 0.1992 0.1699 0.2070 
C 0.5973 0.5973 0.5973 0.5973 
O -0.5679 -0.5679 -0.5679 -0.5679 
SUM 0.0000 0.9757 0.0000 0.9597 
     
C10 0.0540 0.0530 0.0540 0.0372 
N1 -0.3250 -0.3756 -0.3250 -0.3717 
C2 0.5490 0.5652 0.5490 0.5780 
O2 -0.4940 -0.5703 -0.4940 -0.5677 
N3 -0.3840 -0.4192 -0.3840 -0.4344 
HN 0.3050 0.2889 0.3050 0.2957 
C4 0.3730 0.3849 0.3730 0.3772 
O4 -0.5350 -0.6298 -0.5350 -0.6285 
C4A 0.5180 0.3623 0.5180 0.3890 
N5 -0.5500 -0.6804 -0.5500 -0.6963 
C5A 0.3630 0.4407 0.3630 0.4383 
C6 -0.2660 -0.4065 -0.2660 -0.3792 
C7 0.0480 0.0657 0.0480 0.0587 
H 0.1820 0.1574 0.1820 0.1549 
C7M -0.2640 -0.2360 -0.2640 -0.2446 
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HM7 0.0780 0.0498 0.0780 0.0563 
HM7 0.0780 0.0442 0.0780 0.0491 
HM7 0.0780 0.0458 0.0780 0.0398 
C8 0.1860 0.0741 0.1860 0.0753 
C9 -0.3040 -0.3033 -0.3040 -0.2862 
H 0.1770 0.1671 0.1770 0.1669 
C8M -0.2710 -0.2230 -0.2710 -0.2467 
HM8 0.0860 0.0563 0.0860 0.0573 
HM8 0.0860 0.0545 0.0860 0.0615 
HM8 0.0860 0.0507 0.0860 0.0620 
C9A -0.0070 -0.0956 -0.0070 -0.1308 
N10 -0.0990 -0.0886 -0.0990 -0.0509 
C1* -0.0060 0.0190 -0.0060 -0.0248 
H11 0.1040 0.0765 0.1040 0.0960 
H12 0.1040 0.0875 0.1040 0.0875 
C2* 0.2140 0.1732 0.2140 0.1855 
O2* -0.6790 -0.6790 -0.6790 -0.6790 
H2' 0.0400 0.0400 0.0400 0.0400 
HO2 0.4450 0.4450 0.4450 0.4450 
C3* 0.1910 0.1910 0.1910 0.1910 
O3* -0.7890 -0.7890 -0.7890 -0.7890 
H3' 0.0350 0.0350 0.0350 0.0350 
HO3 0.5030 0.5030 0.5030 0.5030 
C4* 0.0100 0.0100 0.0100 0.0100 
O4* -0.7270 -0.7270 -0.7270 -0.7270 
H4' 0.1000 0.1000 0.1000 0.1000 
HO4 0.5180 0.5180 0.5180 0.5180 
C5* 0.3210 0.3210 0.3210 0.3210 
H5' 0.0000 0.0000 0.0000 0.0000 
H5' 0.0000 0.0000 0.0000 0.0000 
O5* -0.6750 -0.6750 -0.6750 -0.6750 
P 1.5650 1.5650 1.5650 1.5650 
O1P -1.0090 -1.0090 -1.0090 -1.0090 
O2P -1.0090 -1.0090 -1.0090 -1.0090 
O3P -1.0090 -1.0090 -1.0090 -1.0090 
SUM -2.0050 -2.9807 -2.0050 -2.9647 
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Figure 1 - Time evolution of the dihedral angle from the first trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 2 - Time evolution of the dihedral angle from the second trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 3 - Time evolution of the dihedral angle from the third trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 4 - Time evolution of the dihedral angle from the fourth trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 5 - Time evolution of the dihedral angle from the fifth trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 6 - Time evolution of the dihedral angle from the sixth trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 7 - Time evolution of the dihedral angle from the seventh trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 8 - Time evolution of the dihedral angle from the eighth trajectory, which characterise the orientation of the Gln63 side chain in the 1YRX (Trp-in 
structure) in the ground state and in the excited state. The X-axis shows the time in ps and Y-axis shows the degree. 
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ES 
 
switch time 
(ps) 
avg distance before 
switching (nm) 
avg distance after 
switching (nm) 
Back switching 
(nm) 
3 1000 55 0.499774 0.669862 
 
4 600 20 0.370991 0.303814 
 
 
700 85 0.306844 0.29752 
 
 
800 5 0.323879 0.302298 
 
5 300 35,65 0.383846 0.327932 0.355653  
900 55 0.389436 0.337309 
 
Table 6 - Average distance between Q63(NE2) and FMN(N5) before and after a switch is 
occurred. 
 
ES 
 
switch time 
(ps) 
avg distance before 
switching (nm) 
avg distance after 
switching (nm) 
Back switching 
(nm) 
3 1000 55 0.303034 0.481254 
 
4 600 20 0.286649 0.313888 
 
 
700 85 0.328016 0.332979 
 
 
800 5 0.297015 0.318334 
 
5 300 35,65 0.294771 0.304491 0.315038  
900 55 0.29051 0.303333 
 
Table 7 - Average distance between Q63(NE2) and FMN(O4) before and after a switch is 
occurred. 
 
ES 
 
switch time 
(ps) 
avg distance before 
switching (nm) 
avg distance after 
switching (nm) 
Back switching 
(nm) 
3 1000 55 0.613805 0.607003 
 
4 600 20 0.408162 0.454528 
 
 
700 85 0.469891 0.411732 
 
 
800 5 0.431713 0.43768 
 
5 300 35,65 0.356078 0.421399 0.331078  
900 55 0.568704 0.429289 
 
Table 8 - Average distance between Q63(NE2) and Y21(OH) before and after a switch is 
occurred. 
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Figure 9 - Time evolution of the dihedral angle from the first trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps and Y-
axis shows the degree. 
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Figure 10 - Time evolution of the dihedral angle from the second trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-
out structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps 
and Y-axis shows the degree. 
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Figure 11 - Time evolution of the dihedral angle from the third trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps and Y-
axis shows the degree. 
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Figure 12 - Time evolution of the dihedral angle from the fourth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps and Y-
axis shows the degree. 
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Figure 13 - Time evolution of the dihedral angle from the fifth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps and Y-
axis shows the degree. 
-40
10
60
110
160
210
260
310
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-NE2(Q63) Excited state
100
200
300
400
500
600
700
800
900
1000
-40
10
60
110
160
210
260
310
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-OE1(Q63) Excited state
100
200
300
400
500
600
700
800
900
1000
0
60
120
180
240
300
360
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-NE2(Q63) Ground state
100
200
300
400
500
600
700
800
900
1000
-180
-120
-60
0
60
120
180
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-OE1(Q63) Ground state
100
200
300
400
500
600
700
800
900
1000
134 
 
  
   
Figure 14 - Time evolution of the dihedral angle from the sixth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps and Y-
axis shows the degree. 
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Figure 15 - Time evolution of the dihedral angle from the seventh trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-
out structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps 
and Y-axis shows the degree. 
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Figure 16 - Time evolution of the dihedral angle from the eighth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of relocated charges (mimicking the excited state). The X-axis shows the time in ps and Y-
axis shows the degree. 
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Figure 17 - Time evolution of the dihedral angle from the first trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 18 - Time evolution of the dihedral angle from the second trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-
out structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 19 - Time evolution of the dihedral angle from the third trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 20 - Time evolution of the dihedral angle from the fourth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 21 - Time evolution of the dihedral angle from the fifth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 22 - Time evolution of the dihedral angle from the sixth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 23 - Time evolution of the dihedral angle from the seventh trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-
out structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
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Figure 24 - Time evolution of the dihedral angle from the eighth trajectory, which characterise the orientation of the Gln63 side chain in the 2IYG (Trp-out 
structure) using the AmberGS charges (ground state) and a set of artificial charges. The X-axis shows the time in ps and Y-axis shows the degree. 
 
-60
0
60
120
180
240
300
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-NE2(Q63) Excited state
100
200
300
400
500
600
700
800
900
1000
-240
-180
-120
-60
0
60
120
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-OE1(Q63) Excited state
100
200
300
400
500
600
700
800
900
1000
-60
0
60
120
180
240
300
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-NE2(Q63) Ground state
100
200
300
400
500
600
700
800
900
1000
-240
-180
-120
-60
0
60
120
0.0 20.0 40.0 60.0 80.0 100.0
CZ(Y21)-CG(Q63)-CD(Q63)-OE1(Q63) Ground state
100
200
300
400
500
600
700
800
900
1000
145 
 
BIBLIOGRAPHY 
1 Stumpfe, D., & Bajorath, J. (2013). Critical assessment of virtual screening for hit 
identification. Chemoinformatics for Drug Discovery, 113-130. 
2 Tanrikulu, Y., Krüger, B., & Proschak, E. (2013). The holistic integration of virtual screening in drug 
discovery. Drug Discovery Today, 18(7), 358-364. 
3 Katara, P. (2013). Role of bioinformatics and pharmacogenomics in drug discovery and development 
process. Network Modeling Analysis in Health Informatics and Bioinformatics, 2(4), 225-230. 
4 Blundell, T. L., Sibanda, B. L., Montalvão, R. W., Brewerton, S., Chelliah, V., Worth, C. L., Harmer, N. J., 
Davies, O. & Burke, D. (2006). Structural biology and bioinformatics in drug design: opportunities and 
challenges for target identification and lead discovery. Philosophical Transactions of the Royal Society 
B: Biological Sciences, 361(1467), 413-423. 
5 Searls, D. B. (2000). Using bioinformatics in gene and drug discovery. Drug Discovery Today, 5(4), 
135-143. 
6 Honore, P., Kage, K., Mikusa, J., Watt, A. T., Johnston, J. F., Wyatt, J. R., Faltynek, C.R., Jarvis, M.F. & 
Lynch, K. (2002). Analgesic profile of intrathecal P2X 3 antisense oligonucleotide treatment in chronic 
inflammatory and neuropathic pain states in rats. Pain, 99(1), 11-19. 
7 Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., 
Richardson, J., Peck, W.L. & Grahames, C. B. (2005). Disruption of the P2X 7 purinoceptor gene 
abolishes chronic inflammatory and neuropathic pain. Pain, 114(3), 386-396. 
8 Zheng, X. S., & Chan, T. F. (2002). Chemical genomics: a systematic approach in biological research 
and drug discovery. Current issues in molecular biology, 4, 33-44. 
9 MacBeath, G. (2001). Chemical genomics: what will it take and who gets to play?. Genome 
biology, 2(6), 1. 
10 Salemme, F. R. (2003). Chemical genomics as an emerging paradigm for postgenomic drug 
discovery. Pharmacogenomics, 4(3), 257-267. 
11 Boppana, K., Dubey, P. K., Jagarlapudi, S. A., Vadivelan, S., & Rambabu, G. (2009). Knowledge based 
identification of MAO-B selective inhibitors using pharmacophore and structure based virtual 
screening models. European journal of medicinal chemistry, 44(9), 3584-3590. 
12 Lionta, E., Spyrou, G., K Vassilatis, D., & Cournia, Z. (2014). Structure-based virtual screening for 
drug discovery: principles, applications and recent advances. Current topics in medicinal 
chemistry, 14(16), 1923-1938. 
13 Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J., & Nadon, R. (2006). Statistical practice in high-
throughput screening data analysis. Nature biotechnology, 24(2), 167-175. 
                                                     
146 
 
                                                                                                                                                                                
14 Sergienko, E. A., & Heynen-Genel, S. (2013). Experimental Approaches to Rapid Identification, 
Profiling, and Characterization of Specific Biological Effects of DOS Compounds. Diversity-Oriented 
Synthesis: Basics and Applications in Organic Synthesis, Drug Discovery, and Chemical Biology, 401-
429. 
15 Keserű, G. M., & Makara, G. M. (2006). Hit discovery and hit-to-lead approaches. Drug discovery 
today, 11(15), 741-748. 
16 Iftekhar, M. & Jameel, S. (2015). Computational Drug Discovery: Drug Discovery Process & 
Methods. Biocuration Labs. 
17 Hughes, J. P., Rees, S., Kalindjian, S. B., & Philpott, K. L. (2011). Principles of early drug 
discovery. British journal of pharmacology, 162(6), 1239-1249. 
18 Fecik, R. A., Frank, K. E., Gentry, E. J., Menon, S. R., Mitscher, L. A., & Telikepalli, H. (1998). The search 
for orally active medications through combinatorial chemistry. Medicinal research reviews, 18(3), 149-
185. 
19 Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999). The design of leadlike combinatorial 
libraries. Angewandte Chemie International Edition, 38(24), 3743-3748. 
20 Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001). Is there a difference between leads and 
drugs? A historical perspective. Journal of chemical information and computer sciences, 41(5), 1308-
1315. 
21 Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999). The design of leadlike combinatorial 
libraries. Angewandte Chemie International Edition, 38(24), 3743-3748. 
22 Grüneberg, S., Stubbs, M. T., & Klebe, G. (2002). Successful virtual screening for novel inhibitors of 
human carbonic anhydrase: strategy and experimental confirmation. Journal of medicinal 
chemistry, 45(17), 3588-3602. 
23 Polgár, T., & M Keseru, G. (2011). Integration of virtual and high throughput screening in lead 
discovery settings. Combinatorial chemistry & high throughput screening, 14(10), 889-897. 
24 Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., Stallings, W. C., Connolly, 
D. T. & Shoichet, B. K. (2002). Molecular docking and high-throughput screening for novel inhibitors of 
protein tyrosine phosphatase-1B. Journal of medicinal chemistry, 45(11), 2213-2221. 
25 Holliday, J. D., Kanoulas, E., Malim, N., & Willett, P. (2011). Multiple search methods for similarity-
based virtual screening: analysis of search overlap and precision. Journal of cheminformatics, 3(1), 1. 
26 Jenkins, J. L., Kao, R. Y., & Shapiro, R. (2003). Virtual screening to enrich hit lists from high-
throughput screening: A case study on small-molecule inhibitors of angiogenin. Proteins: Structure, 
Function, and Bioinformatics, 50(1), 81-93. 
147 
 
                                                                                                                                                                                
27 Betzi, S., Restouin, A., Opi, S., Arold, S. T., Parrot, I., Guerlesquin, F., Morelli, X. & Collette, Y. (2007). 
Protein–protein interaction inhibition (2P2I) combining high throughput and virtual screening: 
application to the HIV-1 Nef protein. Proceedings of the National Academy of Sciences, 104(49), 
19256-19261. 
28 Danishuddin, M., & Khan, A. U. (2015). Structure based virtual screening to discover putative drug 
candidates: necessary considerations and successful case studies. Methods, 71, 135-145. 
29 Johnson, M. A., & Maggiora, G. M. (1990). Concepts and applications of molecular similarity. Wiley. 
30 Martin, Y. C., Kofron, J. L., & Traphagen, L. M. (2002). Do structurally similar molecules have similar 
biological activity?. Journal of medicinal chemistry, 45(19), 4350-4358. 
31 Barratt, M. J., & Frail, D. E. (2012). Drug repositioning: Bringing new life to shelved assets and 
existing drugs. John Wiley & Sons. 
32 Chen, Y., & Shoichet, B. K. (2009). Molecular docking and ligand specificity in fragment-based 
inhibitor discovery. Nature chemical biology, 5(5), 358-364. 
33 Boehm, M. (2011). Virtual Screening of Chemical Space: From Generic Compound Collections to 
Tailored Screening Libraries. Virtual Screening: Principles, Challenges, and Practical Guidelines, 1-33. 
34 Leach, A. R., & Gillet, V. J. (2007). An introduction to chemoinformatics. Springer Science & Business 
Media. 
35 Mannhold, R., & Folkers, G. (2006). Chemogenomics in Drug Discovery: A Medicinal Chemistry 
Perspective (Vol. 22). H. Kubinyi, & G. Müller (Eds.). John Wiley & Sons. 
36 Maggiora, G. M. (2006). On outliers and activity cliffs why QSAR often disappoints. Journal of 
chemical information and modeling, 46(4), 1535-1535. 
37 Rankovic, Z., & Morphy, R. (Eds.). (2010). Lead generation approaches in drug discovery. John 
Wiley & Sons. 
38 Méndez-Lucio, O., Kooistra, A. J., Graaf, C. D., Bender, A., & Medina-Franco, J. L. (2015). Analyzing 
Multitarget Activity Landscapes Using Protein–Ligand Interaction Fingerprints: Interaction 
Cliffs. Journal of chemical information and modeling, 55(2), 251-262. 
39 Furtmann, N., Hu, Y., Gütschow, M., & Bajorath, J. (2015). Identification of Interaction Hot Spots in 
Structures of Drug Targets on the Basis of Three-Dimensional Activity Cliff Information. Chemical 
biology & drug design, 86(6), 1458-1465. 
40 Medina-Franco, J. (Ed.). (2016). Epi-Informatics: discovery and development of small molecule 
epigenetic drugs and probes. Academic Press. 
41 Varnek, A., & Tropsha, A. (2008). Chemoinformatics approaches to virtual screening. Royal Society 
148 
 
                                                                                                                                                                                
of Chemistry. 
42 Roy, K., Kar, S., & Das, R. N. (2015). Understanding the basics of QSAR for applications in 
pharmaceutical sciences and risk assessment. Academic press. 
43 Cross, A. F. A. (1863). Action de l'alcool amylique sur l'organisme (Doctoral dissertation). Faculty of 
Medicine, University of Strasbourg. 
44 Brown, A. C., & Fraser, T. R. (1868). On the connection between chemical constitution and 
physiological action; with special reference to the physiological action of the salts of the ammonium 
bases derived from strychnia, brucia, thebaia, codeia, morphia, and nicotia. Journal of anatomy and 
physiology, 2(2), 224-242. 
45 Richardson, B. W. (1869). On Bichloride of Methylene. British medical journal, 2(462), 487. 
46 Meyer, H. (1899). Zur theorie der alkoholnarkose. Naunyn-Schmiedeberg's Archives of 
Pharmacology, 42(2), 109-118. 
47 Overton, E. (1901). Studien uber die Narkose: zugleich ein Beitrag zur allgemeinen Pharmakologie. 
Gustav Fischer. 
48 Trabe, J. (1904). Theorie der osmose und narkose. Pflügers Archiv European Journal of 
Physiology, 105(11), 541-558. 
49 Seidell, A. (1912). A new bromine method for the determination of thymol, salicylates, and similar 
compounds. Am Chem J, 47, 508-526. 
50 Hansch, C., Maloney, P. P., Fujita, T., & Muir, R. M. (1962). Correlation of biological activity of 
phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature, 
194(4824),178-180 
51 Varnek, A., & Tropsha, A. (2008). Chemoinformatics approaches to virtual screening. Royal Society 
of Chemistry. 
52 Cherkasov, A., Muratov, EN., Fourches, D., Varnek, A., Baskin, II., Cronin, M., Dearden, J., Gramatica, P., 
Martin, YC., Todeschini, R., Consonni, V., Kuz'Min, VE., Cramer, R., Benigni, R., Yang, C., Rathman, J., 
Terfloth, L., Gasteiger, J., Richard, A., & Tropsha, A. (2014). QSAR modeling: where have you been? 
Where are you going to?. Journal of medicinal chemistry, 57(12), 4977-5010. 
53 Mitchell, J. B. (2014). Machine learning methods in chemoinformatics. Wiley Interdisciplinary 
Reviews: Computational Molecular Science, 4(5), 468-481. 
54 Lipinski, C., & Hopkins, A. (2004). Navigating chemical space for biology and 
medicine. Nature, 432(7019), 855-861. 
55 Weininger, D. (1988). SMILES, a chemical language and information system. 1. Introduction to 
methodology and encoding rules. Journal of chemical information and computer sciences, 28(1), 31-
149 
 
                                                                                                                                                                                
36. 
56 Hinselmann, G., Jahn, A., Fechner, N., & Zell, A. (2009, April). Chronic Rat Toxicity Prediction of 
Chemical Compounds Using Kernel Machines. In European Conference on Evolutionary Computation, 
Machine Learning and Data Mining in Bioinformatics (pp. 25-36). Springer Berlin Heidelberg. 
57 Tauler, R., Walczak, B., & Brown, S. D. (2009). Comprehensive chemometrics: chemical and 
biochemical data analysis. Elsevier. 
58 Kotsiantis, S. B., Zaharakis, I. D., & Pintelas, P. E. (2006). Machine learning: a review of classification 
and combining techniques. Artificial Intelligence Review, 26(3), 159-190. 
59 Kouiroukidis, N., & Evangelidis, G. (2011, September). The effects of dimensionality curse in high 
dimensional knn search. In Informatics (PCI), 2011 15th Panhellenic Conference on (pp. 41-45). IEEE. 
60 Ali, A., Shamsuddin, S. M., & Ralescu, A. L. (2015). Classification with class imbalance problem: A 
Review. Int. J. Advance Soft Compu. Appl, 7(3). 
61 Bastos, J. (2008). Credit scoring with boosted decision trees. Munich Personal RePEc Archive - 
MPRA, 8156, 2-4 
62 Quinlan, J. R. (1979). Discovering rules by induction from large collections of examples (pp. 168-
201). Expert systems in the micro electronic age. Edinburgh University Press. 
63 Quinlan, J. R. (1993). C4. 5: Programming for machine learning. Morgan Kauffmann, 38. 
64 Breiman, L., Friedman, J., Stone, C. J., & Olshen, R. A. (1984). Classification and regression trees. CRC 
press. 
65 Breiman, L. (1996). Bagging predictors. Machine learning, 24(2), 123-140. 
66 Freund, Y., & Schapire, R. E. (1996, July). Experiments with a new boosting algorithm. In Icml (Vol. 
96, pp. 148-156). 
67 Berzal, F., Cubero, J. C., Cuenca, F., & Martı́n-Bautista, M. J. (2003). On the quest for easy-to-
understand splitting rules. Data & Knowledge Engineering, 44(1), 31-48. 
68 Maglogiannis, I. G. (2007). Emerging artificial intelligence applications in computer engineering: 
real word AI systems with applications in eHealth, HCI, information retrieval and pervasive 
technologies (Vol. 160). Ios Press. 
69 Coppin, B. (2004). Artificial intelligence illuminated. Jones & Bartlett Learning. 
70 Wolpert, D. H. (1996). The lack of a priori distinctions between learning algorithms. Neural 
computation, 8(7), 1341-1390. 
71 Domingos, P. (2012). A few useful things to know about machine learning. Communications of the 
150 
 
                                                                                                                                                                                
ACM, 55(10), 78-87. 
72 Breiman, L. (2001). Random forests. Machine learning, 45(1), 5-32. 
73 Raileanu, L. E., & Stoffel, K. (2004). Theoretical comparison between the gini index and information 
gain criteria. Annals of Mathematics and Artificial Intelligence, 41(1), 77-93. 
74 Venkatesan, P., & Yamuna, N. R. (2013). Treatment response classification in randomized clinical 
trials: a decision tree approach. Indian Journal of Science and Technology, 6(1), 3912-3917. 
75 Cortes, C., & Vapnik, V. (1995). Support-vector networks. Machine learning, 20(3), 273-297. 
76 Beyer, K., Goldstein, J., Ramakrishnan, R., & Shaft, U. (1999). When is “nearest neighbor” 
meaningful?. In International conference on database theory, 217-235. Springer Berlin Heidelberg. 
77 Lewis, D. D. (1998). Naive (Bayes) at forty: The independence assumption in information retrieval. 
In European conference on machine learning, 4-15. Springer Berlin Heidelberg. 
78 Ko, G. M., Reddy, A. S., Kumar, S., & Garg, R. Data Mining Analysis of HIV-1 Protease Crystal 
Structures. 
79 Palmer, D. S., O'Boyle, N. M., Glen, R. C., & Mitchell, J. B. (2007). Random forest models to predict 
aqueous solubility. Journal of chemical information and modeling, 47(1), 150-158. 
80 Ballester, P. J., & Mitchell, J. B. (2010). A machine learning approach to predicting protein–ligand 
binding affinity with applications to molecular docking. Bioinformatics, 26(9), 1169-1175. 
81 Springer, C., Adalsteinsson, H., Young, M. M., Kegelmeyer, P. W., & Roe, D. C. (2005). PostDOCK: a 
structural, empirical approach to scoring protein ligand complexes. Journal of medicinal 
chemistry, 48(22), 6821-6831. 
82 Zilian, D., & Sotriffer, C. A. (2013). SFCscore RF: a random forest-based scoring function for 
improved affinity prediction of protein–ligand complexes. Journal of chemical information and 
modeling, 53(8), 1923-1933. 
83 Kalyaanamoorthy, S., & Chen, Y. P. P. (2011). Structure-based drug design to augment hit 
discovery. Drug discovery today, 16(17), 831-839. 
84 Kalman, M., & Ben-Tal, N. (2010). Quality assessment of protein model-structures using 
evolutionary conservation. Bioinformatics, 26(10), 1299-1307. 
85 Engle, J. M., Lakshminarayanan, P. S., Carroll, C. N., Zakharov, L. N., Haley, M. M., & Johnson, D. W. 
(2011). Molecular Self-Assembly: Solvent Guests Tune the Conformation of a Series of 2, 6-Bis (2-
anilinoethynyl) pyridine-Based Ureas. Crystal growth & design, 11(11), 5144-5152. 
86 Zhang, Y., & Skolnick, J. (2004). Automated structure prediction of weakly homologous proteins on 
a genomic scale. Proceedings of the National Academy of Sciences of the United States of 
151 
 
                                                                                                                                                                                
America, 101(20), 7594-7599. 
87 Antunes, D. A., Devaurs, D., & Kavraki, L. E. (2015). Understanding the challenges of protein 
flexibility in drug design. Expert opinion on drug discovery, 10(12), 1301-1313. 
88 Koshland, D. E. (1958). Application of a theory of enzyme specificity to protein 
synthesis. Proceedings of the National Academy of Sciences, 44(2), 98-104. 
89 Burgen, A. S. (1981, November). Conformational changes and drug action. In Federation 
proceedings (Vol. 40, No. 13, p. 2723). 
90 Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to 
macromolecule-ligand interactions. Journal of molecular biology, 161(2), 269-288. 
91 DesJarlais, R. L., Sheridan, R. P., Dixon, J. S., Kuntz, I. D., & Venkataraghavan, R. (1986). Docking 
flexible ligands to macromolecular receptors by molecular shape. Journal of medicinal 
chemistry, 29(11), 2149-2153. 
92 Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual 
screening for drug discovery: methods and applications. Nature reviews Drug discovery, 3(11), 935-
949. 
93 Totrov, M., & Abagyan, R. (2008). Flexible ligand docking to multiple receptor conformations: a 
practical alternative. Current opinion in structural biology, 18(2), 178-184. 
94 Teodoro, M. L., & Kavraki, L. E. (2003). Conformational flexibility models for the receptor in 
structure based drug design. Current pharmaceutical design, 9(20), 1635-1648. 
95 Meiler, J., & Baker, D. (2006). ROSETTALIGAND: Protein–small molecule docking with full side-
chain flexibility. Proteins: Structure, Function, and Bioinformatics, 65(3), 538-548. 
96 Lin, J. H., Perryman, A. L., Schames, J. R., & McCammon, J. A. (2002). Computational drug design 
accommodating receptor flexibility: the relaxed complex scheme. Journal of the American Chemical 
Society, 124(20), 5632-5633. 
97 Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996). Discovering high-affinity ligands for 
proteins: SAR by NMR. Science, 274(5292), 1531. 
98 Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. 
(2000). Site-directed ligand discovery. Proceedings of the National Academy of Sciences, 97(17), 9367-
9372. 
99 Barakat, K., & Tuszynski, J. (2011). Relaxed complex scheme suggests novel inhibitors for the lyase 
activity of DNA polymerase beta. Journal of Molecular Graphics and Modelling, 29(5), 702-716. 
100 Barakat, K., & Tuszynski, J. (2011). Relaxed complex scheme suggests novel inhibitors for the 
lyase activity of DNA polymerase beta. Journal of Molecular Graphics and Modelling, 29(5), 702-716. 
152 
 
                                                                                                                                                                                
101 Lin, J. H., Perryman, A. L., Schames, J. R., & McCammon, J. A. (2002). Computational drug design 
accommodating receptor flexibility: the relaxed complex scheme. Journal of the American Chemical 
Society, 124(20), 5632-5633. 
102 Amaro, R. E., Baron, R., & McCammon, J. A. (2008). An improved relaxed complex scheme for 
receptor flexibility in computer-aided drug design. Journal of computer-aided molecular design, 22(9), 
693-705. 
103 Machado, K. S., Winck, A. T., Ruiz, D. D., & de Souza, O. N. (2010). Mining flexible-receptor docking 
experiments to select promising protein receptor snapshots. BMC genomics, 11(5), 1. 
104 Holland, J. H. (1975). Adaptation in natural and artificial systems: an introductory analysis with 
applications to biology, control, and artificial intelligence. U Michigan Press. 
105 Maillot, P. G., & Glassner, A. S. (1990). Graphics gems. Academic Press, London, 498. 
106 Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). 
Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy 
function. Journal of computational chemistry, 19(14), 1639-1662. 
107 Solis, F. J., & Wets, R. J. B. (1981). Minimization by random search techniques. Mathematics of 
operations research, 6(1), 19-30. 
108 Pattabiraman, N., Levitt, M., Ferrin, T. E., & Langridge, R. (1985). Computer graphics in real-time 
docking with energy calculation and minimization. Journal of computational chemistry, 6(5), 432-436. 
109 Goodford, P. J. (1985). A computational procedure for determining energetically favorable binding 
sites on biologically important macromolecules. Journal of medicinal chemistry, 28(7), 849-857. 
110 Morris, G. M., Goodsell, D. S., Huey, R., Hart, W. E., Halliday, S., Belew, R., & Olson, A. J. (2001). 
Automated Docking of Flexible Ligands to Receptors, User’s Guide. 
111 Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ghio, C., Alagona, G., Profeta, S. & Weiner, P. 
(1984). A new force field for molecular mechanical simulation of nucleic acids and proteins. Journal of 
the American Chemical Society, 106(3), 765-784. 
112 Morris, G. M., Goodsell, D. S., Huey, R., & Olson, A. J. (1996). Distributed automated docking of 
flexible ligands to proteins: parallel applications of AutoDock 2.4. Journal of computer-aided molecular 
design, 10(4), 293-304. 
113 Huey, R., Morris, G. M., Olson, A. J., & Goodsell, D. S. (2007). A semiempirical free energy force field 
with charge-based desolvation. Journal of computational chemistry, 28(6), 1145-1152. 
114 Wesson, L., & Eisenberg, D. (1992). Atomic solvation parameters applied to molecular dynamics of 
proteins in solution. Protein Science, 1(2), 227-235. 
153 
 
                                                                                                                                                                                
115 Stouten, P. F., Frömmel, C., Nakamura, H., & Sander, C. (1993). An effective solvation term based on 
atomic occupancies for use in protein simulations. Molecular Simulation, 10(2-6), 97-120. 
116 Courant, R. (1943). Variational methods for the solution of problems of equilibrium and 
vibrations. Bull. Amer. Math. Soc, 49(1), 1-23. 
117 Swope, W. C., Andersen, H. C., Berens, P. H., & Wilson, K. R. (1982). A computer simulation method 
for the calculation of equilibrium constants for the formation of physical clusters of molecules: 
Application to small water clusters. The Journal of Chemical Physics, 76(1), 637-649. 
118 Hockney, R. W., Goel, S. P., & Eastwood, J. W. (1974). Quiet high-resolution computer models of a 
plasma. Journal of Computational Physics, 14(2), 148-158. 
119 Hess, B. (2008). P-LINCS: A parallel linear constraint solver for molecular simulation. Journal of 
Chemical Theory and Computation, 4(1), 116-122. 
120 del Sol, A., Tsai, C. J., Ma, B., & Nussinov, R. (2009). The origin of allosteric functional modulation: 
multiple pre-existing pathways. Structure, 17(8), 1042-1050. 
121 Monod, J., Wyman, J., & Changeux, J. P. (1965). On the nature of allosteric transitions: a plausible 
model. Journal of molecular biology, 12(1), 88-118. 
122 Koshland Jr, D. E., Nemethy, G., & Filmer, D. (1966). Comparison of experimental binding data and 
theoretical models in proteins containing subunits*. Biochemistry, 5(1), 365-385. 
123 Tsai, C. J., Del Sol, A., & Nussinov, R. (2009). Protein allostery, signal transmission and dynamics: a 
classification scheme of allosteric mechanisms. Molecular Biosystems, 5(3), 207-216. 
124 Laskowski, R. A., Gerick, F., & Thornton, J. M. (2009). The structural basis of allosteric regulation 
in proteins. FEBS letters, 583(11), 1692-1698. 
125 Lu, S., Li, S., & Zhang, J. (2014). Harnessing allostery: a novel approach to drug 
discovery. Medicinal research reviews, 34(6), 1242-1285. 
126 Boehr, D. D., McElheny, D., Dyson, H. J., & Wright, P. E. (2006). The dynamic energy landscape of 
dihydrofolate reductase catalysis. science, 313(5793), 1638-1642. 
127 Malmendal, A., Evenäs, J., Forsén, S., & Akke, M. (1999). Structural dynamics in the C-terminal 
domain of calmodulin at low calcium levels. Journal of molecular biology, 293(4), 883-899. 
128 Volkman, B. F., Lipson, D., Wemmer, D. E., & Kern, D. (2001). Two-state allosteric behavior in a 
single-domain signaling protein. Science, 291(5512), 2429-2433. 
129 Kumar, S., Ma, B., Tsai, C. J., Sinha, N., & Nussinov, R. (2000). Folding and binding cascades: 
dynamic landscapes and population shifts. Protein Science, 9(1), 10-19. 
154 
 
                                                                                                                                                                                
130 Tsai, C. J., Ma, B., & Nussinov, R. (1999). Folding and binding cascades: shifts in energy 
landscapes. Proceedings of the National Academy of Sciences, 96(18), 9970-9972. 
131 Panjkovich, A., & Daura, X. (2012). Exploiting protein flexibility to predict the location of allosteric 
sites. BMC bioinformatics, 13(1), 273. 
132 Lockless, S. W., & Ranganathan, R. (1999). Evolutionarily conserved pathways of energetic 
connectivity in protein families. Science, 286(5438), 295-299. 
133 Lu, S., Huang, W., & Zhang, J. (2014). Recent computational advances in the identification of 
allosteric sites in proteins. Drug discovery today, 19(10), 1595-1600.   
134 Novinec, M., Korenč, M., Caflisch, A., Ranganathan, R., Lenarčič, B., & Baici, A. (2014). A novel 
allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational 
methods. Nature communications, 5, 3287. 
135 Panjkovich, A., & Daura, X. (2014). PARS: a web server for the prediction of protein allosteric and 
regulatory sites. Bioinformatics, 30(9), 1314-1315. 
136 Huang, W., Lu, S., Huang, Z., Liu, X., Mou, L., Luo, Y., Zhao Y, Liu Y, Chen Z, Hou T, & Zhang, J. (2013). 
Allosite: a method for predicting allosteric sites. Bioinformatics, 29(18), 2357-2359. 
137 van Westen, G. J., Gaulton, A., & Overington, J. P. (2014). Chemical, target, and bioactive properties 
of allosteric modulation. PLoS Comput Biol, 10(4), e1003559. 
138 Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F.A., Light, Y., Mak, 
L., McGlinchey, S. & Nowotka, M. (2014). The ChEMBL bioactivity database: an update. Nucleic acids 
research, 42(D1), D1083-D1090. 
139 Greener, J. G., & Sternberg, M. J. (2015). AlloPred: prediction of allosteric pockets on proteins 
using normal mode perturbation analysis. BMC bioinformatics, 16(1), 335. 
140 Demerdash, O. N., Daily, M. D., & Mitchell, J. C. (2009). Structure-based predictive models for 
allosteric hot spots. PLoS Comput Biol, 5(10), e1000531. 
141 Erman, B. (2011). Relationships between ligand binding sites, protein architecture and correlated 
paths of energy and conformational fluctuations. Physical biology, 8(5), 056003. 
142 Kaya, C., Armutlulu, A., Ekesan, S., & Haliloglu, T. (2013). MCPath: Monte Carlo path generation 
approach to predict likely allosteric pathways and functional residues. Nucleic acids research, 41(W1), 
W249-W255. 
143 Hardy, J. A., & Wells, J. A. (2004). Searching for new allosteric sites in enzymes. Current opinion in 
structural biology, 14(6), 706-715. 
144 Long, D., & Yang, D. (2009). Buffer interference with protein dynamics: a case study on human 
155 
 
                                                                                                                                                                                
liver fatty acid binding protein. Biophysical journal, 96(4), 1482-1488. 
145 Paul Brear, PhD Thesis, University of St Andrews 2012 
146 Ballester, P. J., & Mitchell, J. B. (2010). A machine learning approach to predicting protein–ligand 
binding affinity with applications to molecular docking. Bioinformatics, 26(9), 1169-1175. 
147 Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003). Random 
forest: a classification and regression tool for compound classification and QSAR modeling. Journal of 
chemical information and computer sciences, 43(6), 1947-1958. 
148 Huang, Z., Zhu, L., Cao, Y., Wu, G., Liu, X., Chen, Y., Wang, Q., Shi, T., Zhao, Y., Wang, Y. & Li, W. (2011). 
ASD: a comprehensive database of allosteric proteins and modulators. Nucleic acids research, 39(suppl 
1), D663-D669. 
149 Laskowski, R. A. (2001). PDBsum: summaries and analyses of PDB structures. Nucleic acids 
research, 29(1), 221-222. 
150 Wang, R., Fang, X., Lu, Y., Yang, C. Y., & Wang, S. (2005). The PDBbind database: methodologies and 
updates. Journal of medicinal chemistry, 48(12), 4111-4119. 
151 Cheng, T., Li, X., Li, Y., Liu, Z., & Wang, R. (2009). Comparative assessment of scoring functions on a 
diverse test set. Journal of chemical information and modeling, 49(4), 1079-1093. 
152 Cuff, A. L., Sillitoe, I., Lewis, T., Redfern, O. C., Garratt, R., Thornton, J., & Orengo, C. A. (2009). The 
CATH classification revisited—architectures reviewed and new ways to characterize structural 
divergence in superfamilies. Nucleic acids research, 37(suppl 1), D310-D314. 
153 Xu, G., Potter, J. A., Russell, R. J., Oggioni, M. R., Andrew, P. W., & Taylor, G. L. (2008). Crystal 
structure of the NanB sialidase from Streptococcus pneumoniae. Journal of molecular biology, 384(2), 
436-449.  
154 Liaw, A., & Wiener, M. (2002). Classification and regression by randomForest. R news, 2(3), 18-22. 
155 Team, R. C. (2013). R: A language and environment for statistical computing. 
156 Bondi, A. (1964). van der Waals volumes and radii. The Journal of physical chemistry, 68(3), 441-
451. 
157 Kirtay, C. K., Mitchell, J. B., & Lumley, J. A. (2005). Knowledge based potentials: The reverse 
Boltzmann methodology, virtual screening and molecular weight dependence. QSAR & Combinatorial 
Science, 24(4), 527-536. 
158 Cheng, T., Li, X., Li, Y., Liu, Z., & Wang, R. (2009). Comparative assessment of scoring functions on a 
diverse test set. Journal of chemical information and modeling, 49(4), 1079-1093. 
159 Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A. (1999). The maximal affinity of 
156 
 
                                                                                                                                                                                
ligands. Proceedings of the National Academy of Sciences, 96(18), 9997-10002. 
160 Steinbeck, C., Han, Y., Kuhn, S., Horlacher, O., Luttmann, E., & Willighagen, E. (2003). The 
Chemistry Development Kit (CDK): An open-source Java library for chemo-and bioinformatics. Journal 
of chemical information and computer sciences, 43(2), 493-500. 
161 Svetnik, V., Liaw, A., Tong, C., & Wang, T. (2004, June). Application of Breiman’s random forest to 
modeling structure-activity relationships of pharmaceutical molecules. In International Workshop on 
Multiple Classifier Systems (pp. 334-343). Springer Berlin Heidelberg. 
162 Chiu, H. J., Bakolitsa, C., Skerra, A., Lomize, A., Carlton, D., Miller, M. D., Krishna, S.S., Abdubek, P., 
Astakhova, T., Axelrod, H.L. & Clayton, T. (2010). Structure of the first representative of Pfam family 
PF09410 (DUF2006) reveals a structural signature of the calycin superfamily that suggests a role in 
lipid metabolism. Acta Crystallographica Section F: Structural Biology and Crystallization 
Communications, 66(10), 1153-1159. 
163 Sancar, F., & Czajkowski, C. (2011). Allosteric modulators induce distinct movements at the GABA-
binding site interface of the GABA-A receptor. Neuropharmacology, 60(2), 520-528. 
164 Stanger, K., Steffek, M., Zhou, L., Pozniak, C. D., Quan, C., Franke, Y., Tom, J., Tam, C., Krylova, I., 
Elliott, J.M. & Lewcock, J. W. (2012). Allosteric peptides bind a caspase zymogen and mediate caspase 
tetramerization. Nature chemical biology, 8(7), 655-660. 
165 Wang, Y., & Patel, D. J. (1993). Solution structure of the human telomeric repeat d [AG3(T2AG3)3] 
G-tetraplex. Structure, 1(4), 263-282. 
166 Hud, N. V., Smith, F. W., Anet, F. A., & Feigon, J. (1996). The selectivity for K+ versus Na+ in DNA 
quadruplexes is dominated by relative free energies of hydration: a thermodynamic analysis by 1H 
NMR. Biochemistry, 35(48), 15383-15390. 
167 Armas, P., Nasif, S., & Calcaterra, N. B. (2008). Cellular nucleic acid binding protein binds G-rich 
single-stranded nucleic acids and may function as a nucleic acid chaperone. Journal of cellular 
biochemistry, 103(3), 1013-1036. 
168 Bang, I. (1910). Untersuchungen über die Guanylsäure. Biochemische Zeitschrift, 26, 293-311. 
169 Gellert, M., Lipsett, M. N., & Davies, D. R. (1962). Helix formation by guanylic acid. Proceedings of 
the National Academy of Sciences, 48(12), 2013-2018. 
170 Williamson, J. R., Raghuraman, M. K., & Cech, T. R. (1989). Monovalent cation-induced structure of 
telomeric DNA: the G-quartet model. Cell, 59(5), 871-880. 
171 Burge, S., Parkinson, G. N., Hazel, P., Todd, A. K., & Neidle, S. (2006). Quadruplex DNA: sequence, 
topology and structure. Nucleic acids research, 34(19), 5402-5415. 
172 Balagurumoorthy, P., & Brahmachari, S. K. (1994). Structure and stability of human telomeric 
sequence. Journal of Biological Chemistry, 269(34), 21858-21869. 
173 Luedtke, N. W. (2009). Targeting G-quadruplex DNA with small molecules.CHIMIA International 
157 
 
                                                                                                                                                                                
Journal for Chemistry, 63(3), 134-139. 
174 Kim, M. Y., Gleason-Guzman, M., Izbicka, E., Nishioka, D., & Hurley, L. H. (2003). The different 
biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with 
intramolecular or intermolecular G-quadruplex structures. Cancer research, 63(12), 3247-3256. 
175 Liu, Z., & Gilbert, W. (1994). The yeast KEM1 gene encodes a nuclease specific for G4 tetraplex 
DNA: implication of in vivo functions for this novel DNA structure. Cell, 77(7), 1083-1092. 
176 Sun, H., Yabuki, A., & Maizels, N. (2001). A human nuclease specific for G4 DNA. Proceedings of the 
National Academy of Sciences, 98(22), 12444-12449. 
177 Oganesian, L., & Bryan, T. M. (2007). Physiological relevance of telomeric G-quadruplex formation: 
a potential drug target. Bioessays, 29(2), 155-165. 
178 Ren, J., & Chaires, J. B. (1999). Sequence and structural selectivity of nucleic acid binding 
ligands. Biochemistry, 38(49), 16067-16075. 
179 Reed, J., Gunaratnam, M., Beltran, M., Reszka, A. P., Vilar, R., & Neidle, S. (2008). TRAP–LIG, a 
modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small 
molecules. Analytical biochemistry, 380(1), 99-105. 
180 Nicoludis, J. M., Barrett, S. P., Mergny, J. L., & Yatsunyk, L. A. (2012). Interaction of human telomeric 
DNA with N-methyl mesoporphyrin IX. Nucleic acids research, 40(12), 5432-5447. 
181 Monchaud, D., Granzhan, A., Saettel, N., Guédin, A., Mergny, J. L., & Teulade-Fichou, M. P. (2010). 
“One Ring to Bind Them All” - Part I: The Efficiency of the Macrocyclic Scaffold for G-Quadruplex DNA 
Recognition. Journal of nucleic acids, 2010, 1-19 
182 Siddiqui-Jain, A., Grand, C. L., Bearss, D. J., & Hurley, L. H. (2002). Direct evidence for a G-
quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC 
transcription. Proceedings of the National Academy of Sciences, 99(18), 11593-11598. 
183 Palumbo, S. L., Memmott, R. M., Uribe, D. J., Krotova-Khan, Y., Hurley, L. H., & Ebbinghaus, S. W. 
(2008). A novel G-quadruplex-forming GGA repeat region in the c-myb promoter is a critical regulator 
of promoter activity. Nucleic acids research, 36(6), 1755-1769. 
184 Gomez, D., O'Donohue, M. F., Wenner, T., Douarre, C., Macadré, J., Koebel, P., Giraud-Panis, M.J., 
Kaplan, H., Kolkes, A., Shin-ya, K. & Riou, J. F. (2006). The G-quadruplex ligand telomestatin inhibits 
POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in 
human cells. Cancer Research, 66(14), 6908-6912. 
185 Patel, D. J., Phan, A. T., & Kuryavyi, V. (2007). Human telomere, oncogenic promoter and 5′-UTR G-
quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic acids 
research, 35(22), 7429-7455. 
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